NC_045512	AA	Alignment	FJ647223	JX504050	NC_038294	Genome	NC_004718	FJ647218	MN996527	NC_028806	AY714217	KF367457	NC_038861	NC_002306	MG772934	AY463059	Variant	Annotation	Impact	Reference
1	M	8	2	0	5	21563	1	2	1	7	1	2	4	8	2	1	no	Signal Peptide ; 		
2	F	9	3	0	6	21566	2	3	2	8	2	3	5	9	3	2	no	Signal Peptide ; 		
3	V	11	5	3	7	21569	3	4	3	9	3	4	6	10	4	3	no	Signal Peptide ; 		
4	F	12	6	4	8	21572	4	5	4	10	4	5	7	11	5	4	no	Signal Peptide ; 		
5	L	13	7	5	9	21575	5	6	5	11	5	6	8	12	6	5	no	"Signal Peptide, L5F observed in at least two continents with 20 <1% frequency [1] ; "		[1](10.1101/2020.05.21.108563) ; 
6	V	14	8	6	10	21578	6	7	6	12	6	7	9	13	7	6	no	Signal Peptide ; 		
7	L	15	9	7	11	21581	7	8	7	13	7	8	10	14	8	7	no	Signal Peptide ; 		
8	L	16	10	8	12	21584	8	9	8	14	8	9	11	15	9	8	no	Signal Peptide ; 		
9	P	17	11	0	13	21587	9	10	9	15	9	10	12	16	10	9	no	Signal Peptide ; 		
10	L	18	12	9	14	21590	10	11	10	16	10	11	13	17	11	10	no	Signal Peptide ; 		
11	V	19	13	10	15	21593	11	12	11	17	11	12	14	18	12	11	no	Signal Peptide ; 		
12	S	20	14	11	16	21596	12	13	12	18	12	13	15	19	13	12	no	Signal Peptide ; 		
13	S	21	15	12	17	21599	13	14	13	19	13	14	16	20	14	13	no	Signal Peptide ; 		
14	Q	33	21	18	29	21602	18	20	14	25	18	19	20	24	15	18	no	S1; 		
15	C	34	22	19	30	21605	19	21	15	26	19	20	21	25	16	19	no	S1; 		
16	V	35	23	0	31	21608	20	22	16	0	20	21	22	26	0	20	no	S1; 		
17	N	36	24	0	32	21611	21	23	17	0	21	22	23	27	17	21	no	S1; 		
18	L	37	25	0	33	21614	22	24	18	0	22	23	24	28	18	22	no	S1; 		
19	T	38	26	0	34	21617	23	25	19	0	23	24	25	29	19	23	no	S1; 		
20	T	39	27	0	35	21620	24	26	20	0	24	25	26	30	20	24	no	S1; 		
21	R	40	28	0	36	21623	25	27	21	0	25	26	27	31	21	25	no	S1; 		
22	T	41	29	0	37	21626	26	28	22	0	26	27	28	32	22	26	no	S1; 		
23	Q	42	30	0	38	21629	0	29	23	0	0	0	0	0	23	0	no	S1; 		
24	L	43	31	0	39	21632	0	30	24	0	0	0	0	0	24	0	no	S1; 		
25	P	48	35	0	44	21635	27	34	25	0	27	28	0	0	25	27	no	S1; 		
26	P	49	36	0	45	21638	28	35	26	0	28	29	0	0	26	28	no	S1; 		
27	A	50	37	0	46	21641	29	36	27	0	29	30	0	0	27	29	no	S1; 		
28	Y	51	38	0	47	21644	30	37	28	0	30	31	0	0	28	30	no	S1; 		
29	T	57	44	20	49	21647	33	43	29	27	33	34	30	34	29	33	no	S1; 		
30	N	58	45	21	50	21650	34	44	30	28	34	35	31	35	30	34	no	S1; Direct Contact (DC) with human ACE2 [1] 		[1]( 10.1101/2020.05.01.072371) ; 
31	S	59	46	22	51	21653	35	45	31	29	35	36	32	36	31	35	no	S1; Direct Contact (DC) with human ACE2 [1] ; Hotspot :  key interaction site with ACE2 [1]		[1]( 10.1101/2020.05.01.072371) ; 
32	F	60	47	23	52	21656	36	46	32	30	36	37	33	37	32	36	no	S1; 		
33	T	61	48	24	53	21659	37	47	33	31	37	38	34	38	33	37	no	S1; 		
34	R	62	49	25	54	21662	38	48	34	32	38	39	35	39	34	38	no	S1; 		
35	G	63	50	26	55	21665	39	49	35	33	39	40	36	40	35	39	no	S1; 		
36	V	64	51	27	56	21668	40	50	36	34	40	41	37	41	36	40	no	S1; 		
37	Y	65	52	28	57	21671	41	51	37	35	41	42	38	42	37	41	no	S1; 		
38	Y	66	53	0	58	21674	42	52	38	36	42	43	39	43	38	42	no	S1; Direct Contact (DC) with human ACE2 [1] 		[1]( 10.1101/2020.05.01.072371) ; 
39	P	67	54	0	59	21677	43	53	39	37	43	44	40	44	39	43	no	S1; 		
40	D	68	55	29	60	21680	44	54	40	38	44	45	41	45	40	44	no	S1; (DCex) no direct contact but could influence binding affinity with human ACE2 [1] 		[1]( 10.1101/2020.05.01.072371) ; 
41	K	72	56	30	61	21683	45	55	41	39	45	46	45	46	41	45	no	S1; 		
42	V	73	57	31	62	21686	46	56	42	40	46	47	46	47	42	46	no	S1; 		
43	F	74	58	32	63	21689	47	57	43	41	47	48	47	48	43	47	no	S1; 		
44	R	75	59	33	64	21692	48	58	44	42	48	49	48	49	44	48	no	S1; 		
45	S	76	60	34	65	21695	49	59	45	43	49	50	49	50	45	49	no	S1; 		
46	S	77	61	35	66	21698	50	60	46	44	50	51	50	51	46	50	no	S1; 		
47	V	78	62	36	67	21701	51	61	47	45	51	52	51	52	47	51	no	S1; 		
48	L	79	63	37	68	21704	52	62	48	46	52	53	52	53	48	52	no	S1; 		
49	H	80	64	38	69	21707	53	63	49	47	53	54	53	54	49	53	no	"S1; H49Y variation identified in Asia, Europe, and North America [1] ; "		[1](10.1101/2020.05.21.108563) ; 
50	S	81	65	39	70	21710	54	64	50	48	54	55	54	55	50	54	no	S1; predicted epitopes for T-cytotoxic cells with [1] ; 		[1](10.1101/2020.05.21.108563) ; 
51	T	82	66	40	71	21713	55	65	51	49	55	56	55	56	51	55	no	S1; predicted epitopes for T-cytotoxic cells with [1] ; 		[1](10.1101/2020.05.21.108563) ; 
52	Q	83	67	41	72	21716	56	66	52	50	56	57	56	57	52	56	no	S1; predicted epitopes for T-cytotoxic cells with [1] ; 		[1](10.1101/2020.05.21.108563) ; 
53	D	84	68	42	73	21719	57	67	53	51	57	58	57	58	53	57	no	S1; predicted epitopes for T-cytotoxic cells with [1] ; 		[1](10.1101/2020.05.21.108563) ; 
54	L	85	69	43	74	21722	58	68	54	52	58	59	58	59	54	58	no	S1; predicted epitopes for T-cytotoxic cells with [1] ; 		[1](10.1101/2020.05.21.108563) ; 
55	F	86	70	44	75	21725	59	69	55	53	59	60	59	60	55	59	no	S1; predicted epitopes for T-cytotoxic cells with [1] ; 		[1](10.1101/2020.05.21.108563) ; 
56	L	87	0	0	0	21728	60	0	56	0	60	61	0	0	56	60	no	S1; predicted epitopes for T-cytotoxic cells with [1] ; 		[1](10.1101/2020.05.21.108563) ; 
57	P	88	71	45	76	21731	61	70	57	54	61	62	60	61	57	61	no	S1; predicted epitopes for T-cytotoxic cells with [1] ; 		[1](10.1101/2020.05.21.108563) ; 
58	F	89	72	0	77	21734	62	71	58	55	62	63	61	62	58	62	no	S1; predicted epitopes for T-cytotoxic cells with [1] ; 		[1](10.1101/2020.05.21.108563) ; 
59	F	90	73	0	78	21737	63	72	59	56	63	64	62	0	59	63	no	S1; 		
60	S	91	74	0	79	21740	64	73	60	57	64	65	0	0	60	64	no	S1; 		
61	N	92	75	0	80	21743	65	74	61	58	65	66	0	0	61	65	no	S1; mixture of oligomannose-type glycans and complex-type glycans [1] ; 		[1](10.1101/2020.03.26.010322) ; 
62	V	96	76	46	84	21746	66	75	62	59	66	67	63	63	62	66	no	S1; 		
63	T	97	77	47	85	21749	67	76	63	60	67	68	64	64	63	67	no	S1; 		
64	W	98	78	48	86	21752	68	77	64	61	68	69	65	65	64	68	no	S1; 		
65	F	99	79	49	87	21755	69	78	65	62	69	70	66	66	65	69	no	S1; 		
66	H	100	80	0	88	21758	70	79	66	0	70	71	67	67	66	70	no	S1; 		
67	A	101	81	50	89	21761	71	80	67	63	71	72	68	68	67	71	no	S1; 		
68	I	102	82	51	90	21764	72	81	68	64	72	73	69	69	68	72	no	S1; 		
69	H	103	83	52	91	21767	73	82	69	65	73	74	70	70	69	73	no	S1; 		
70	V	104	84	53	92	21770	74	83	70	66	74	75	71	71	70	74	no	S1; 		
71	S	105	85	54	93	21773	75	84	71	67	75	76	72	72	71	75	no	S1; 		
72	G	106	86	55	94	21776	0	85	72	68	0	0	73	73	0	0	no	S1; 		
73	T	107	87	56	95	21779	0	86	73	69	0	0	74	74	72	0	no	S1; 		
74	N	108	88	57	96	21782	0	87	74	70	0	0	75	75	73	0	no	S1; 		
75	G	109	89	58	97	21785	0	88	75	71	0	0	76	76	74	0	no	S1; 		
76	T	110	90	0	98	21788	0	89	76	0	0	0	77	77	75	0	no	S1; N-terminal Domain; (DCex) no direct contact but could influence binding affinity with human ACE2 [1] 		[1]( 10.1101/2020.05.01.072371) ; 
77	K	111	91	0	99	21791	0	90	77	0	0	0	78	78	76	0	no	S1; 		
78	R	112	92	0	100	21794	0	91	78	0	0	0	79	79	77	0	no	S1; 		
79	F	113	93	0	101	21797	76	92	79	0	76	77	80	80	78	76	no	S1; Direct Contact (DC) with human ACE2 [1] 		[1]( 10.1101/2020.05.01.072371) ; 
80	D	114	94	0	102	21800	77	93	80	0	77	78	81	81	79	77	no	S1; 		
81	N	115	95	59	103	21803	78	94	81	72	78	79	82	82	80	78	no	S1; 		
82	P	146	96	84	104	21806	79	95	82	98	79	80	111	113	81	79	no	S1; Direct Contact (DC) with human ACE2 [1] 		[1]( 10.1101/2020.05.01.072371) ; 
83	V	151	98	89	109	21809	80	97	83	103	80	81	116	118	82	80	no	S1; 		
84	L	152	99	90	110	21812	81	98	84	104	81	82	117	119	83	81	no	S1; 		
85	P	153	100	91	111	21815	82	99	85	105	82	83	118	120	84	82	no	S1; 		
86	F	154	101	92	112	21818	83	100	86	106	83	84	119	121	85	83	no	S1; 		
87	N	155	102	93	113	21821	84	101	87	107	84	85	120	122	86	84	no	S1; 		
88	D	156	103	94	114	21824	85	102	88	108	85	86	121	123	87	85	no	S1; 		
89	G	157	104	95	115	21827	86	103	89	109	86	87	122	124	88	86	no	S1; 		
90	V	158	105	96	116	21830	87	104	90	110	87	88	123	125	89	87	no	S1; 		
91	Y	159	106	0	117	21833	88	105	91	111	88	89	124	126	90	88	no	S1; 		
92	F	160	107	97	118	21836	89	106	92	112	89	90	125	127	91	89	no	S1; 		
93	A	161	108	98	119	21839	90	107	93	113	90	91	0	128	92	90	no	S1; 		
94	S	162	109	99	120	21842	91	108	94	114	91	92	0	129	93	91	no	S1; 		
95	T	163	110	100	121	21845	92	109	95	115	92	93	0	130	94	92	no	S1; 		
96	E	164	111	101	122	21848	93	110	96	116	93	94	0	131	95	93	no	S1; 		
97	K	165	112	102	123	21851	94	111	97	117	94	95	126	132	96	94	no	S1; 		
98	S	166	113	103	124	21854	95	112	98	118	95	96	127	133	97	95	no	S1; 		
99	N	167	114	104	125	21857	96	113	99	119	96	97	128	134	98	96	no	S1; 		
100	I	168	115	105	126	21860	97	114	100	120	97	98	129	135	99	97	no	S1; 		
101	I	169	116	106	127	21863	98	115	101	121	98	99	130	136	100	98	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
102	R	214	125	0	145	21866	99	124	102	156	99	100	172	175	101	99	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
103	G	215	126	137	146	21869	100	125	103	157	100	101	173	176	102	100	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
104	W	216	127	138	147	21872	101	126	104	158	101	102	174	177	103	101	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
105	I	217	128	139	148	21875	102	127	105	159	102	103	175	178	104	102	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
106	F	218	129	140	149	21878	103	128	106	160	103	104	176	179	105	103	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
107	G	219	130	141	150	21881	104	129	107	161	104	105	177	180	106	104	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
108	T	220	131	142	151	21884	105	130	108	162	105	106	178	181	107	105	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
109	T	221	132	143	152	21887	106	131	109	163	106	107	179	182	108	106	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
110	L	222	133	144	153	21890	107	132	110	164	107	108	180	183	109	107	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
111	D	223	134	145	154	21893	108	133	111	165	108	109	181	184	110	108	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
112	S	224	135	146	155	21896	109	134	112	166	109	110	182	185	111	109	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
113	K	250	136	155	181	21899	110	135	113	175	110	111	192	195	112	110	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
114	T	251	137	156	182	21902	111	136	114	176	111	112	193	196	113	111	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
115	Q	252	138	157	183	21905	112	137	115	177	112	113	194	197	114	112	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
116	S	253	139	158	184	21908	113	138	116	178	113	114	195	198	115	113	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
117	L	254	140	160	185	21911	114	139	117	179	114	115	196	199	116	114	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
118	L	255	141	161	186	21914	115	140	118	180	115	116	197	200	117	115	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
119	I	256	142	162	187	21917	116	141	119	181	116	117	198	201	118	116	no	S1; 		
120	V	257	143	163	188	21920	117	142	120	182	117	118	199	202	119	117	no	S1; 		
121	N	258	144	164	189	21923	118	143	121	183	118	119	200	203	120	118	no	S1; 		
122	N	259	145	165	190	21926	119	144	122	184	119	120	201	204	121	119	no	S1; mixture of oligomannose-type glycans and complex-type glycans [1] ; 		[1](10.1101/2020.03.26.010322) ; 
123	A	260	146	166	191	21929	120	145	123	185	120	121	202	205	122	120	no	S1; 		
124	T	261	147	169	192	21932	121	146	124	186	121	122	203	206	123	121	no	S1; 		
125	N	262	148	170	193	21935	122	147	125	187	122	123	204	207	124	122	no	S1; 		
126	V	263	149	171	194	21938	123	148	126	188	123	124	205	208	125	123	no	S1; 		
127	V	264	150	172	195	21941	124	149	127	189	124	125	206	209	126	124	no	S1; 		
128	I	270	151	178	196	21944	125	150	128	195	125	126	211	214	127	125	no	S1; 		
129	K	271	152	179	197	21947	126	151	129	196	126	127	212	215	128	126	no	S1; 		
130	V	272	153	180	198	21950	127	152	130	197	127	128	213	216	129	127	no	S1; 		
131	C	273	154	181	199	21953	128	153	131	198	128	129	214	217	130	128	no	S1; 		
132	E	274	155	182	200	21956	129	154	132	199	129	130	215	218	131	129	no	S1; 		
133	F	275	156	183	201	21959	130	155	133	200	130	131	216	219	132	130	no	S1; 		
134	Q	276	157	184	202	21962	131	156	134	201	131	132	217	220	133	131	no	S1; 		
135	F	285	158	185	206	21965	132	157	135	202	132	133	226	221	134	132	no	S1; 		
136	C	286	159	186	207	21968	133	158	136	203	133	134	227	222	135	133	no	S1; 		
137	N	287	160	187	208	21971	134	159	137	204	134	135	228	223	136	134	no	S1; 		
138	D	288	161	188	209	21974	135	160	138	205	135	136	229	224	137	135	no	S1; 		
139	P	289	162	189	210	21977	136	161	139	206	136	137	230	225	138	136	no	S1; 		
140	F	290	163	190	211	21980	137	162	140	207	137	138	231	226	139	137	no	S1; 		
141	L	291	164	0	212	21983	138	163	141	208	138	139	232	227	140	138	no	S1; 		
142	G	298	165	0	213	21986	139	164	142	0	139	140	233	234	141	139	no	S1; 		
143	V	299	166	0	214	21989	140	165	143	0	140	141	234	235	142	140	no	S1; 		
144	Y	300	167	0	215	21992	141	166	144	0	141	142	235	236	143	141	no	S1; Deletion observed in a SARS-2 Cov isolate [1]		[1](10.1101/2020.04.07.029132) ; 
145	Y	301	0	0	0	21995	0	0	145	0	0	0	236	237	144	0	no	S1; 		
146	H	302	0	0	0	21998	0	0	146	209	0	0	237	238	145	0	no	S1; 		
147	K	303	0	191	0	22001	0	0	147	210	0	0	238	239	0	0	no	S1; 		
148	N	304	0	192	216	22004	0	0	148	211	0	0	239	240	146	0	no	S1; 		
149	N	305	168	193	217	22007	142	167	149	212	142	143	240	241	147	142	no	S1; 		
150	K	306	169	194	218	22010	143	168	150	213	143	144	241	242	148	143	no	S1; 		
151	S	307	170	195	219	22013	144	169	151	214	144	145	242	243	149	144	no	S1; 		
152	W	308	171	196	220	22016	145	170	152	215	145	146	243	244	150	145	no	S1; 		
153	M	309	172	197	221	22019	146	171	153	216	146	147	244	245	151	146	no	S1; 		
154	E	310	173	198	222	22022	147	172	154	217	147	148	245	246	152	147	no	S1; 		
155	S	311	174	199	223	22025	148	173	155	218	148	149	246	247	153	148	no	S1; 		
156	E	312	175	200	224	22028	149	174	156	219	149	150	0	0	154	149	no	S1; 		
157	F	313	176	201	225	22031	150	175	157	220	150	151	0	0	155	150	no	S1; 		
158	R	314	177	202	226	22034	151	176	158	221	151	152	0	0	156	151	no	S1; 		
159	V	315	178	203	227	22037	152	177	159	222	152	153	247	248	157	152	no	S1; 		
160	Y	316	179	204	228	22040	153	178	160	223	153	154	248	249	158	153	no	S1; 		
161	S	317	180	205	229	22043	154	179	161	224	154	155	249	250	159	154	no	S1; 		
162	S	318	181	206	230	22046	155	180	162	225	155	156	250	251	160	155	no	S1; 		
163	A	319	182	207	231	22049	156	181	163	226	156	157	251	252	161	156	no	S1; 		
164	N	320	183	0	232	22052	157	182	164	227	157	158	252	253	162	157	no	S1; 		
165	N	321	184	208	233	22055	158	183	165	228	158	159	253	254	163	158	no	S1; mixture of oligomannose-type glycans and complex-type glycans [1] ; 		[1](10.1101/2020.03.26.010322) ; 
166	C	324	185	209	234	22058	159	184	166	229	159	160	254	257	164	159	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
167	T	325	186	210	235	22061	160	185	167	230	160	161	255	258	165	160	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
168	F	326	187	211	236	22064	161	186	168	231	161	162	256	259	166	161	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
169	E	327	188	212	237	22067	162	187	169	232	162	163	257	260	167	162	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
170	Y	328	189	213	238	22070	163	188	170	233	163	164	258	261	168	163	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
171	V	329	190	214	239	22073	164	189	171	234	164	165	259	262	169	164	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
172	S	330	191	215	240	22076	165	190	172	235	165	166	260	263	170	165	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
173	Q	331	192	216	241	22079	166	191	173	236	166	167	261	264	171	166	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
174	P	332	193	217	242	22082	167	192	174	237	167	168	262	265	172	167	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
175	F	333	194	218	243	22085	168	193	175	238	168	169	263	266	173	168	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
176	L	334	195	219	244	22088	169	194	176	239	169	170	264	267	174	169	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
177	M	335	196	220	245	22091	170	195	177	240	170	171	265	268	175	170	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
178	D	336	197	221	246	22094	171	196	178	241	171	172	266	269	176	171	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
179	L	337	198	222	247	22097	172	197	179	242	172	173	267	270	177	172	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
180	E	338	199	223	248	22100	173	198	180	243	173	174	268	271	178	173	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
181	G	339	200	224	249	22103	174	199	181	244	174	175	269	272	179	174	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
182	K	340	0	225	0	22106	175	0	182	245	175	176	270	273	180	175	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
183	Q	342	0	227	0	22109	176	0	183	247	176	177	272	275	181	176	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
184	G	343	0	228	0	22112	177	0	184	248	177	178	273	276	182	177	yes	S1; T cell epitope [1] ; forecasted as components of discontinuous B-cell epitopes [2];		[1](10.1016/j.chom.2020.03.002) ; [2](10.21203/rs.3.rs-16262/v1); 
185	N	344	0	229	0	22115	178	0	185	249	178	179	274	277	183	178	yes	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
186	F	345	0	230	0	22118	179	0	186	250	179	180	275	278	184	179	yes	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
187	K	346	0	231	0	22121	180	0	187	251	180	181	276	279	185	180	yes	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
188	N	347	201	232	250	22124	181	200	188	252	181	182	277	280	186	181	yes	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
189	L	348	202	233	251	22127	182	201	189	253	182	183	278	281	187	182	yes	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
190	R	349	203	234	252	22130	183	202	190	254	183	184	279	282	188	183	yes	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
191	E	350	204	235	253	22133	184	203	191	255	184	185	280	283	189	184	yes	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
192	F	351	205	236	254	22136	185	204	192	256	185	186	281	284	190	185	yes	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
193	V	352	206	237	255	22139	186	205	193	257	186	187	282	285	191	186	yes	S1; RBD; RBM; Variable residues between SARS-CoV-2 and SARS-CoV; critical residues in Polyclonal anti-SARS-1 antibodies and different between SARS-CoV-2 and SARS-CoV RBDs; ACE2-binding residue; SARS-CoV-derived discontinuous B cell epitopes associated with antibody m396	Could impact Response to antibodies; Residue reported to decrease ACE2 Binding when mutated in SARS	[1](10.1038/s41423-020-0400-4) ; [2](10.1038/s41467-020-15562-9) ; [3](10.1038/s41423-020-0374-2) ; [4](10.1186/1743-422X-2-73) ; [5](10.1126/science.abb7269) ; [6](10.3390/v12030254)
194	F	353	207	238	256	22142	187	206	194	258	187	188	283	286	192	187	yes	S1; HLA-DRB1*01:01; B cell epitope region		[1](10.3390/v12030254) ;  [2](10.1016/j.chom.2020.03.002) ; 
195	K	354	208	239	257	22145	188	207	195	259	188	189	284	287	193	188	yes	S1; B cell epitope region [1]; North America Mutation; other mutations more likely to appear [2] 		[1](10.1016/j.chom.2020.03.002) ;  [2](10.1016/j.ygeno.2020.04.016) ;
196	N	355	209	240	258	22148	189	208	196	260	189	190	285	288	194	189	yes	S1; B cell epitope region [1] 		[1](10.1016/j.chom.2020.03.002) ; 
197	I	356	210	241	259	22151	190	209	197	261	190	191	286	289	195	190	yes	S1; B cell epitope region [1] 		[1](10.1016/j.chom.2020.03.002) ; 
198	D	357	211	242	260	22154	191	210	198	262	191	192	287	290	196	191	yes	S1; 		
199	G	361	212	246	264	22157	192	211	199	266	192	193	291	294	197	192	yes	S1; T Cell Epitopes [1] 		[1](10.1016/j.chom.2020.03.002) ; 
200	Y	362	213	247	265	22160	193	212	200	267	193	194	292	295	198	193	yes	S1; 		
201	F	363	214	248	266	22163	194	213	201	268	194	195	293	296	199	194	yes	S1; B cell epitope region [1] 		[1](10.1016/j.chom.2020.03.002) ; 
202	K	364	215	249	267	22166	195	214	202	269	195	196	294	297	200	195	yes	S1		
203	I	365	216	250	268	22169	196	215	203	270	196	197	295	298	201	196	yes	S1		
204	Y	366	217	251	269	22172	197	216	204	271	197	198	296	299	202	197	yes	S1; T cell epitope; Epitope HLA locus A group 2 subtype 2:01; “HR1”; Fusion Core :  target of fusion/entry inhibitors; One of the 8 residues that differs from SARS-Cov Fusion Core ; position f in the heptad repeat abcdefg pattern;	T variant more similar to SARS-1 fusion Core; Change in impact of fusion/entry inhibitor drugs; little to no impact expected on HR structure	[1](10.1016/j.chom.2020.03.002); [2](10.1038/s41423-020-0374-2);  [3](10.1016/j.virol.2005.02.022) ; [4](10.1016/S0140-6736(04)15788-7) ;  [5](10.1101/2020.03.30.016931);
205	S	367	218	252	270	22175	198	217	205	272	198	199	297	300	203	198	yes	S1; HLA-B*15:01 [1] ; HLA-B*27:05 [1]; HLA-B*58:01 [1]; HLA-C*15:02 [1];  T Cell Epitopes [2] 		[1](10.3390/v12030254) ; [2](10.1016/j.chom.2020.03.002) ; 
206	K	368	219	253	271	22178	199	218	206	273	199	200	298	301	204	199	yes	S1; HLA-DRB1*01:01		1 : 10.3390/v12030254
207	H	369	220	254	272	22181	200	219	207	274	200	201	299	302	205	200	no	S1		
208	T	370	221	255	273	22184	201	220	208	275	201	202	300	303	206	201	no	S1		
209	P	371	222	256	274	22187	202	221	209	276	202	203	301	304	207	202	no	S1		
210	I	372	0	257	0	22190	203	0	210	277	203	204	302	305	208	203	no	S1		
211	N	373	0	258	0	22193	204	0	211	278	204	205	303	306	209	204	no	S1		
212	L	374	0	259	0	22196	205	0	212	279	205	206	304	307	210	205	no	S1		
213	V	375	0	260	0	22199	206	0	213	280	206	207	305	308	211	206	no	S1		
214	R	376	0	261	0	22202	207	0	214	281	207	208	306	309	212	207	no	S1		
215	D	377	0	262	0	22205	208	0	215	282	208	209	307	310	213	208	no	S1		
216	L	378	0	263	0	22208	209	0	216	283	209	210	308	311	214	209	no	S1		
217	P	379	0	264	0	22211	210	0	217	284	210	211	309	312	215	210	no	S1		
218	Q	447	0	330	0	22214	211	0	218	347	211	212	375	380	216	211	no	S1		
219	G	448	0	331	0	22217	212	0	219	348	212	213	376	381	217	212	no	S1		
220	F	449	0	332	0	22220	213	0	220	349	213	214	377	382	218	213	no	S1		
221	S	450	223	333	275	22223	214	222	221	350	214	215	378	383	219	214	no	S1		
222	A	451	224	334	276	22226	215	223	222	351	215	216	379	384	220	215	no	S1		
223	L	452	225	335	277	22229	216	224	223	352	216	217	380	385	221	216	no	S1		
224	E	453	226	336	278	22232	217	225	224	353	217	218	381	386	222	217	no	S1		
225	P	454	227	337	279	22235	218	226	225	354	218	219	382	387	223	218	no	S1		
226	L	455	228	338	280	22238	219	227	226	355	219	220	383	388	224	219	no	S1		
227	V	456	229	0	281	22241	220	228	227	356	220	221	384	389	225	220	no	S1		
228	D	458	230	339	283	22244	221	229	228	357	221	222	386	391	226	221	no	S1		
229	L	459	231	340	284	22247	222	230	229	358	222	223	387	392	227	222	no	S1		
230	P	460	232	341	285	22250	223	231	230	359	223	224	388	393	228	223	no	S1		
231	I	461	233	342	286	22253	224	232	231	360	224	225	389	394	229	224	no	S1		
232	G	462	234	343	287	22256	225	233	232	361	225	226	390	395	230	225	no	S1		
233	I	463	235	344	288	22259	226	234	233	362	226	227	391	396	231	226	no	S1		
234	N	464	236	345	289	22262	227	235	234	363	227	228	392	397	232	227	no	S1; predominantly oligomannose-type [1]; 		[1](10.1101/2020.03.26.010322) ; 
235	I	482	237	363	290	22265	228	236	235	381	228	229	407	412	233	228	no	S1		
236	T	483	238	364	291	22268	229	237	236	382	229	230	408	413	234	229	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
237	R	484	239	365	292	22271	230	238	237	383	230	231	409	414	235	230	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
238	F	485	240	366	293	22274	231	239	238	384	231	232	410	415	236	231	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
239	Q	486	241	367	294	22277	232	240	239	385	232	233	411	416	237	232	no	S1; T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
240	T	487	242	368	295	22280	233	241	240	386	233	234	412	417	238	233	no	S1; predicted epitopes for T-cytotoxic cells with [1] ;  T cell epitope [2] ; 		[1](10.1101/2020.05.21.108563) ;  [2](10.1016/j.chom.2020.03.002) ; 
241	L	488	243	369	296	22283	234	242	241	387	234	235	413	418	239	234	no	S1; predicted epitopes for T-cytotoxic cells with [1] ;  T cell epitope [2] ; 		[1](10.1101/2020.05.21.108563) ;  [2](10.1016/j.chom.2020.03.002) ; 
242	L	489	244	370	297	22286	235	243	242	388	235	236	414	419	240	235	no	S1; predicted epitopes for T-cytotoxic cells with [1] ;  T cell epitope [2] ; 		[1](10.1101/2020.05.21.108563) ;  [2](10.1016/j.chom.2020.03.002) ; 
243	A	490	245	371	298	22289	236	244	243	389	236	237	415	420	241	236	no	S1; predicted epitopes for T-cytotoxic cells with [1] ;  T cell epitope [2] ; 		[1](10.1101/2020.05.21.108563) ;  [2](10.1016/j.chom.2020.03.002) ; 
244	L	491	246	372	299	22292	237	245	244	390	237	238	416	421	242	237	no	S1; predicted epitopes for T-cytotoxic cells with [1] ;  T cell epitope [2] ; 		[1](10.1101/2020.05.21.108563) ;  [2](10.1016/j.chom.2020.03.002) ; 
245	H	492	247	373	300	22295	238	246	245	391	238	239	417	422	243	238	no	S1; predicted epitopes for T-cytotoxic cells with [1] ;  T cell epitope [2] ; 		[1](10.1101/2020.05.21.108563) ;  [2](10.1016/j.chom.2020.03.002) ; 
246	R	493	248	374	301	22298	0	247	246	392	0	0	418	423	244	0	no	S1; predicted epitopes for T-cytotoxic cells with [1] ;  T cell epitope [2] ; 		[1](10.1101/2020.05.21.108563) ;  [2](10.1016/j.chom.2020.03.002) ; 
247	S	494	249	375	302	22301	0	248	247	393	0	0	419	424	245	0	no	S1; predicted epitopes for T-cytotoxic cells with [1] ;  T cell epitope [2] ; 		[1](10.1101/2020.05.21.108563) ;  [2](10.1016/j.chom.2020.03.002) ; 
248	Y	495	250	376	303	22304	0	249	248	394	0	0	420	425	246	0	no	S1; predicted epitopes for T-cytotoxic cells with [1] ;  T cell epitope [2] ; 		[1](10.1101/2020.05.21.108563) ;  [2](10.1016/j.chom.2020.03.002) ; 
249	L	496	0	377	304	22307	0	0	249	395	0	0	421	426	0	0	no	S1; predicted epitopes for T-cytotoxic cells with [1] ;  T cell epitope [2] ; 		[1](10.1101/2020.05.21.108563) ;  [2](10.1016/j.chom.2020.03.002) ; 
250	T	497	0	378	0	22310	0	0	250	396	0	0	422	427	0	0	no	S1; T-Helper epitope [1] ;  T cell epitope [2] ; 		[1](10.1101/2020.05.21.108563) ;  [2](10.1016/j.chom.2020.03.002) ; 
251	P	498	0	379	0	22313	0	0	251	397	0	0	423	428	0	0	no	S1; T-Helper epitope [1] ;  T cell epitope [2] ; 		[1](10.1101/2020.05.21.108563) ;  [2](10.1016/j.chom.2020.03.002) ; 
252	G	518	0	399	0	22316	239	0	252	417	239	240	443	448	247	239	no	S1; T-Helper epitope [1] ;  T cell epitope [2] ; 		[1](10.1101/2020.05.21.108563) ;  [2](10.1016/j.chom.2020.03.002) ; 
253	D	519	0	400	0	22319	240	0	253	418	240	241	444	449	248	240	no	S1; T-Helper epitope [1] ;  T cell epitope [2] ; 		[1](10.1101/2020.05.21.108563) ;  [2](10.1016/j.chom.2020.03.002) ; 
254	S	520	0	401	0	22322	241	0	254	419	241	242	445	450	249	241	no	S1; T-Helper epitope [1] ;  T cell epitope [2] ; 		[1](10.1101/2020.05.21.108563) ;  [2](10.1016/j.chom.2020.03.002) ; 
255	S	521	0	402	0	22325	242	0	255	420	242	243	446	451	250	242	no	S1; T-Helper epitope [1] ;  T cell epitope [2] ; 		[1](10.1101/2020.05.21.108563) ;  [2](10.1016/j.chom.2020.03.002) ; 
256	S	522	0	403	0	22328	243	0	256	421	243	244	447	452	251	243	no	S1; T-Helper epitope [1] ;  T cell epitope [2] ; 		[1](10.1101/2020.05.21.108563) ;  [2](10.1016/j.chom.2020.03.002) ; 
257	G	528	251	405	305	22331	244	250	257	427	244	245	449	454	252	244	no	S1; T-Helper epitope [1] ;  T cell epitope [2] ; 		[1](10.1101/2020.05.21.108563) ;  [2](10.1016/j.chom.2020.03.002) ; 
258	W	529	252	406	306	22334	245	251	258	428	245	246	450	455	253	245	no	S1; T-Helper epitope [1] ;  T cell epitope [2] ; 		[1](10.1101/2020.05.21.108563) ;  [2](10.1016/j.chom.2020.03.002) ; 
259	T	530	253	407	307	22337	246	252	259	429	246	247	451	456	254	246	no	S1; T-Helper epitope [1] ; 		[1](10.1101/2020.05.21.108563) ; 
260	A	531	254	408	308	22340	247	253	260	430	247	248	452	457	255	247	no	S1; T-Helper epitope [1] ; 		[1](10.1101/2020.05.21.108563) ; 
261	G	532	255	409	309	22343	248	254	261	431	248	249	453	458	256	248	no	S1; T-Helper epitope [1] ; 		[1](10.1101/2020.05.21.108563) ; 
262	A	533	256	410	310	22346	249	255	262	432	249	250	454	459	257	249	no	S1; T-Helper epitope [1] ; 		[1](10.1101/2020.05.21.108563) ; 
263	A	534	257	411	311	22349	250	256	263	433	250	251	455	460	258	250	no	S1; T-Helper epitope [1] ; 		[1](10.1101/2020.05.21.108563) ; 
264	A	535	258	412	312	22352	251	257	264	434	251	252	456	461	259	251	no	S1; T-Helper epitope [1] ; 		[1](10.1101/2020.05.21.108563) ; 
265	Y	536	259	413	313	22355	252	258	265	435	252	253	457	462	260	252	no	S1		
266	Y	537	260	414	314	22358	253	259	266	436	253	254	458	463	261	253	no	S1		
267	V	538	261	415	315	22361	254	260	267	437	254	255	459	464	262	254	no	S1		
268	G	539	262	416	316	22364	255	261	268	438	255	256	460	465	263	255	no	S1		
269	Y	540	263	417	317	22367	256	262	269	439	256	257	461	466	264	256	no	S1		
270	L	541	264	418	318	22370	257	263	270	440	257	258	462	467	265	257	no	S1		
271	Q	542	265	419	319	22373	258	264	271	441	258	259	463	468	266	258	no	S1		
272	P	543	266	420	320	22376	259	265	272	442	259	260	464	469	267	259	no	S1		
273	R	544	267	421	321	22379	260	266	273	443	260	261	465	470	268	260	no	S1		
274	T	545	268	422	322	22382	261	267	274	444	261	262	466	471	269	261	no	S1		
275	F	546	269	423	323	22385	262	268	275	445	262	263	467	472	270	262	no	S1		
276	L	547	270	424	324	22388	263	269	276	446	263	264	468	473	271	263	no	S1		
277	L	548	271	425	325	22391	264	270	277	447	264	265	469	474	272	264	no	S1		
278	K	549	272	426	326	22394	265	271	278	448	265	266	470	475	273	265	no	S1		
279	Y	550	273	427	327	22397	266	272	279	449	266	267	471	476	274	266	no	S1		
280	N	551	274	0	328	22400	267	273	280	0	267	268	0	0	275	267	no	S1		
281	E	552	275	428	329	22403	268	274	281	450	268	269	472	477	276	268	no	S1		
282	N	553	276	429	330	22406	269	275	282	451	269	270	473	478	277	269	no	S1		
283	G	554	277	430	331	22409	270	276	283	452	270	271	474	479	278	270	no	S1		
284	T	555	278	431	332	22412	271	277	284	453	271	272	475	480	279	271	no	S1		
285	I	556	279	432	333	22415	272	278	285	454	272	273	476	481	280	272	no	S1		
286	T	557	280	433	334	22418	273	279	286	455	273	274	477	482	281	273	no	S1		
287	D	558	281	434	335	22421	274	280	287	456	274	275	478	483	282	274	no	S1; B Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
288	A	559	282	435	336	22424	275	281	288	457	275	276	479	484	283	275	no	S1; B Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
289	V	560	283	436	337	22427	276	282	289	458	276	277	480	485	284	276	no	S1; B Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
290	D	561	284	437	338	22430	277	283	290	459	277	278	481	486	285	277	no	S1; B Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
291	C	562	285	438	339	22433	278	284	291	460	278	279	482	487	286	278	no	S1; B Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
292	A	563	286	439	340	22436	279	285	292	461	279	280	483	488	287	279	no	S1; B Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
293	L	564	287	0	341	22439	280	286	293	0	280	281	0	0	288	280	no	S1; B Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
294	D	565	288	440	342	22442	281	287	294	462	281	282	484	489	289	281	no	S1; B Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
295	P	566	289	441	343	22445	282	288	295	463	282	283	485	490	290	282	no	S1; B Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
296	L	567	290	442	344	22448	283	289	296	464	283	284	486	491	291	283	no	S1; B Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
297	S	568	291	443	345	22451	284	290	297	465	284	285	487	492	292	284	no	S1; B Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
298	E	569	292	444	346	22454	285	291	298	466	285	286	488	493	293	285	no	S1; B Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
299	T	570	293	445	347	22457	286	292	299	467	286	287	489	494	294	286	no	S1; B Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
300	K	571	294	446	348	22460	287	293	300	468	287	288	490	495	295	287	no	S1; B Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
301	C	572	295	447	349	22463	288	294	301	469	288	289	491	496	296	288	no	S1; B Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
302	T	573	296	448	350	22466	289	295	302	470	289	290	492	497	297	289	no	S1; B Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
303	L	574	297	449	351	22469	290	296	303	471	290	291	493	498	298	290	no	S1; B Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
304	K	575	298	450	352	22472	291	297	304	472	291	292	494	499	299	291	no	S1; B Cell Epitope [1] ; T Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
305	S	576	299	451	353	22475	292	298	305	473	292	293	495	500	300	292	no	S1; B Cell Epitope [1] ; T Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
306	F	577	300	452	354	22478	293	299	306	474	293	294	496	501	301	293	no	S1; B Cell Epitope [1] ; T Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
307	T	578	301	453	355	22481	294	300	307	475	294	295	497	502	302	294	no	S1; B Cell Epitope [1] ; T Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
308	V	579	302	454	356	22484	295	301	308	476	295	296	498	503	303	295	no	S1; B Cell Epitope [1] ; T Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
309	E	580	303	455	357	22487	296	302	309	477	296	297	499	504	304	296	no	S1; B Cell Epitope [1] ; T Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
310	K	581	304	456	358	22490	297	303	310	478	297	298	500	505	305	297	no	S1; B Cell Epitope [1] ; T Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
311	G	582	305	457	359	22493	298	304	311	479	298	299	501	506	306	298	no	S1; B Cell Epitope [1] ; T Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
312	I	583	306	458	360	22496	299	305	312	480	299	300	502	507	307	299	no	S1; B Cell Epitope [1] ; T Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
313	Y	584	307	459	361	22499	300	306	313	481	300	301	503	508	308	300	no	S1; B Cell Epitope [1] ; T Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
314	Q	585	308	0	362	22502	301	307	314	482	301	302	504	509	309	301	no	S1; B Cell Epitope [1] [2] ; T Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002)  ; [2](10.21203/rs.3.rs-16262/v1) ;
315	T	586	309	0	363	22505	302	308	315	483	302	303	505	510	310	302	no	S1; B Cell Epitope [1] [2] ; T Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002)  ; [2](10.21203/rs.3.rs-16262/v1) ;
316	S	587	310	460	364	22508	303	309	316	484	303	304	506	511	311	303	no	S1; B Cell Epitope [1] [2] ; T Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002)  ; [2](10.21203/rs.3.rs-16262/v1) ;
317	N	588	311	461	365	22511	304	310	317	485	304	305	507	512	312	304	no	S1; B Cell Epitope [1] [2] ; T Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002)  ; [2](10.21203/rs.3.rs-16262/v1) ;
318	F	589	312	462	366	22514	305	311	318	486	305	306	508	513	313	305	no	S1 ; T Cell Epitope [1]; B Cell Epitope  [2] ; 		[1](10.1016/j.chom.2020.03.002)  ; [2](10.21203/rs.3.rs-16262/v1) ;
319	R	590	313	463	367	22517	306	312	319	487	306	307	509	514	314	306	no	S1 ; T Cell Epitope [1]; B Cell Epitope  [2] ; 		[1](10.1016/j.chom.2020.03.002)  ; [2](10.21203/rs.3.rs-16262/v1) ;
320	V	591	314	464	368	22520	307	313	320	488	307	308	510	515	315	307	no	S1 ; T Cell Epitope [1]; B Cell Epitope  [2] ; 		[1](10.1016/j.chom.2020.03.002)  ; [2](10.21203/rs.3.rs-16262/v1) ;
321	Q	592	315	465	369	22523	308	314	321	489	308	309	511	516	316	308	no	S1 ; T Cell Epitope [1]; B Cell Epitope  [2] ; 		[1](10.1016/j.chom.2020.03.002)  ; [2](10.21203/rs.3.rs-16262/v1) ;
322	P	593	316	466	370	22526	309	315	322	490	309	310	512	517	317	309	no	S1 ; B Cell Epitope  [1] ; 		[1](10.21203/rs.3.rs-16262/v1) ;
323	T	594	317	467	371	22529	310	316	323	491	310	311	513	518	318	310	no	S1 ; B Cell Epitope  [1] ; 		[1](10.21203/rs.3.rs-16262/v1) ;
324	E	595	318	468	372	22532	311	317	324	492	311	312	514	519	319	311	no	S1 ; B Cell Epitope  [1] ; 		[1](10.21203/rs.3.rs-16262/v1) ;
325	S	596	319	469	373	22535	312	318	325	493	312	313	515	520	320	312	no	S1		
326	I	597	320	470	374	22538	313	319	326	494	313	314	0	0	321	313	no	S1		
327	V	598	321	471	375	22541	314	320	327	495	314	315	0	0	322	314	no	"S1 ; B Cell Epitope. HLA-B*27:05 , HLA-C*14:02 [1] ; "		[1](10.3390/v12030254) ; 
328	R	599	322	472	376	22544	315	321	328	496	315	316	516	521	323	315	no	"S1 ; B Cell Epitope. HLA-B*27:05 , HLA-C*14:02 [1] ; "		[1](10.3390/v12030254) ; 
329	F	600	323	473	377	22547	316	322	329	497	316	317	517	522	324	316	no	"S1; (DCex) no direct contact but could influence binding affinity with human ACE2 [1]  ; B Cell Epitope.  HLA-B*27:05, HLA-C*14:02, HLA-B*07:02, HLA-B*35:01 , HLA-B*51:01 [2] ; "		[1](10.1101/2020.05.01.072371) ; [2](10.3390/v12030254) ; 
330	P	601	324	474	378	22550	317	323	330	498	317	318	518	523	325	317	no	"S1; B Cell Epitope.  HLA-B*27:05, HLA-C*14:02, HLA-B*07:02, HLA-B*35:01 , HLA-B*51:01 [1] ; "		[1](10.3390/v12030254) ; 
331	N	602	325	475	379	22553	318	324	331	499	318	319	519	524	326	318	no	"S1; B Cell Epitope.  HLA-B*27:05, HLA-C*14:02, HLA-B*07:02, HLA-B*35:01 , HLA-B*51:01 [1] ; "		[1](10.3390/v12030254) ; 
332	I	603	326	476	380	22556	319	325	332	500	319	320	520	525	327	319	no	"S1; RBD;  B Cell Epitope.  HLA-B*27:05, HLA-C*14:02, HLA-B*07:02, HLA-B*35:01 , HLA-B*51:01 [1] ; "		[1](10.3390/v12030254) ; 
333	T	604	327	477	381	22559	320	326	333	501	320	321	521	526	328	320	no	"S1; RBD; B-cell epitopes, high antigenicity score and good surface accessibility [1]; B Cell Epitope.  HLA-B*27:05, HLA-C*14:02, HLA-B*07:02, HLA-B*35:01 , HLA-B*51:01 [1] ; "		[1](10.21203/rs.3.rs-16262/v1); [2](10.3390/v12030254) ; 
334	N	605	328	478	382	22562	321	327	334	502	321	322	522	527	329	321	no	"S1; RBD; B-cell epitopes, high antigenicity score and good surface accessibility [1]; B Cell Epitope.  HLA-B*27:05, HLA-C*14:02, HLA-B*07:02, HLA-B*35:01 , HLA-B*51:01 [1] ; "		[1](10.21203/rs.3.rs-16262/v1); [2](10.3390/v12030254) ; 
335	L	606	329	0	0	22565	322	328	335	0	322	323	0	0	330	322	no	"S1; RBD; B-cell epitopes, high antigenicity score and good surface accessibility [1]; B Cell Epitope.  HLA-B*27:05, HLA-C*14:02, HLA-B*07:02, HLA-B*35:01 , HLA-B*51:01 [1] ; "		[1](10.21203/rs.3.rs-16262/v1); [2](10.3390/v12030254) ; 
336	C	607	330	0	383	22568	323	329	336	0	323	324	0	0	331	323	no	"S1; RBD; disulfide bonds with residue 348 (in SARS cov) [1] ; B-cell epitopes, high antigenicity score and good surface accessibility [2]; B Cell Epitope.  HLA-B*27:05, HLA-C*14:02, HLA-B*07:02, HLA-B*35:01 , HLA-B*51:01 [3] ; "		[1](10.1038/s41423-020-0400-4) ; [2](10.21203/rs.3.rs-16262/v1); [3](10.3390/v12030254) ; 
337	P	608	331	0	384	22571	324	330	337	0	324	325	0	0	332	324	no	"S1; RBD; B-cell epitopes, high antigenicity score and good surface accessibility [1]; B Cell Epitope , HLA-B*07:02, HLA-B*35:01 , HLA-B*51:01 [2] ; "		[1](10.21203/rs.3.rs-16262/v1); ; [2](10.3390/v12030254) ; 
338	F	609	332	0	385	22574	325	331	338	0	325	326	0	0	333	325	no	"S1; RBD; B-cell epitopes, high antigenicity score and good surface accessibility [1]; B Cell Epitope , HLA-B*07:02, HLA-B*35:01 , HLA-B*51:01 [2] ; "		[1](10.21203/rs.3.rs-16262/v1); ; [2](10.3390/v12030254) ; 
339	G	610	333	0	386	22577	326	332	339	0	326	327	0	0	334	326	no	"S1; RBD ; B Cell Epitope , HLA-B*07:02, HLA-B*35:01 , HLA-B*51:01 [2] ; "		[1](10.3390/v12030254) ; 
340	E	611	334	0	387	22580	327	333	340	0	327	328	0	0	335	327	no	S1; RBD		
341	V	612	335	0	388	22583	328	334	341	0	328	329	0	0	336	328	no	S1; RBD		
342	F	613	336	479	389	22586	329	335	342	503	329	330	523	528	337	329	no	S1; RBD		
343	N	614	337	480	390	22589	330	336	343	504	330	331	524	529	338	330	no	S1; RBD		
344	A	615	338	481	391	22592	331	337	344	505	331	332	525	530	339	331	no	S1; RBD		
345	T	616	339	482	392	22595	332	338	345	506	332	333	526	531	340	332	no	S1; RBD		
346	R	617	340	483	393	22598	333	339	346	507	333	334	527	532	341	333	no	S1; RBD		
347	F	618	341	484	0	22601	334	340	347	508	334	335	528	533	342	334	no	S1; RBD		
348	A	619	342	485	394	22604	335	341	348	509	335	336	529	534	343	335	no	S1; RBD		
349	S	620	343	486	395	22607	336	342	349	510	336	337	530	535	344	336	no	S1; RBD		
350	V	621	344	487	396	22610	337	343	350	511	337	338	531	536	345	337	no	S1; RBD		
351	Y	625	345	491	397	22613	338	344	351	515	338	339	535	540	346	338	no	S1; RBD		
352	A	626	346	492	398	22616	339	345	352	516	339	340	536	541	347	339	no	S1; RBD		
353	W	627	347	493	399	22619	340	346	353	517	340	341	537	542	348	340	no	S1; RBD		
354	N	628	348	494	400	22622	341	347	354	518	341	342	538	543	349	341	no	S1; RBD; Variable residues between SARS-CoV-2 and SARS-CoV [1]		[1](10.1038/s41423-020-0400-4) ; 
355	R	629	349	495	401	22625	342	348	355	519	342	343	539	544	350	342	no	S1;  RBD ; 		
356	K	630	350	496	402	22628	343	349	356	520	343	344	540	545	351	343	no	S1; RBD		
357	R	631	351	497	403	22631	344	350	357	521	344	345	541	546	352	344	no	S1; RBD		
358	I	632	352	498	404	22634	345	351	358	522	345	346	542	547	353	345	no	S1; RBD		
359	S	633	353	499	405	22637	346	352	359	523	346	347	543	548	354	346	no	S1; RBD;  (DCex) no direct contact but could influence binding affinity with human ACE2 [1] ; SARS-CoV-derived discontinuous B cell epitopes associated to m396 [2]; 		[1](10.1101/2020.05.01.072371) ; [2](10.3390/v12030254) ;
360	N	634	354	501	406	22640	347	353	360	524	347	348	544	549	355	347	no	S1; RBD		
361	C	635	355	502	407	22643	348	354	361	525	348	349	545	550	356	348	no	S1; RBD; disulfide bonds with residue 323 (in SARS cov) [1] 		[1](10.1038/s41423-020-0400-4) ; 
362	V	636	356	503	408	22646	349	355	362	526	349	350	546	551	357	349	no	S1; RBD		
363	A	637	357	504	409	22649	350	356	363	527	350	351	547	552	358	350	no	S1; RBD ; SARS-CoV-derived discontinuous B cell epitopes associated to m396 and identical in SARS-2 Cov [1]; 		[2](10.3390/v12030254) ;
364	D	638	358	505	410	22652	351	357	364	528	351	352	548	553	359	351	no	S1; RBD		
365	Y	639	359	506	411	22655	352	358	365	529	352	353	549	554	360	352	no	S1; RBD ; SARS-CoV-derived discontinuous B cell epitopes associated to m396 and identical in SARS-2 Cov [1]; 		[1](10.1038/s41423-020-0400-4) ; 
366	S	640	360	507	412	22658	353	359	366	530	353	354	550	555	361	353	no	S1; RBD		
367	V	641	361	508	413	22661	354	360	367	531	354	355	551	556	362	354	yes	"S1; RBD; V367F observed in at least two continents with 20 <1% frequency [1] ; 	"		[1](10.1101/2020.05.21.108563) ; 
368	L	642	362	0	414	22664	355	361	368	0	355	356	552	557	363	355	no	S1; RBD		
369	Y	643	363	0	415	22667	356	362	369	0	356	357	553	558	364	356	no	S1; RBD		
370	N	644	364	0	416	22670	357	363	370	0	357	358	554	559	365	357	no	S1; RBD		
371	S	645	365	0	417	22673	358	364	371	0	358	359	555	560	366	358	no	S1; RBD ; T Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
372	A	647	366	0	418	22676	359	365	372	0	359	360	557	562	367	359	no	S1; RBD ; T Cell Epitope [1] ; B Cell Epitope  [2] ; 		[1](10.1016/j.chom.2020.03.002) ; [2](10.21203/rs.3.rs-16262/v1) ;
373	S	648	367	0	419	22679	360	366	373	0	360	361	558	563	368	360	no	S1; RBD ; T Cell Epitope [1] ; B Cell Epitope  [2] ; 		[1](10.1016/j.chom.2020.03.002) ; [2](10.21203/rs.3.rs-16262/v1) ;
374	F	649	368	509	420	22682	361	367	374	532	361	362	559	564	369	361	no	S1; RBD ; T Cell Epitope [1] ; B Cell Epitope  [2] ; 		[1](10.1016/j.chom.2020.03.002) ; [2](10.21203/rs.3.rs-16262/v1) ;
375	S	650	369	510	421	22685	362	368	375	533	362	363	560	565	370	362	no	S1; RBD ; T Cell Epitope [1] ; B Cell Epitope  [2] ; 		[1](10.1016/j.chom.2020.03.002) ; [2](10.21203/rs.3.rs-16262/v1) ;
376	T	651	370	511	422	22688	363	369	376	534	363	364	561	566	371	363	no	S1; RBD ; T Cell Epitope [1] ; B Cell Epitope  [2] ; 		[1](10.1016/j.chom.2020.03.002) ; [2](10.21203/rs.3.rs-16262/v1) ;
377	F	652	371	512	423	22691	364	370	377	535	364	365	562	567	372	364	no	S1; RBD ; T Cell Epitope [1] ; B Cell Epitope  [2] ; 		[1](10.1016/j.chom.2020.03.002) ; [2](10.21203/rs.3.rs-16262/v1) ;
378	K	653	372	513	424	22694	365	371	378	536	365	366	563	568	373	365	no	S1; RBD ; T Cell Epitope [1] ; B Cell Epitope  [2] ; 		[1](10.1016/j.chom.2020.03.002) ; [2](10.21203/rs.3.rs-16262/v1) ;
379	C	654	373	514	425	22697	366	372	379	537	366	367	564	569	374	366	no	S1; RBD; disulfide bonds with residue 419 (in SARS cov) [1]  ; T Cell Epitope [2] ; B Cell Epitope  [3] ; 		[1](10.1038/s41423-020-0400-4) ; [2](10.1016/j.chom.2020.03.002) ; [3](10.21203/rs.3.rs-16262/v1) ;
380	Y	655	374	515	426	22700	367	373	380	538	367	368	565	570	375	367	no	S1; RBD ; T Cell Epitope [1] ; B Cell Epitope  [2] ; 		[1](10.1016/j.chom.2020.03.002) ; [2](10.21203/rs.3.rs-16262/v1) ;
381	G	656	375	516	427	22703	368	374	381	539	368	369	566	571	376	368	no	S1; RBD ; T Cell Epitope [1] ; B Cell Epitope  [2] ; 		[1](10.1016/j.chom.2020.03.002) ; [2](10.21203/rs.3.rs-16262/v1) ;
382	V	657	376	517	428	22706	369	375	382	540	369	370	567	572	377	369	no	S1; RBD ; T Cell Epitope [1] ; B Cell Epitope  [2] ; 		[1](10.1016/j.chom.2020.03.002) ; [2](10.21203/rs.3.rs-16262/v1) ;
383	S	658	377	518	429	22709	370	376	383	541	370	371	568	573	378	370	no	S1; RBD ; T Cell Epitope [1] ; B Cell Epitope  [2] ; 		[1](10.1016/j.chom.2020.03.002) ; [2](10.21203/rs.3.rs-16262/v1) ;
384	P	659	378	519	430	22712	371	377	384	542	371	372	569	574	379	371	no	S1; RBD ; T Cell Epitope [1] ; B Cell Epitope  [2] ; 		[1](10.1016/j.chom.2020.03.002) ; [2](10.21203/rs.3.rs-16262/v1) ;
385	T	660	379	520	431	22715	372	378	385	543	372	373	570	575	380	372	no	S1; RBD ; T Cell Epitope [1] ; B Cell Epitope  [2] ; 		[1](10.1016/j.chom.2020.03.002) ; [2](10.21203/rs.3.rs-16262/v1) ;
386	K	661	380	521	432	22718	373	379	386	544	373	374	571	576	381	373	no	S1; RBD ; T Cell Epitope [1] ; B Cell Epitope  [2] ; 		[1](10.1016/j.chom.2020.03.002) ; [2](10.21203/rs.3.rs-16262/v1) ;
387	L	662	381	522	433	22721	374	380	387	545	374	375	572	577	382	374	no	S1; RBD ; T Cell Epitope [1] ; B Cell Epitope  [2] ; 		[1](10.1016/j.chom.2020.03.002) ; [2](10.21203/rs.3.rs-16262/v1) ;
388	N	663	382	523	434	22724	375	381	388	546	375	376	573	578	383	375	no	S1; RBD ; B Cell Epitope  [1] ; 		[1](10.21203/rs.3.rs-16262/v1) ;
389	D	664	383	524	435	22727	376	382	389	547	376	377	574	579	384	376	no	S1; RBD ; B Cell Epitope  [1] ; 		[1](10.21203/rs.3.rs-16262/v1) ;
390	L	669	384	525	436	22730	377	383	390	548	377	378	579	584	385	377	no	S1; RBD; (DCex) no direct contact but could influence binding affinity with human ACE2 [1]  ; B Cell Epitope  [2] ; S1; RBD ; SARS-CoV-derived discontinuous B cell epitopes associated to m396 [1]; 		[1](10.1101/2020.05.01.072371) ; [2](10.21203/rs.3.rs-16262/v1) ; [3](10.3390/v12030254) ;
391	C	670	385	526	437	22733	378	384	391	549	378	379	580	585	386	378	no	S1; RBD ; B Cell Epitope  [1] ; SARS-CoV-derived discontinuous B cell epitopes associated to m396 and identical in SARS-2 Cov [2]; 		[1](10.21203/rs.3.rs-16262/v1) ; [2](10.3390/v12030254) ;
392	F	671	386	527	438	22736	379	385	392	550	379	380	581	586	387	379	no	S1; RBD ; B Cell Epitope  [1] ; S1; RBD ; SARS-CoV-derived discontinuous B cell epitopes associated to m396 and identical in SARS-2 Cov [1]; 		[1](10.21203/rs.3.rs-16262/v1) ; [2](10.3390/v12030254) ;
393	T	672	387	528	439	22739	380	386	393	551	380	381	582	587	388	380	no	S1; RBD ; B Cell Epitope  [1] ; 		[1](10.21203/rs.3.rs-16262/v1) ;
394	N	673	388	529	440	22742	381	387	394	552	381	382	583	588	389	381	no	S1; RBD ; B Cell Epitope  [1] ; 		[1](10.21203/rs.3.rs-16262/v1) ;
395	V	674	389	530	441	22745	382	388	395	553	382	383	584	589	390	382	no	S1; RBD ; B Cell Epitope  [1] ; SARS-CoV-derived discontinuous B cell epitopes associated to m396 and identical in SARS-2 Cov [2]; 		[1](10.21203/rs.3.rs-16262/v1) ; [2](10.3390/v12030254) ;
396	Y	675	390	0	442	22748	383	389	396	0	383	384	585	590	391	383	no	S1; RBD ; B Cell Epitope  [1] ; 		[1](10.21203/rs.3.rs-16262/v1) ;
397	A	676	391	0	443	22751	384	390	397	0	384	385	586	591	392	384	no	S1; RBD ; B Cell Epitope  [1] ; 		[1](10.21203/rs.3.rs-16262/v1) ;
398	D	677	392	0	444	22754	385	391	398	0	385	386	587	592	393	385	no	"S1;RBD; residues fully conserved among SARS-CoV-2, SARS-CoV, and MERS-CoV [1]"		[1](10.1038/s41423-020-0400-4) ; 
399	S	678	393	0	445	22757	386	392	399	0	386	387	588	593	394	386	no	S1; RBD		
400	F	679	394	0	446	22760	387	393	400	0	387	388	589	594	395	387	no	S1; RBD		
401	V	680	395	0	447	22763	388	394	401	0	388	389	0	0	396	388	no	S1; RBD		
402	I	681	396	0	448	22766	389	395	402	0	389	390	0	0	397	389	no	S1; RBD		
403	R	682	397	0	449	22769	390	396	403	0	390	391	0	0	398	390	no	S1; RBD		
404	G	683	398	0	450	22772	391	397	404	0	391	392	0	0	399	391	no	S1; RBD		
405	D	684	399	0	451	22775	392	398	405	0	392	393	0	0	400	392	no	S1; RBD		
406	E	685	400	0	452	22778	393	399	406	0	393	394	0	0	401	393	no	S1; RBD; B-cell epitope [1] [2];		[1](10.21203/rs.3.rs-16262/v1) ; [2](10.21203/rs.3.rs-16262/v1) ;
407	V	686	401	0	453	22781	394	400	407	0	394	395	0	0	402	394	no	S1; RBD; B-cell epitope [1] [2];		[1](10.21203/rs.3.rs-16262/v1) ; [2](10.21203/rs.3.rs-16262/v1) ;
408	R	687	402	0	454	22784	395	401	408	0	395	396	0	0	403	395	no	S1; RBD; B-cell epitope [1] [2]; Mutation observed  R to I in a SARS-2 cov isolate [3] ; 		[1](10.21203/rs.3.rs-16262/v1) ; [2](10.21203/rs.3.rs-16262/v1) ; [3](10.1101/2020.04.07.029132) ; 
409	Q	688	403	0	455	22787	396	402	409	0	396	397	0	0	404	396	no	S1; RBD; B-cell epitope [1] [2];		[1](10.21203/rs.3.rs-16262/v1) ; [2](10.21203/rs.3.rs-16262/v1) ;
410	I	689	404	0	456	22790	397	403	410	0	397	398	0	0	405	397	no	S1; RBD; B-cell epitope [1] [2];		[1](10.21203/rs.3.rs-16262/v1) ; [2](10.21203/rs.3.rs-16262/v1) ;
411	A	690	405	0	457	22793	398	404	411	0	398	399	0	0	406	398	no	S1; RBD; B-cell epitope [1] [2];		[1](10.21203/rs.3.rs-16262/v1) ; [2](10.21203/rs.3.rs-16262/v1) ;
412	P	691	406	0	458	22796	399	405	412	0	399	400	0	0	407	399	no	S1; RBD; B-cell epitope [1] [2];		[1](10.21203/rs.3.rs-16262/v1) ; [2](10.21203/rs.3.rs-16262/v1) ;
413	G	692	407	0	459	22799	400	406	413	0	400	401	0	0	408	400	no	S1; RBD; B-cell epitope [1] [2];		[1](10.21203/rs.3.rs-16262/v1) ; [2](10.21203/rs.3.rs-16262/v1) ;
414	Q	693	408	0	460	22802	401	407	414	0	401	402	590	595	409	401	no	S1; RBD; B-cell epitope [1] [2];		[1](10.21203/rs.3.rs-16262/v1) ; [2](10.21203/rs.3.rs-16262/v1) ;
415	T	694	409	0	461	22805	402	408	415	0	402	403	591	596	410	402	no	S1; RBD; B-cell epitope [1] [2];		[1](10.21203/rs.3.rs-16262/v1) ; [2](10.21203/rs.3.rs-16262/v1) ;
416	G	695	410	0	462	22808	403	409	416	0	403	404	592	597	411	403	no	S1; RBD; B-cell epitope [1] [2];		[1](10.21203/rs.3.rs-16262/v1) ; [2](10.21203/rs.3.rs-16262/v1) ;
417	K	696	411	0	463	22811	404	410	417	0	404	405	593	598	412	404	no	S1; RBD; B-cell epitope [1] [2]; ; hACE2 Binding [5] ; 		[1](10.21203/rs.3.rs-16262/v1) ; [2](10.21203/rs.3.rs-16262/v1) ;
418	I	697	412	531	464	22814	405	411	418	554	405	406	594	599	413	405	no	S1; RBD; B-cell epitope [1] [2];		[1](10.21203/rs.3.rs-16262/v1) ; [2](10.21203/rs.3.rs-16262/v1) ;
419	A	698	413	532	465	22817	406	412	419	555	406	407	595	600	414	406	no	S1; RBD; disulfide bonds with residue 366 (in SARS cov) [1] ; B-cell epitope [2];		[1](10.1038/s41423-020-0400-4) ; [2](10.21203/rs.3.rs-16262/v1)
420	D	699	414	533	466	22820	407	413	420	556	407	408	596	601	415	407	no	S1; RBD; B-cell epitope [1] [2];		[1](10.21203/rs.3.rs-16262/v1) ; [2](10.21203/rs.3.rs-16262/v1) ;
421	Y	700	415	534	467	22823	408	414	421	557	408	409	597	602	416	408	no	S1; RBD; B-cell epitope [1] [2];		[1](10.21203/rs.3.rs-16262/v1) ; [2](10.21203/rs.3.rs-16262/v1) ;
422	N	701	416	535	468	22826	409	415	422	558	409	410	598	603	417	409	no	S1; RBD ; B-cell epitope [1]		[1](10.21203/rs.3.rs-16262/v1) ;
423	Y	702	417	536	469	22829	410	416	423	559	410	411	599	604	418	410	no	S1; RBD ; B-cell epitope [1]		[1](10.21203/rs.3.rs-16262/v1) ;
424	K	703	418	537	470	22832	411	417	424	560	411	412	600	605	419	411	no	S1; RBD ; T Cell Epitope [1] ; B-cell epitope  [2];		[1](10.1016/j.chom.2020.03.002) ; [2](10.21203/rs.3.rs-16262/v1) ;
425	L	704	419	538	471	22835	412	418	425	561	412	413	601	606	420	412	no	S1; RBD ; T Cell Epitope [1] ; B-cell epitope  [2];		[1](10.1016/j.chom.2020.03.002) ; [2](10.21203/rs.3.rs-16262/v1) ;
426	P	705	420	539	472	22838	413	419	426	562	413	414	602	607	421	413	no	S1; RBD ; T Cell Epitope [1] ; SARS-CoV-derived discontinuous B cell epitopes associated to m39 and 80R  [2];		[1](10.1016/j.chom.2020.03.002) ;  [2](10.3390/v12030254) ;
427	D	706	421	540	473	22841	414	420	427	563	414	415	603	608	422	414	no	S1; RBD ; T Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
428	D	707	422	546	474	22844	415	421	428	564	415	416	604	609	423	415	no	S1; RBD ; T Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
429	F	708	423	547	475	22847	416	422	429	565	416	417	605	610	424	416	no	S1; RBD ; T Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
430	T	709	424	548	476	22850	417	423	430	566	417	418	606	611	425	417	no	S1; RBD ; T Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
431	G	710	425	549	477	22853	418	424	431	567	418	419	607	612	426	418	no	S1; RBD ; T Cell Epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
432	C	711	426	550	478	22856	419	425	432	568	419	420	608	613	427	419	no	S1; RBD ; T Cell Epitope [1] ; SARS-CoV-derived discontinuous B cell epitopes associated to 80R  [2];		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ;
433	V	712	427	551	479	22859	420	426	433	569	420	421	609	614	428	420	no	S1; RBD; RBM; Highly Conserved [1] ; T Cell Epitope [1] ; SARS-CoV-derived discontinuous B cell epitopes associated to 80R  [5];		[1](10.1016/j.cell.2020.03.045) ;  [2](10.1038/s41423-020-0400-4) ;  [3](10.1038/s41423-020-0374-2) ;  [4](10.1016/j.chom.2020.03.002) ; [5](10.3390/v12030254) ;
434	I	713	428	552	480	22862	421	427	434	570	421	422	610	615	429	421	no	S1; RBD		
435	A	714	429	553	481	22865	422	428	435	571	422	423	611	616	430	422	no	S1; RBD		
436	W	715	430	554	482	22868	423	429	436	572	423	424	612	617	431	423	no	S1; RBD ; SARS-CoV-derived discontinuous B cell epitopes associated to m396 and 80R and identical in SARS-2 Cov [1];		[1](10.3390/v12030254) ; [2](10.3390/v12030254) ;
437	N	716	431	555	483	22871	424	430	437	573	424	425	613	618	432	424	no	S1; RBD; RBM in contact with ACE2 [1] ; SARS-CoV-derived discontinuous B cell epitopes associated to 80R and identical in SARS-2 Cov [2];		[1](10.4049/jimmunol.176.10.6085) ; [2](10.3390/v12030254) ;
438	S	717	432	556	484	22874	425	431	438	574	425	426	614	619	433	425	no	S1; RBD; RBM in contact with ACE2 [1]		[1](10.4049/jimmunol.176.10.6085) ;
439	N	718	433	557	485	22877	426	432	439	575	426	427	615	620	434	426	no	S1; RBD; RBM; Variable residues between SARS-CoV-2 and SARS-CoV; critical residues in Polyclonal anti-SARS-1 antibodies and different between SARS-CoV-2 and SARS-CoV RBDs; SARS-CoV-derived discontinuous B cell epitopes associated to 80R [5];	Could impact Response to antibodies; Residue reported to decrease ACE2 Binding when mutated in SARS	[1](10.1038/s41423-020-0400-4) ; [2](10.1038/s41467-020-15562-9) ; [3](doi.org/10.1038/s41423-020-0374-2) ; [4](10.1186/1743-422X-2-73) ; [5](10.3390/v12030254) ;
440	N	719	434	558	486	22880	427	433	440	576	427	428	616	621	435	427	no	S1; RBD; RBM in contact with ACE2 [1] ; T Cell Epitope [2] ;  SARS-CoV-derived discontinuous B cell epitopes associated to 80R and identical in SARS-2 Cov [3];		[1](10.4049/jimmunol.176.10.6085) ; [2](10.1016/j.chom.2020.03.002) ; [3](10.3390/v12030254) ;
441	L	720	435	559	487	22883	428	434	441	577	428	429	617	622	436	428	no	S1; RBD; RBM in contact with ACE2 [1] ; T Cell Epitope [2] ; 		[1](10.4049/jimmunol.176.10.6085) ; [2](10.1016/j.chom.2020.03.002) ; 
442	D	721	436	560	488	22886	429	435	442	578	429	430	618	623	437	429	yes	S1; RBD; RBM in contact with ACE2 [1] ; at re- ceptor complex interface and considered critical for cross- species and human-to-human transmission of SARS-CoV [2] ; SARS-CoV-derived discontinuous B cell epitopes associated to 80R [3];	Disruption of Conf I-IV and VI epitopes if mutated [1]; 	[1](10.4049/jimmunol.176.10.6085) ;   [2](10.1007/s11427-020-1637-5) ; [3](10.3390/v12030254) ;
443	S	722	437	561	489	22889	430	436	443	579	430	431	619	624	438	430	no	S1; RBD; RBM in contact with ACE2 [1] ; T Cell Epitope [2] ; 		[1](10.4049/jimmunol.176.10.6085) ; [2](10.1016/j.chom.2020.03.002) ; 
444	K	723	438	562	490	22892	431	437	444	580	431	432	620	625	439	431	no	S1; RBD; RBM in contact with ACE2 [1] ; T Cell Epitope [2] ; 		[1](10.4049/jimmunol.176.10.6085) ; [2](10.1016/j.chom.2020.03.002) ; 
445	V	724	439	563	491	22895	432	438	445	581	432	433	621	626	0	432	no	S1; RBD; RBM in contact with ACE2 [1] ; T Cell Epitope [2] ; 		[1](10.4049/jimmunol.176.10.6085) ; [2](10.1016/j.chom.2020.03.002) ; 
446	G	725	440	564	492	22898	433	439	446	582	433	434	622	627	0	433	no	S1; RBD; RBM in contact with ACE2 [1] ; T Cell Epitope [2] ; 		[1](10.4049/jimmunol.176.10.6085) ; [2](10.1016/j.chom.2020.03.002) ; 
447	G	730	445	0	0	22901	434	444	447	0	434	435	0	0	0	434	no	S1; RBD; RBM in contact with ACE2 [1] ; T Cell Epitope [2] ; 		[1](10.4049/jimmunol.176.10.6085) ; [2](10.1016/j.chom.2020.03.002) ; 
448	N	731	446	0	0	22904	435	445	448	0	435	436	0	0	0	435	no	S1; RBD; RBM in contact with ACE2 [1] ; T Cell Epitope [2] ; 		[1](10.4049/jimmunol.176.10.6085) ; [2](10.1016/j.chom.2020.03.002) ; 
449	Y	732	447	0	0	22907	436	446	449	0	436	437	0	0	0	436	no	S1; RBD; RBM in contact with ACE2 [1] ; T Cell Epitope [2] ; 		[1](10.4049/jimmunol.176.10.6085) ; [2](10.1016/j.chom.2020.03.002) ; 
450	N	733	448	0	496	22910	437	447	450	0	437	438	0	0	440	437	no	S1; RBD; RBM in contact with ACE2 [1] ; T Cell Epitope [2] ; 		[1](10.4049/jimmunol.176.10.6085) ; [2](10.1016/j.chom.2020.03.002) ; 
451	Y	734	449	0	497	22913	438	448	451	0	438	439	0	0	441	438	no	S1; RBD; RBM in contact with ACE2 [1] ; T Cell Epitope [2] ; 		[1](10.4049/jimmunol.176.10.6085) ; [2](10.1016/j.chom.2020.03.002) ; 
452	L	735	450	0	498	22916	439	449	452	0	439	440	0	0	442	439	no	S1; RBD; RBM in contact with ACE2 [1] ; T Cell Epitope [2] ; 		[1](10.4049/jimmunol.176.10.6085) ; [2](10.1016/j.chom.2020.03.002) ; 
453	Y	736	451	0	499	22919	440	450	453	0	440	441	0	0	443	440	no	S1; RBD; RBM in contact with ACE2 [1] ; T Cell Epitope [2] ; 		[1](10.4049/jimmunol.176.10.6085) ; [2](10.1016/j.chom.2020.03.002) ; 
454	R	737	452	0	0	22922	441	451	454	0	441	442	0	0	444	441	yes	S1; RBD; RBM in contact with ACE2 [1] ; T Cell Epitope [2] ; 	Disruption of Conf I-IV and VI epitopes if mutated [1]; 	[1](10.4049/jimmunol.176.10.6085) ; [2](10.1016/j.chom.2020.03.002) ; 
455	L	738	453	0	500	22925	442	452	455	0	442	443	0	0	445	442	no	S1; RBD; RBM in contact with ACE2 [1] ; B cell epitope [2] ; T Cell Epitope [3] ; known rare non- synonymous alteration L455I [4] ; hACE2 Binding [5] ; 		[1](10.4049/jimmunol.176.10.6085) ;   [2](10.1101/2020.05.21.108563) ; [3](10.1016/j.chom.2020.03.002) ; [4](10.1038/s41577-020-0311-8) ; [5](10.1016/j.cell.2020.03.045) ; 
456	F	739	454	0	501	22928	443	453	456	0	443	444	0	0	446	443	no	"S1; RBD; RBM in contact with ACE2 [1] ; B cell epitope [2] ; T Cell Epitope [3] ; known rare non- synonymous alteration F456V , similar to variation in SARS Cov [4] ; hACE2 Binding [5] ; "		[1](10.4049/jimmunol.176.10.6085) ;   [2](10.1101/2020.05.21.108563) ; [3](10.1016/j.chom.2020.03.002) ; [4](10.1038/s41577-020-0311-8) ; [5](10.1016/j.cell.2020.03.045) ; 
457	R	740	455	0	502	22931	444	454	457	0	444	445	0	0	447	444	no	"S1; RBD; RBM in contact with ACE2 [1] ; B cell epitope [2] ; T Cell Epitope [3] ;	"		[1](10.4049/jimmunol.176.10.6085) ;   [2](10.1101/2020.05.21.108563) ; [3](10.1016/j.chom.2020.03.002) ; 
458	K	741	456	0	503	22934	445	455	458	0	445	446	0	0	448	445	no	"S1; RBD; RBM in contact with ACE2 [1] ; B cell epitope [2] ; 	"		[1](10.4049/jimmunol.176.10.6085) ;   [2](10.1101/2020.05.21.108563) ; 
459	S	742	457	0	504	22937	446	456	459	0	446	447	0	0	449	446	no	"S1; RBD; RBM in contact with ACE2 [1] ; B cell epitope [2] ;  SARS-CoV-derived discontinuous B cell epitopes associated to S230 [3]; 	"		[1](10.4049/jimmunol.176.10.6085) ;   [2](10.1101/2020.05.21.108563) ; [3](10.3390/v12030254);
460	N	743	458	0	505	22940	447	457	460	0	447	448	0	0	450	447	no	"S1; RBD; RBM in contact with ACE2 [1] ; B cell epitope [2] ; 	"		[1](10.4049/jimmunol.176.10.6085) ;   [2](10.1101/2020.05.21.108563) ; 
461	L	744	459	0	506	22943	448	458	461	0	448	449	0	0	451	448	no	"S1; RBD; RBM in contact with ACE2 [1] ; B cell epitope [2] ; 	"		[1](10.4049/jimmunol.176.10.6085) ;   [2](10.1101/2020.05.21.108563) ; 
462	K	745	460	0	507	22946	449	459	462	0	449	450	0	0	452	449	no	S1; RBD; RBM in contact with ACE2 [1] ; B cell epitope [2] ; T cell epitope [3]  SARS-CoV-derived discontinuous B cell epitopes associated to S230 [4]; 		[1](10.4049/jimmunol.176.10.6085) ;   [2](10.1101/2020.05.21.108563) ; [3](10.1016/j.chom.2020.03.002) ;  [4](10.3390/v12030254);
463	P	746	461	0	508	22949	450	460	463	0	450	451	0	0	453	450	no	S1; RBD; RBM in contact with ACE2 [1] ; B cell epitope [2] ; T cell epitope [3]  SARS-CoV-derived discontinuous B cell epitopes associated to S230 [4]; 		[1](10.4049/jimmunol.176.10.6085) ;   [2](10.1101/2020.05.21.108563) ; [3](10.1016/j.chom.2020.03.002) ;  [4](10.3390/v12030254);
464	F	747	462	0	509	22952	451	461	464	0	451	452	0	0	454	451	no	S1; RBD; RBM in contact with ACE2 [1] ; B cell epitope [2] ; T cell epitope [3] 		[1](10.4049/jimmunol.176.10.6085) ;   [2](10.1101/2020.05.21.108563) ; [3](10.1016/j.chom.2020.03.002) ; 
465	E	748	463	0	510	22955	452	462	465	0	452	453	0	0	455	452	yes	S1; RBD; RBM in contact with ACE2 [1] ; B cell epitope [2] ; T cell epitope [3] 	Disruption of Conf III epitope if mutated [1]; 	[1](10.4049/jimmunol.176.10.6085) ;   [2](10.1101/2020.05.21.108563) ; [3](10.1016/j.chom.2020.03.002) ; 
466	R	749	464	0	511	22958	453	463	466	0	453	454	0	0	456	453	no	S1; RBD; RBM in contact with ACE2 [1] ; B cell epitope [2] ; T cell epitope [3] 		[1](10.4049/jimmunol.176.10.6085) ;   [2](10.1101/2020.05.21.108563) ; [3](10.1016/j.chom.2020.03.002) ; 
467	D	750	465	0	0	22961	454	464	467	0	454	455	0	0	457	454	yes	S1; RBD; RBM in contact with ACE2 [1] ; B cell epitope [2] ; T cell epitope [3] 	Disruption of Conf I-IV and VI epitopes if mutated [1]; 	[1](10.4049/jimmunol.176.10.6085) ;   [2](10.1101/2020.05.21.108563) ; [3](10.1016/j.chom.2020.03.002) ; 
468	I	751	466	0	0	22964	455	465	468	0	455	456	0	0	458	455	no	S1; RBD; RBM in contact with ACE2 [1] ; B cell epitope [2] ; T cell epitope [3] 		[1](10.4049/jimmunol.176.10.6085) ;   [2](10.1101/2020.05.21.108563) ; [3](10.1016/j.chom.2020.03.002) ; 
469	S	752	467	0	0	22967	456	466	469	0	456	457	0	0	459	456	no	S1; RBD; RBM in contact with ACE2 [1] ; B cell epitope [2] ; T cell epitope [3]  ; SARS-CoV-derived discontinuous B cell epitopes associated to 80R [3];		[1](10.4049/jimmunol.176.10.6085) ;   [2](10.1101/2020.05.21.108563) ; [3](10.1016/j.chom.2020.03.002) ; [4](10.3390/v12030254) ;
470	T	762	477	0	512	22970	457	476	470	0	457	458	0	0	460	457	no	S1; RBD; RBM in contact with ACE2 [1] ; B cell epitope [2] ; T cell epitope [3]  ; SARS-CoV-derived discontinuous B cell epitopes associated to 80R [3];		[1](10.4049/jimmunol.176.10.6085) ;   [2](10.1101/2020.05.21.108563) ; [3](10.1016/j.chom.2020.03.002) ; [4](10.3390/v12030254) ;
471	E	763	478	0	513	22973	458	477	471	0	458	459	0	0	461	458	no	S1; RBD; RBM in contact with ACE2 [1] ; B cell epitope [2] ; T cell epitope [3] ; SARS-CoV-derived discontinuous B cell epitopes associated to 80R [3];		[1](10.4049/jimmunol.176.10.6085) ;   [2](10.1101/2020.05.21.108563) ; [3](10.1016/j.chom.2020.03.002) ; [4](10.3390/v12030254) ;
472	I	764	479	0	514	22976	459	478	472	0	459	460	0	0	0	459	no	S1; RBD; RBM in contact with ACE2 [1] ; at re- ceptor complex interface and considered critical for cross- species and human-to-human transmission of SARS-CoV [2] ; B cell epitope [3] ; T cell epitope [4]; SARS-CoV-derived discontinuous B cell epitopes associated to 80R [5];		"[1](10.4049/jimmunol.176.10.6085) ;   [2](10.1007/s11427-020-1637-5) ; [3](10.1016/j.chom.2020.03.002) ;	 [5](10.3390/v12030254) ;"
473	Y	765	480	0	515	22979	460	479	473	0	460	461	0	0	0	460	no	S1; RBD; RBM in contact with ACE2 [1] ; B cell epitope [2] ; T cell epitope [3] ; hACE2 Binding [4] ; SARS-CoV-derived discontinuous B cell epitopes associated to 80R and identical in SARS-2 Cov [5];		[1](10.4049/jimmunol.176.10.6085) ;   [2](10.1101/2020.05.21.108563) ; [3](10.1016/j.chom.2020.03.002) ; [4](10.1016/j.cell.2020.03.045) ; [5](10.3390/v12030254) ;
474	Q	766	481	0	516	22982	461	480	474	0	461	462	0	0	0	461	no	S1; RBD; RBM in contact with ACE2 [1] ; B cell epitope [2] ; T cell epitope [3]; SARS-CoV-derived discontinuous B cell epitopes associated to 80R and identical in SARS-2 Cov [4];		[1](10.4049/jimmunol.176.10.6085) ;   [2](10.1101/2020.05.21.108563) ; [3](10.1016/j.chom.2020.03.002) ; [4](10.3390/v12030254) ;
475	A	767	482	0	517	22985	462	481	475	0	462	463	0	0	0	462	no	S1; RBD; RBM in contact with ACE2 [1] ; B cell epitope [2]  ; hACE2 Binding [3] ; SARS-CoV-derived discontinuous B cell epitopes associated to S230 and 80R and identical in SARS-2 Cov [4];		[1](10.4049/jimmunol.176.10.6085) ;   [2](10.1101/2020.05.21.108563) ; [3](10.1016/j.cell.2020.03.045) ; [4](10.3390/v12030254);
476	G	768	483	0	518	22988	463	482	476	0	463	464	0	0	0	463	yes	"S1; RBD; RBM in contact with ACE2 [1] ; B cell epitope [2] ; known rare non- synonymous alteration G476S135, similar to variation in SARS Cov [3] ; hACE2 Binding [4] ; SARS-CoV-derived discontinuous B cell epitopes associated to 80R [5];"	Disruption of Conf III epitope if mutated [1]; 	[1](10.4049/jimmunol.176.10.6085) ;   [2](10.1101/2020.05.21.108563) ;  [3](10.1038/s41577-020-0311-8) ; [4](10.1016/j.cell.2020.03.045) ; [5](10.3390/v12030254) ;
477	S	769	484	0	519	22991	464	483	477	0	464	465	0	0	0	464	no	"S1; RBD; RBM in contact with ACE2 [3] ; Variable residues between SARS-CoV-2 and SARS-CoV ; B cell epitope [4] ; 	"		[1](10.1038/s41423-020-0400-4); [2](doi.org/10.1038/s41423-020-0374-2) ; [3](10.4049/jimmunol.176.10.6085) ; [4](10.1101/2020.05.21.108563); 
478	T	774	489	565	524	22994	465	488	478	583	465	466	623	628	0	465	no	"S1; RBD; RBM in contact with ACE2 [1] ; B cell epitope [2] ; SARS-CoV-derived discontinuous B cell epitopes associated to 80R and identical in SARS-2 Cov [3];	"		[1](10.4049/jimmunol.176.10.6085) ;   [2](10.1101/2020.05.21.108563) ; [3](10.3390/v12030254) ;
479	P	775	490	566	525	22997	466	489	479	584	466	467	624	629	0	466	no	S1; RBD; RBM in contact with ACE2 [1] ; at re- ceptor complex interface and considered critical for cross- species and human-to-human transmission of SARS-CoV [2] ; SARS-CoV-derived discontinuous B cell epitopes associated to 80R[3];		[1](10.4049/jimmunol.176.10.6085) ;   [2](10.1007/s11427-020-1637-5) ; [3](10.3390/v12030254) ;
480	C	776	491	567	526	23000	467	490	480	585	467	468	625	630	0	467	no	S1; RBD; disulfide bonds with residue 474 (in SARS cov) [1] ; SARS-CoV-derived discontinuous B cell epitopes associated to 80R [2];		[1](10.1038/s41423-020-0400-4) ; [2](10.3390/v12030254) ;
481	N	778	492	568	527	23003	468	492	481	586	468	469	626	631	0	468	no	S1; RBD; RBM in contact with ACE2 [1] ; SARS-CoV-derived discontinuous B cell epitopes associated to 80R and identical in SARS-2 Cov [2];		[1](10.4049/jimmunol.176.10.6085) ; [2](10.3390/v12030254) ;
482	G	779	493	569	528	23006	469	493	482	587	469	470	627	632	0	469	no	S1; RBD; RBM in contact with ACE2 [3] Variable residues between SARS-CoV-2 and SARS-CoV; SARS-CoV-derived discontinuous B cell epitopes associated to m396 and 80R and identical in SARS-2 Cov [4];		[1](10.1038/s41423-020-0400-4); [2](doi.org/10.1038/s41423-020-0374-2); [3](10.4049/jimmunol.176.10.6085); [4](10.3390/v12030254) ;
483	V	780	494	570	529	23009	0	494	483	588	0	0	628	633	0	0	no	S1; RBD; RBM in contact with ACE2 [1]; known rare non- synonymous alteration V483A similar to a variation in MERS that is linked to reduced viral protein binding to the host receptor and increased resistance to antibody neutralization from serum sam- ples [2]  ; hACE2 Binding [3] ; 		[1](10.4049/jimmunol.176.10.6085) ; [2](10.1038/s41577-020-0311-8) ; [3](10.1016/j.cell.2020.03.045) ; 
484	E	781	495	571	530	23012	470	495	484	589	470	471	629	634	0	470	no	"S1; RBD; RBM in contact with ACE2 [1], SARS-CoV-derived discontinuous B cell epitopes associated to m396  [2];  SARS-CoV-derived discontinuous B cell epitopes associated to m396 and 80R and identical in SARS-2 Cov [2];"		[1](10.4049/jimmunol.176.10.6085) ; [2](10.3390/v12030254) ;
485	G	782	496	572	531	23015	471	496	485	590	471	472	630	635	0	471	no	S1; RBD; RBM; Variable residues between SARS-CoV-2 and SARS-CoV; SARS-CoV-derived discontinuous B cell epitopes associated to m396 and 80R and identical in SARS-2 Cov   [2];		[1](10.1038/s41423-020-0400-4) ; [2](10.1038/s41423-020-0374-2) ; [3](10.3390/v12030254) ;
486	F	806	520	0	0	23018	472	0	486	0	472	473	0	0	462	472	no	S1; RBD; insertion into hydrophobic pocket in human ACE2 (comprising Leu79; Met82 and Tyr83) [1] ;  L486F change from SARS-cov increase flexibility of RBD loop and improve affinity [1] ; critical for cross- species and human-to-human transmission of SARS-CoV [2] ; hACE2 Binding [3] ; SARS-CoV-derived discontinuous B cell epitopes associated to m396 and 80R and identical in SARS-2 Cov [4];		[1](10.1101/2020.05.01.072371); [2](10.1126/science.1116480); [3](10.1016/j.cell.2020.03.045) ;  [4](10.3390/v12030254) ;
487	N	807	521	0	0	23021	473	0	487	0	473	474	0	0	463	473	no	S1; RBD; RBM in contact with ACE2 [1] ; at re- ceptor complex interface and considered critical for cross- species and human-to-human transmission of SARS-CoV [2] ; hACE2 Binding [3] ; SARS-CoV-derived discontinuous B cell epitopes associated to m396 and 80R v [4];		[1](10.4049/jimmunol.176.10.6085) ;   [2](10.1007/s11427-020-1637-5) ; [3](10.1016/j.cell.2020.03.045) ; [4](10.3390/v12030254) ;
488	C	808	522	0	0	23024	474	0	488	0	474	475	0	0	464	474	no	S1; RBD; RBM in contact with ACE2 [2] disulfide bonds with residue 467 (in SARS cov) [1]  ; SARS-CoV-derived discontinuous B cell epitopes associated to m396 and 80R and identical in SARS-2 Cov [3];		[1](10.1038/s41423-020-0400-4) ; [2](10.4049/jimmunol.176.10.6085); [3](10.3390/v12030254) ;
489	Y	814	528	573	545	23027	475	0	489	591	475	476	631	636	465	475	no	S1; RBD; RBM in contact with ACE2 [1]  ; hACE2 Binding [2] ; SARS-CoV-derived discontinuous B cell epitopes associated to m396 and 80R (and  maybe identical in SARS-2 Cov) [3];		[1](10.4049/jimmunol.176.10.6085) ; [2](10.1016/j.cell.2020.03.045) ; [3](10.3390/v12030254) ;
490	F	815	529	574	546	23030	476	0	490	592	476	477	632	637	466	476	no	S1; RBD; RBM in contact with ACE2 [1] ; hACE2 Binding [2] ; SARS-CoV-derived discontinuous B cell epitopes associated to m396 and identical in SARS-2 Cov [3];		[1](10.4049/jimmunol.176.10.6085) ; [2](10.1016/j.cell.2020.03.045) ; [3](10.3390/v12030254) ;
491	P	816	530	575	547	23033	477	0	491	593	477	478	633	638	467	477	no	S1; RBD; RBM in contact with ACE2 [1] ; at re- ceptor complex interface and considered critical for cross- species and human-to-human transmission of SARS-CoV [2] ; SARS-CoV-derived discontinuous B cell epitopes associated to m396 and 80R and identical in SARS-2 Cov  [3];		[1](10.4049/jimmunol.176.10.6085) ;   [2](10.1007/s11427-020-1637-5) ; [3](10.3390/v12030254) ;
492	L	817	531	576	548	23036	478	0	492	594	478	479	634	639	468	478	no	S1; RBD; RBM in contact with ACE2 [1] ; SARS-CoV-derived discontinuous B cell epitopes associated to m396 and 80R and identical in SARS-2 Cov [2];		[1](10.4049/jimmunol.176.10.6085) ; [2](10.3390/v12030254) ;
493	Q	818	532	577	549	23039	479	0	493	595	479	480	635	640	469	479	no	S1; RBD; RBM in contact with ACE2 [1] ; critical for cross- species and human-to-human transmission of SARS-CoV [2] ; hACE2 Binding [3] ; 		[1](10.4049/jimmunol.176.10.6085) ;   [2](10.1126/science.1116480); [3](10.1016/j.cell.2020.03.045) ; 
494	S	819	533	578	550	23042	480	0	494	596	480	481	636	641	470	480	no	S1; RBD; RBM in contact with ACE2 [1] SARS-CoV-derived discontinuous B cell epitopes associated to m396 and identical in SARS-2 Cov [2];		[1](10.4049/jimmunol.176.10.6085) ; [2](10.3390/v12030254) ;
495	Y	820	534	579	551	23045	481	0	495	597	481	482	637	642	471	481	no	S1; RBD		
496	G	821	535	580	552	23048	482	0	496	598	482	483	638	643	472	482	no	S1; RBD ; hACE2 Binding [1] ; 		[1](10.1016/j.cell.2020.03.045) ; 
497	F	863	574	581	553	23051	483	533	497	599	483	484	639	644	473	483	no	S1; RBD		
498	Q	864	575	582	554	23054	484	534	498	600	484	485	640	645	474	484	no	S1; RBD ; hACE2 Binding [1] ; 		[1](10.1016/j.cell.2020.03.045) ; 
499	P	865	576	583	555	23057	485	535	499	601	485	486	641	646	475	485	no	S1; RBD		
500	T	866	577	584	556	23060	486	536	500	602	486	487	642	647	476	486	no	S1; RBD ; hACE2 Binding [1] ; 		[1](10.1016/j.cell.2020.03.045) ; 
501	N	867	578	585	557	23063	487	537	501	603	487	488	643	648	477	487	no	S1; RBD; critical for cross- species and human-to-human transmission of SARS-CoV [1] ; hACE2 Binding [2] ; 		[1](10.1126/science.1116480) ; [2](10.1016/j.cell.2020.03.045) ; 
502	G	868	579	586	558	23066	488	538	502	604	488	489	644	649	478	488	no	S1; RBD ; forecasted as components of discontinuous B-cell epitopes [1] ; hACE2 Binding [2] ; 		[1](10.21203/rs.3.rs-16262/v1); [2](10.1016/j.cell.2020.03.045) ; 
503	V	869	580	587	559	23069	489	539	503	605	489	490	645	650	479	489	no	S1; RBD		
504	G	870	581	588	560	23072	490	540	504	606	490	491	646	651	480	490	no	"S1; RBD ; B-cell epitope HLA-A*24:02, HLA-A*23:01 [1]"		[1](10.3390/v12030254);
505	Y	872	583	590	561	23075	491	542	505	608	491	492	647	652	481	491	no	"S1; RBD ; hACE2 Binding [1] ; HLA-A*24:02, HLA-A*23:01 [2] ; "		[1](10.1016/j.cell.2020.03.045) ;  [2](10.3390/v12030254);
506	Q	873	584	591	562	23078	492	543	506	609	492	493	648	653	482	492	no	"S1; RBD ; HLA-A*24:02 , HLA-A*23:01 [[1]"		[1](10.3390/v12030254);
507	P	874	585	592	563	23081	493	544	507	610	493	494	649	654	483	493	no	"S1; RBD ; HLA-A*24:02 , HLA-A*01:01, HLA-A*23:01, HLA-A*01:01 [ [1]"		[1](10.3390/v12030254);
508	Y	875	586	593	564	23084	494	545	508	611	494	495	650	655	484	494	no	"S1; RBD ; HLA-A*24:02 , HLA-A*01:01, HLA-A*23:01, HLA-A*01:01 [ [1]"		[1](10.3390/v12030254);
509	R	876	587	594	565	23087	495	546	509	612	495	496	651	656	485	495	no	"S1; RBD ; HLA-A*24:02 , HLA-A*01:01, HLA-A*23:01, HLA-A*01:01 [ [1]"		[1](10.3390/v12030254);
510	V	877	588	595	566	23090	496	547	510	613	496	497	652	657	486	496	no	"S1; RBD ; HLA-A*24:02 , HLA-A*01:01, HLA-A*23:01, HLA-A*01:01 [ [1]"		[1](10.3390/v12030254);
511	V	878	589	596	567	23093	497	548	511	614	497	498	653	658	487	497	no	"S1; RBD ; HLA-A*24:02 , HLA-A*01:01, HLA-A*23:01, HLA-A*01:01 [ [1]"		[1](10.3390/v12030254);
512	V	879	590	597	568	23096	498	549	512	615	498	499	654	659	488	498	no	"S1; RBD ; HLA-A*24:02 , HLA-A*01:01, HLA-A*23:01, HLA-A*01:01 [ [1]"		[1](10.3390/v12030254);
513	L	880	591	598	569	23099	499	550	513	616	499	500	655	660	489	499	no	"S1; RBD ; HLA-A*24:02 , HLA-A*01:01, HLA-A*23:01, HLA-A*01:01 [ [1]"		[1](10.3390/v12030254);
514	S	881	592	599	570	23102	500	551	514	617	500	501	656	661	490	500	no	"S1; RBD ; HLA-A*24:02 , HLA-A*01:01, HLA-A*23:01, HLA-A*01:01 [ [1]"		[1](10.3390/v12030254);
515	F	882	593	600	571	23105	501	552	515	618	501	502	657	662	491	501	no	"S1; RBD ; HLA-A*24:02 , HLA-A*01:01, HLA-A*01:01 [ [1]"		[1](10.3390/v12030254);
516	E	883	594	601	572	23108	502	553	516	619	502	503	658	663	492	502	no	"S1; RBD ; HLA-A*24:02 , HLA-A*01:01, HLA-A*01:01 [ [1]"		[1](10.3390/v12030254);
517	L	888	595	606	573	23111	503	554	517	624	503	504	663	668	493	503	no	S1; RBD ; HLA-A*24:02 [1]		[1](10.3390/v12030254);
518	L	889	596	607	574	23114	504	555	518	625	504	505	664	669	494	504	no	S1; RBD ; HLA-A*24:02 [1]		[1](10.3390/v12030254);
519	H	890	597	608	575	23117	505	556	519	626	505	506	665	670	495	505	no	S1; RBD ; HLA-A*24:02 [1]		[1](10.3390/v12030254);
520	A	891	598	609	576	23120	506	557	520	627	506	507	666	671	496	506	no	S1; RBD; highly Conserved [1] ; HLA-A*24:02 [2] ; 		[1]( 10.1016/j.cell.2020.03.045) ;  [2](10.3390/v12030254);
521	P	896	601	610	581	23123	507	560	521	628	507	508	667	672	497	507	no	S1; RBD ; HLA-A*24:02 [1]		[1](10.3390/v12030254);
522	A	897	602	611	582	23126	508	561	522	629	508	509	668	673	498	508	no	S1; RBD; Lowly Conserved [1] ; HLA-A*24:02 [2] ; 		[1]( 10.1016/j.cell.2020.03.045) ;  [2](10.3390/v12030254);
523	T	898	603	612	583	23129	509	562	523	630	509	510	669	674	499	509	no	S1; RBD ; HLA-A*24:02 [1]		[1](10.3390/v12030254);
524	V	899	604	613	584	23132	510	563	524	631	510	511	670	675	500	510	no	S1; B Cell Epitope [1] ; HLA-A*24:02 [2] ; 		[1](10.1016/j.chom.2020.03.002) ;  [2](10.3390/v12030254);
525	C	900	605	614	585	23135	511	564	525	632	511	512	671	676	501	511	no	S1; B Cell Epitope [1] ; HLA-A*24:02 [2] ; 		[1](10.1016/j.chom.2020.03.002) ;  [2](10.3390/v12030254);
526	G	901	606	615	586	23138	512	565	526	633	512	513	672	677	502	512	no	S1; B Cell Epitope [1] ;  HLA-A*24:02 [2] ; 		[1](10.1016/j.chom.2020.03.002) ;  [2](10.3390/v12030254);
527	P	902	607	616	587	23141	513	566	527	634	513	514	673	678	503	513	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
528	K	903	608	617	588	23144	514	567	528	635	514	515	674	679	504	514	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
529	K	904	609	618	589	23147	515	568	529	636	515	516	675	680	505	515	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
530	S	908	613	619	593	23150	516	572	530	637	516	517	676	681	506	516	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
531	T	909	614	620	594	23153	517	573	531	638	517	518	677	682	507	517	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
532	N	910	615	621	595	23156	518	574	532	639	518	519	678	683	508	518	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
533	L	911	616	622	596	23159	519	575	533	640	519	520	679	684	509	519	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
534	V	912	617	623	597	23162	520	576	534	641	520	521	680	685	510	520	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
535	K	915	618	624	600	23165	521	577	535	642	521	522	681	686	511	521	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
536	N	916	619	625	601	23168	522	578	536	643	522	523	682	687	512	522	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
537	K	917	620	626	602	23171	523	579	537	644	523	524	683	688	513	523	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
538	C	918	621	627	603	23174	524	580	538	645	524	525	684	689	514	524	no	S1; B Cell Epitope [1] ;  HLA-DRB1*01:01 [2] ; 		[1](10.1016/j.chom.2020.03.002) ;  [2](10.3390/v12030254);
539	V	919	622	628	604	23177	525	581	539	646	525	526	685	690	515	525	no	S1; B Cell Epitope [1] ;  HLA-DRB1*01:01 [2] ; 		[1](10.1016/j.chom.2020.03.002) ;  [2](10.3390/v12030254);
540	N	920	623	629	605	23180	526	582	540	647	526	527	686	691	516	526	no	S1; B Cell Epitope [1] ;  HLA-DRB1*01:01 [2] ; 		[1](10.1016/j.chom.2020.03.002) ;  [2](10.3390/v12030254);
541	F	921	624	630	606	23183	527	583	541	648	527	528	687	692	517	527	no	S1; B Cell Epitope [1] ;  HLA-DRB1*01:01 [2] ; 		[1](10.1016/j.chom.2020.03.002) ;  [2](10.3390/v12030254);
542	N	922	625	631	607	23186	528	584	542	649	528	529	688	693	518	528	no	S1; B Cell Epitope [1] ;  HLA-DRB1*01:01 [2] ; 		[1](10.1016/j.chom.2020.03.002) ;  [2](10.3390/v12030254);
543	F	923	626	632	608	23189	529	585	543	650	529	530	689	694	519	529	no	S1; B Cell Epitope [1] ;  HLA-DRB1*01:01 [2] ; 		[1](10.1016/j.chom.2020.03.002) ;  [2](10.3390/v12030254);
544	N	924	627	633	609	23192	530	586	544	651	530	531	690	695	520	530	no	S1; B Cell Epitope [1] ;  HLA-DRB1*01:01 [2] ; 		[1](10.1016/j.chom.2020.03.002) ;  [2](10.3390/v12030254);
545	G	925	628	634	610	23195	531	587	545	652	531	532	691	696	521	531	no	S1; B Cell Epitope [1] ;  HLA-DRB1*01:01 [2] ; 		[1](10.1016/j.chom.2020.03.002) ;  [2](10.3390/v12030254);
546	L	926	629	635	611	23198	532	588	546	653	532	533	692	697	522	532	no	S1; B Cell Epitope [1] ;  HLA-DRB1*01:01 [2] ; 		[1](10.1016/j.chom.2020.03.002) ;  [2](10.3390/v12030254);
547	T	927	630	636	612	23201	533	589	547	654	533	534	693	698	523	533	no	S1; B Cell Epitope [1] ;  HLA-DRB1*01:01 [2] ; 		[1](10.1016/j.chom.2020.03.002) ;  [2](10.3390/v12030254);
548	G	928	631	637	613	23204	534	590	548	655	534	535	694	699	524	534	no	S1; B Cell Epitope [1] ;  HLA-DRB1*01:01 [2] ; 		[1](10.1016/j.chom.2020.03.002) ;  [2](10.3390/v12030254);
549	T	929	632	638	614	23207	535	591	549	656	535	536	695	700	525	535	no	S1; B Cell Epitope [1] ;  HLA-DRB1*01:01 [2] ; 		[1](10.1016/j.chom.2020.03.002) ;  [2](10.3390/v12030254);
550	G	930	633	639	615	23210	536	592	550	657	536	537	696	701	526	536	no	S1; B Cell Epitope [1] ;  HLA-DRB1*01:01 [2] ; 		[1](10.1016/j.chom.2020.03.002) ;  [2](10.3390/v12030254);
551	V	931	634	640	616	23213	537	593	551	658	537	538	697	702	527	537	no	S1; B Cell Epitope [1] ;  HLA-DRB1*01:01 [2] ; 		[1](10.1016/j.chom.2020.03.002) ;  [2](10.3390/v12030254);
552	L	932	635	641	617	23216	538	594	552	659	538	539	698	703	528	538	no	S1; B Cell Epitope [1] ;  HLA-DRB1*01:01 [2] ; 		[1](10.1016/j.chom.2020.03.002) ;  [2](10.3390/v12030254);
553	T	933	636	642	618	23219	539	595	553	660	539	540	699	704	529	539	no	S1; B Cell Epitope [1] ;  HLA-DRB1*01:01 [2] ; 		[1](10.1016/j.chom.2020.03.002) ;  [2](10.3390/v12030254);
554	E	934	637	643	619	23222	540	596	554	661	540	541	700	705	530	540	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
555	S	935	638	644	620	23225	541	597	555	662	541	542	701	706	531	541	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
556	N	936	639	645	621	23228	542	598	556	663	542	543	702	707	532	542	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
557	K	937	640	646	622	23231	543	599	557	664	543	544	703	708	533	543	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
558	K	938	641	647	623	23234	544	600	558	665	544	545	704	709	534	544	no	S1; B Cell Epitope [1] ; forecasted as components of discontinuous B-cell epitopes [2]; 		[1](10.1016/j.chom.2020.03.002) ; [2](10.21203/rs.3.rs-16262/v1); 
559	F	939	642	648	624	23237	545	601	559	666	545	546	705	710	535	545	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
560	L	940	643	649	625	23240	546	602	560	667	546	547	706	711	536	546	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
561	P	942	645	650	626	23243	547	604	561	668	547	548	707	712	537	547	no	S1; B Cell Epitope [1] ; forecasted as components of discontinuous B-cell epitopes [2]; 		[1](10.1016/j.chom.2020.03.002) ; [2](10.21203/rs.3.rs-16262/v1); 
562	F	943	646	651	627	23246	548	605	562	669	548	549	708	713	538	548	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
563	Q	944	647	652	628	23249	549	606	563	670	549	550	709	714	539	549	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
564	Q	945	648	653	629	23252	550	607	564	671	550	551	710	715	540	550	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
565	F	946	649	654	630	23255	551	608	565	672	551	552	711	716	541	551	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
566	G	947	650	655	631	23258	552	609	566	673	552	553	712	717	542	552	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
567	R	948	651	656	632	23261	553	610	567	674	553	554	713	718	543	553	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
568	D	949	652	657	633	23264	554	611	568	675	554	555	714	719	544	554	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
569	I	950	653	0	634	23267	555	612	569	0	555	556	0	0	545	555	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
570	A	951	654	658	635	23270	556	613	570	676	556	557	715	720	546	556	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
571	D	952	655	659	636	23273	557	614	571	677	557	558	716	721	547	557	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
572	T	953	656	660	637	23276	558	615	572	678	558	559	717	722	548	558	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
573	T	954	657	661	638	23279	559	616	573	679	559	560	718	723	549	559	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
574	D	955	658	662	639	23282	560	617	574	680	560	561	719	724	550	560	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
575	A	956	659	663	640	23285	561	618	575	681	561	562	720	725	551	561	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
576	V	957	660	664	641	23288	562	619	576	682	562	563	721	726	552	562	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
577	R	958	661	665	642	23291	563	620	577	683	563	564	722	727	553	563	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
578	D	959	662	666	643	23294	564	621	578	684	564	565	723	728	554	564	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
579	P	960	663	667	0	23297	565	622	579	685	565	566	724	729	555	565	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
580	Q	961	664	668	644	23300	566	623	580	686	566	567	725	730	556	566	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
581	T	962	665	669	645	23303	567	624	581	687	567	568	726	731	557	567	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
582	L	963	666	670	646	23306	568	625	582	688	568	569	727	732	558	568	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
583	E	964	667	671	647	23309	569	626	583	689	569	570	728	733	559	569	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
584	I	965	668	672	648	23312	570	627	584	690	570	571	729	734	560	570	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
585	L	966	669	673	649	23315	571	628	585	691	571	572	730	735	561	571	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
586	D	967	670	674	650	23318	572	629	586	692	572	573	731	736	562	572	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
587	I	968	671	675	651	23321	573	630	587	693	573	574	732	737	563	573	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
588	T	969	672	676	652	23324	574	631	588	694	574	575	733	738	564	574	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
589	P	970	673	677	653	23327	575	632	589	695	575	576	734	739	565	575	no	S1; B Cell Epitope [1] ;  HLA-DRB1*01:01 [2] ;		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); 
590	C	971	674	678	654	23330	576	633	590	696	576	577	735	740	566	576	no	S1; B Cell Epitope [1] ;  HLA-DRB1*01:01 [2] ;		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); 
591	S	972	675	679	655	23333	577	634	591	697	577	578	736	741	567	577	no	S1; B Cell Epitope [1] ;  HLA-DRB1*01:01 [2] ;		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); 
592	F	973	676	680	656	23336	578	635	592	698	578	579	737	742	568	578	no	S1; B Cell Epitope [1] ;  HLA-DRB1*01:01 [2] ;		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); 
593	G	974	677	681	657	23339	579	636	593	699	579	580	738	743	569	579	no	S1; B Cell Epitope [1] ;  HLA-DRB1*01:01 [2] ;		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); 
594	G	975	678	682	658	23342	580	637	594	700	580	581	739	744	570	580	no	S1; B Cell Epitope [1] ;  HLA-DRB1*01:01 [2] ;		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); 
595	V	976	679	683	659	23345	581	638	595	701	581	582	740	745	571	581	no	S1; B Cell Epitope [1] ;  HLA-DRB1*01:01 [2] ;		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); 
596	S	977	680	684	660	23348	582	639	596	702	582	583	741	746	572	582	no	S1; B Cell Epitope [1] ;  HLA-DRB1*01:01 [2] ;		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); 
597	V	978	681	685	661	23351	583	640	597	703	583	584	742	747	573	583	no	S1; B Cell Epitope [1] ;  HLA-DRB1*01:01 [2] ;		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); 
598	I	979	682	686	662	23354	584	641	598	704	584	585	743	748	574	584	no	S1; B Cell Epitope [1] ;  HLA-DRB1*01:01 [2] ;		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); 
599	T	980	683	687	663	23357	585	642	599	705	585	586	744	749	575	585	no	S1; B Cell Epitope [1] ;  HLA-DRB1*01:01 [1] ;		[1](10.3390/v12030254); 
600	P	981	684	688	664	23360	586	643	600	706	586	587	745	750	576	586	no	S1; B Cell Epitope [1] ;  HLA-DRB1*01:01 [1] ;		[1](10.3390/v12030254); 
601	G	982	685	689	665	23363	587	644	601	707	587	588	746	751	577	587	no	S1; B Cell Epitope [1] ;  HLA-DRB1*01:01 [2] ;		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); 
602	T	983	686	690	666	23366	588	645	602	708	588	589	747	752	578	588	no	S1; B Cell Epitope [1] ;  HLA-DRB1*01:01 [2] ;		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254); 
603	N	984	0	691	667	23369	589	0	603	709	589	590	748	753	579	589	no	S1; B Cell Epitope [1] ;  S1; mixture of oligomannose-type glycans and complex-type glycans [2] ; HLA-DRB1*01:01 [3] ;		[1](10.1016/j.chom.2020.03.002) ;  [2](10.1101/2020.03.26.010322) ; [3](10.3390/v12030254); 
604	T	985	0	692	668	23372	590	0	604	710	590	591	749	754	580	590	no	S1; B Cell Epitope [1] ;  HLA-DRB1*01:01 [2] ;		[1](10.1016/j.chom.2020.03.002) ; [2](10.21203/rs.3.rs-16262/v1); 
605	S	986	687	693	669	23375	591	646	605	711	591	592	750	755	581	591	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
606	N	987	688	694	670	23378	592	647	606	712	592	593	751	756	582	592	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
607	Q	988	689	695	0	23381	593	648	607	713	593	594	752	757	583	593	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
608	V	989	690	696	0	23384	594	649	608	714	594	595	753	758	584	594	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
609	A	990	691	697	671	23387	595	650	609	715	595	596	754	759	585	595	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
610	V	991	692	698	672	23390	596	651	610	716	596	597	755	760	586	596	no	S1;  T cell epitope [1] ; B Cell Epitope [2] ;  		[1](10.1101/2020.05.21.108563) ; [2](10.1016/j.chom.2020.03.002) ; 
611	L	992	693	699	673	23393	597	652	611	717	597	598	756	761	587	597	no	S1;  T cell epitope [1] ; B Cell Epitope [2] ;  		[1](10.1101/2020.05.21.108563) ; [2](10.1016/j.chom.2020.03.002) ; 
612	Y	993	694	700	674	23396	598	653	612	718	598	599	757	762	588	598	no	S1;  T cell epitope [1] ; B Cell Epitope [2] ;  		[1](10.1101/2020.05.21.108563) ; [2](10.1016/j.chom.2020.03.002) ; 
613	Q	994	695	701	675	23399	599	654	613	719	599	600	758	763	589	599	no	S1;  T cell epitope [1] ; B Cell Epitope [2] ;  		[1](10.1101/2020.05.21.108563) ; [2](10.1016/j.chom.2020.03.002) ; 
614	D	995	696	702	676	23402	600	655	614	720	600	601	759	764	590	600	yes	"S1; variation with most expressive frequency reported by 17 recent published/preprinted study, under positive selection, T cell epitope [1] ; B Cell Epitope [2] ; Mutation observed at nt 23403 in Europe [3] ; High frequency SNP [4] ;"	no evidence of impact on virus functionality [1] ; 	[1](10.1101/2020.05.21.108563) ; [2](10.1016/j.chom.2020.03.002) ; [3](10.1186/s12967-020-02344-6); [4](10.1016/j.ygeno.2020.04.016)
615	V	996	697	703	677	23405	601	656	615	721	601	602	760	765	591	601	no	S1;  T cell epitope [1] ; B Cell Epitope [2] ;  		[1](10.1101/2020.05.21.108563) ; [2](10.1016/j.chom.2020.03.002) ; 
616	N	997	698	706	678	23408	602	657	616	722	602	603	761	766	592	602	no	S1;  T cell epitope [1] ; B Cell Epitope [2] ;  		[1](10.1101/2020.05.21.108563) ; [2](10.1016/j.chom.2020.03.002) ; 
617	C	998	699	707	679	23411	603	658	617	723	603	604	762	767	593	603	no	S1;  T cell epitope [1] ; B Cell Epitope [2] ;  		[1](10.1101/2020.05.21.108563) ; [2](10.1016/j.chom.2020.03.002) ; 
618	T	999	700	708	680	23414	604	659	618	724	604	605	763	768	594	604	no	S1;  T cell epitope [1] ; B Cell Epitope [2] ;  		[1](10.1101/2020.05.21.108563) ; [2](10.1016/j.chom.2020.03.002) ; 
619	E	1000	701	709	681	23417	605	660	619	725	605	606	764	769	595	605	no	S1;  T cell epitope [1] ; B Cell Epitope [2] ;  		[1](10.1101/2020.05.21.108563) ; [2](10.1016/j.chom.2020.03.002) ; 
620	V	1001	702	0	682	23420	606	661	620	0	606	607	765	770	596	606	no	S1;  T cell epitope [1] ; B Cell Epitope [2] ;  		[1](10.1101/2020.05.21.108563) ; [2](10.1016/j.chom.2020.03.002) ; 
621	P	1002	703	0	683	23423	607	662	621	0	607	608	766	771	597	607	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
622	V	1003	704	0	684	23426	608	663	622	0	608	609	0	0	598	608	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
623	A	1004	705	0	685	23429	609	664	623	0	609	610	0	0	599	609	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
624	I	1005	706	0	686	23432	610	665	624	0	610	611	0	0	600	610	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
625	H	1008	707	0	689	23435	611	666	625	0	611	612	0	0	601	611	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
626	A	1009	708	0	690	23438	612	667	626	0	612	613	0	0	602	612	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
627	D	1010	709	0	691	23441	613	668	627	0	613	614	0	0	603	613	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
628	Q	1011	710	0	692	23444	614	669	628	0	614	615	0	0	604	614	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
629	L	1012	711	710	693	23447	615	670	629	726	615	616	767	772	605	615	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
630	T	1013	712	711	694	23450	616	671	630	727	616	617	768	773	606	616	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
631	P	1014	713	712	695	23453	617	672	631	728	617	618	769	774	607	617	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
632	T	1015	0	713	696	23456	618	0	632	729	618	619	770	775	608	618	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
633	W	1016	0	714	697	23459	619	0	633	730	619	620	771	776	609	619	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
634	R	1017	0	715	698	23462	620	0	634	731	620	621	772	777	610	620	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
635	V	1018	0	716	699	23465	621	0	635	732	621	622	773	778	611	621	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
636	Y	1019	0	717	700	23468	622	0	636	733	622	623	774	779	612	622	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
637	S	1020	0	718	701	23471	623	0	637	734	623	624	775	780	613	623	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
638	T	1021	0	0	702	23474	624	0	638	0	624	625	776	781	614	624	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
639	G	1022	0	0	703	23477	625	0	639	0	625	626	777	782	615	625	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
640	S	1023	714	0	704	23480	626	673	640	0	626	627	778	783	616	626	no	S1; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
641	N	1024	715	0	705	23483	627	674	641	0	627	628	779	784	617	627	no	S1; 		
642	V	1025	716	0	706	23486	628	675	642	0	628	629	780	785	618	628	no	S1; 		
643	F	1026	717	0	707	23489	629	676	643	0	629	630	781	786	619	629	no	S1; 		
644	Q	1027	718	0	708	23492	630	677	644	0	630	631	782	787	620	630	no	S1; 		
645	T	1028	719	0	709	23495	631	678	645	0	631	632	783	788	621	631	no	S1; 		
646	R	1029	720	0	710	23498	632	679	646	0	632	633	784	789	622	632	no	S1; 		
647	A	1030	721	0	711	23501	633	680	647	0	633	634	785	790	623	633	no	S1; 		
648	G	1031	722	0	712	23504	634	681	648	0	634	635	786	791	624	634	no	"S1; B-cell epitopes, high antigenicity score and good surface accessibility [1];"		[1](10.21203/rs.3.rs-16262/v1);
649	C	1032	723	0	713	23507	635	682	649	0	635	636	787	792	625	635	no	"S1; B-cell epitopes, high antigenicity score and good surface accessibility [1];"		[1](10.21203/rs.3.rs-16262/v1);
650	L	1033	724	0	714	23510	636	683	650	0	636	637	788	793	626	636	no	"S1; B-cell epitopes, high antigenicity score and good surface accessibility [1];"		[1](10.21203/rs.3.rs-16262/v1);
651	I	1034	725	0	715	23513	637	684	651	0	637	638	789	794	627	637	no	"S1; B-cell epitopes, high antigenicity score and good surface accessibility [1];"		[1](10.21203/rs.3.rs-16262/v1);
652	G	1035	726	0	716	23516	638	685	652	0	638	639	790	795	628	638	no	"S1; B-cell epitopes, high antigenicity score and good surface accessibility [1];"		[1](10.21203/rs.3.rs-16262/v1);
653	A	1036	727	719	717	23519	639	686	653	735	639	640	791	796	629	639	no	"S1; B-cell epitopes, high antigenicity score and good surface accessibility [1];"		[1](10.21203/rs.3.rs-16262/v1);
654	E	1037	728	720	718	23522	640	687	654	736	640	641	792	797	630	640	no	"S1; B-cell epitopes, high antigenicity score and good surface accessibility [1];"		[1](10.21203/rs.3.rs-16262/v1);
655	H	1038	729	721	719	23525	641	688	655	737	641	642	793	798	631	641	no	"S1; B-cell epitopes, high antigenicity score and good surface accessibility [1];"		[1](10.21203/rs.3.rs-16262/v1);
656	V	1039	730	722	720	23528	642	689	656	738	642	643	794	799	632	642	no	"S1; B-cell epitopes, high antigenicity score and good surface accessibility [1]; "		[1](10.21203/rs.3.rs-16262/v1);
657	N	1042	733	0	722	23531	643	692	657	0	643	644	0	0	633	643	no	"S1; B-cell epitopes, high antigenicity score and good surface accessibility [1]; hybrid-type glycans[2]"		[1](10.21203/rs.3.rs-16262/v1); [2](10.1101/2020.03.26.010322) ; 
658	N	1043	734	0	723	23534	644	693	658	0	644	645	0	0	634	644	no	"S1; B-cell epitopes, high antigenicity score and good surface accessibility [1];"		[1](10.21203/rs.3.rs-16262/v1);
659	S	1044	735	0	724	23537	645	694	659	0	645	646	0	0	635	645	no	"S1; B-cell epitopes, high antigenicity score and good surface accessibility [1];"		[1](10.21203/rs.3.rs-16262/v1);
660	Y	1045	736	0	725	23540	646	695	660	0	646	647	0	0	636	646	no	"S1; B-cell epitopes, high antigenicity score and good surface accessibility [1];"		[1](10.21203/rs.3.rs-16262/v1);
661	E	1046	737	723	726	23543	647	696	661	739	647	648	795	800	637	647	no	"S1; B-cell epitopes, high antigenicity score and good surface accessibility [1];"		[1](10.21203/rs.3.rs-16262/v1);
662	C	1047	738	724	727	23546	648	697	662	740	648	649	796	801	638	648	no	"S1; B-cell epitopes, high antigenicity score and good surface accessibility [1];"		[1](10.21203/rs.3.rs-16262/v1);
663	D	1048	739	725	728	23549	649	698	663	741	649	650	0	0	639	649	no	"S1; B-cell epitopes, high antigenicity score and good surface accessibility [1];"		[1](10.21203/rs.3.rs-16262/v1);
664	I	1049	740	726	729	23552	650	699	664	742	650	651	797	802	640	650	no	S2; 		
665	P	1050	741	727	730	23555	651	700	665	743	651	652	798	803	641	651	no	S2; 		
666	I	1051	742	728	731	23558	652	701	666	744	652	653	799	804	642	652	no	S2; 		
667	G	1056	743	733	732	23561	653	702	667	749	653	654	804	809	643	653	no	S2; B-cell epitopes [1]		[1](10.3390/v12030254)
668	A	1057	744	734	733	23564	654	703	668	750	654	655	805	810	644	654	no	S2; B-cell epitopes [1]		[1](10.3390/v12030254)
669	G	1058	745	735	734	23567	655	704	669	751	655	656	806	811	645	655	no	S2; B-cell epitopes [1]		[1](10.3390/v12030254)
670	I	1059	746	736	735	23570	656	705	670	752	656	657	807	812	646	656	no	S2; B-cell epitopes [1]		[1](10.3390/v12030254)
671	C	1060	747	737	736	23573	657	706	671	753	657	658	808	813	647	657	no	S2; B-cell epitopes [1]		[1](10.3390/v12030254)
672	A	1061	748	738	737	23576	658	707	672	754	658	659	809	814	648	658	no	S2; B-cell epitopes [1]		[1](10.3390/v12030254)
673	S	1062	749	739	738	23579	659	708	673	755	659	660	810	815	649	659	no	S2; B-cell epitopes [1]		[1](10.3390/v12030254)
674	Y	1063	750	740	739	23582	660	709	674	756	660	661	811	816	650	660	no	S2; B-cell epitopes [1]		[1](10.3390/v12030254)
675	Q	1064	751	741	740	23585	661	710	675	757	661	662	812	817	651	661	no	S2; B-cell epitopes [1]		[1c(10.3390/v12030254)
676	T	1065	752	742	741	23588	662	711	676	758	662	663	813	818	652	662	no	S2; 		
677	Q	1066	753	743	742	23591	663	712	677	759	663	664	814	819	653	663	no	S2; 		
678	T	1067	754	744	743	23594	664	713	678	760	664	665	815	820	654	664	no	S2; 		
679	N	1068	0	0	0	23597	0	0	679	0	0	0	0	0	0	0	no	S2; 		
680	S	1069	0	0	0	23600	0	0	680	0	0	0	0	0	0	0	no	S2; 		
681	P	1070	0	0	0	23603	0	0	681	0	0	0	0	0	0	0	no	S2; 		
682	R	1071	0	0	0	23606	0	0	682	0	0	0	0	0	0	0	no	S2; 		
683	R	1072	0	0	744	23609	665	0	683	0	665	666	0	0	655	665	no	S2; 		
684	A	1073	0	0	745	23612	666	0	684	0	666	667	0	0	656	666	no	S2; 		
685	R	1074	0	0	746	23615	667	0	685	0	667	668	0	0	657	667	no	S2; 		
686	S	1075	0	0	747	23618	668	0	686	0	668	669	0	0	658	668	no	S2; 		
687	V	1076	755	0	748	23621	669	714	687	0	669	670	0	0	659	669	no	S2; 		
688	A	1077	756	0	749	23624	670	715	688	0	670	671	0	0	660	670	no	S2; 		
689	S	1078	757	0	750	23627	671	716	689	0	671	672	0	0	661	671	no	S2; 		
690	Q	1079	758	0	751	23630	672	717	690	0	672	673	0	0	662	672	no	S2; T cell Epitopes [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
691	S	1080	759	0	752	23633	673	718	691	0	673	674	0	0	663	673	no	S2; T cell Epitopes [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
692	I	1081	760	0	753	23636	674	719	692	0	674	675	0	0	664	674	no	S2; T cell Epitopes [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
693	I	1082	761	0	754	23639	675	720	693	0	675	676	0	0	665	675	no	S2; T cell Epitopes [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
694	A	1083	762	0	755	23642	676	721	694	0	676	677	0	0	666	676	no	S2; T cell Epitopes [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
695	Y	1088	764	745	760	23645	677	723	695	761	677	678	816	821	667	677	no	S2; T cell Epitopes [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
696	T	1089	765	747	761	23648	678	724	696	762	678	679	817	822	668	678	no	S2; T cell Epitopes [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
697	M	1090	766	748	762	23651	679	725	697	763	679	680	818	823	669	679	no	S2; T cell Epitopes [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
698	S	1091	767	749	763	23654	680	726	698	764	680	681	819	824	670	680	no	S2; T cell Epitopes [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
699	L	1092	768	750	764	23657	681	727	699	765	681	682	820	825	671	681	no	S2; T cell Epitopes [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
700	G	1093	769	751	765	23660	682	728	700	766	682	683	821	826	672	682	no	S2; T cell Epitopes [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
701	A	1094	770	752	766	23663	683	729	701	767	683	684	822	827	673	683	no	S2; T cell Epitopes [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
702	E	1095	771	753	767	23666	684	730	702	768	684	685	823	828	674	684	no	S2; T cell Epitopes [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
703	N	1096	772	754	768	23669	685	731	703	769	685	686	824	829	675	685	no	S2; T cell Epitopes [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
704	S	1097	773	755	769	23672	686	732	704	770	686	687	825	830	676	686	no	S2; T cell Epitopes [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
705	V	1098	774	756	770	23675	687	733	705	771	687	688	826	831	677	687	no	S2; T cell Epitopes [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
706	A	1099	775	757	771	23678	688	734	706	772	688	689	827	832	678	688	no	S2; T cell Epitopes [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
707	Y	1100	776	758	772	23681	689	735	707	773	689	690	828	833	679	689	no	S2; T cell Epitopes [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
708	S	1101	777	759	773	23684	690	736	708	774	690	691	829	834	680	690	no	S2; 		
709	N	1102	778	760	774	23687	691	737	709	775	691	692	830	835	681	691	no	S2; predominantly oligomannose-type [1]; 		[1](10.1101/2020.03.26.010322) ; 
710	N	1103	779	761	775	23690	692	738	710	776	692	693	831	836	682	692	no	S2; 		
711	S	1104	780	762	776	23693	693	739	711	777	693	694	832	837	683	693	no	S2; 		
712	I	1105	781	763	777	23696	694	740	712	778	694	695	833	838	684	694	no	S2; 		
713	A	1115	791	764	781	23699	695	750	713	779	695	696	834	839	685	695	no	S2; 		
714	I	1116	792	765	782	23702	696	751	714	780	696	697	835	840	686	696	no	S2; 		
715	P	1117	793	766	783	23705	697	752	715	781	697	698	836	841	687	697	no	S2; 		
716	T	1118	794	767	784	23708	698	753	716	782	698	699	837	842	688	698	no	S2; 		
717	N	1119	795	768	785	23711	699	754	717	783	699	700	838	843	689	699	no	S2; mixture of oligomannose-type glycans and complex-type glycans [1] ;		[1](10.1101/2020.03.26.010322) ; 
718	F	1120	796	769	786	23714	700	755	718	784	700	701	839	844	690	700	no	S2; 		
719	T	1121	797	770	787	23717	701	756	719	785	701	702	840	845	691	701	no	S2; 		
720	I	1122	798	771	788	23720	702	757	720	786	702	703	841	846	692	702	no	S2; 		
721	S	1123	799	772	789	23723	703	758	721	787	703	704	842	847	693	703	no	S2; 		
722	V	1124	800	773	790	23726	704	759	722	788	704	705	843	848	694	704	no	S2; 		
723	T	1125	801	774	791	23729	705	760	723	789	705	706	844	849	695	705	no	S2; 		
724	T	1126	802	775	792	23732	706	761	724	790	706	707	845	850	696	706	no	S2; 		
725	E	1127	803	776	793	23735	707	762	725	791	707	708	846	851	697	707	no	S2; 		
726	I	1128	804	777	794	23738	708	763	726	792	708	709	847	852	698	708	no	S2; 		
727	L	1129	805	778	795	23741	709	764	727	793	709	710	848	853	699	709	no	S2; 		
728	P	1130	806	779	796	23744	710	765	728	794	710	711	849	854	700	710	no	S2; 		
729	V	1131	807	780	797	23747	711	766	729	795	711	712	850	855	701	711	no	S2; 		
730	S	1132	808	781	798	23750	712	767	730	796	712	713	851	856	702	712	no	S2; 		
731	M	1133	809	782	799	23753	713	768	731	797	713	714	852	857	703	713	no	S2; 		
732	T	1134	810	783	800	23756	714	769	732	798	714	715	853	858	704	714	no	S2; 		
733	K	1135	811	784	801	23759	715	770	733	799	715	716	854	859	705	715	no	S2; 		
734	T	1136	812	785	802	23762	716	771	734	800	716	717	855	860	706	716	no	S2; 		
735	S	1137	813	786	803	23765	717	772	735	801	717	718	856	861	707	717	no	S2; 		
736	V	1138	814	787	804	23768	718	773	736	802	718	719	857	862	708	718	no	S2; 		
737	D	1139	815	788	805	23771	719	774	737	803	719	720	858	863	709	719	no	S2; 		
738	C	1140	816	789	806	23774	720	775	738	804	720	721	859	864	710	720	no	S2; 		
739	T	1141	817	790	807	23777	721	776	739	805	721	722	860	865	711	721	no	S2; 		
740	M	1142	818	791	808	23780	722	777	740	806	722	723	861	866	712	722	no	S2; 		
741	Y	1143	819	792	809	23783	723	778	741	807	723	724	862	867	713	723	no	S2; 		
742	I	1144	820	793	810	23786	724	779	742	808	724	725	863	868	714	724	no	S2; 		
743	C	1145	821	794	811	23789	725	780	743	809	725	726	864	869	715	725	no	S2; 		
744	G	1146	822	795	812	23792	726	781	744	810	726	727	865	870	716	726	no	S2; 		
745	D	1147	823	796	813	23795	727	782	745	811	727	728	866	871	717	727	no	S2; 		
746	S	1148	824	797	814	23798	728	783	746	812	728	729	867	872	718	728	no	S2; 		
747	T	1149	825	798	815	23801	729	784	747	813	729	730	868	873	719	729	no	S2; T cell Epitopes [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
748	E	1150	826	799	816	23804	730	785	748	814	730	731	869	874	720	730	no	S2; T cell Epitopes [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
749	C	1151	827	800	817	23807	731	786	749	815	731	732	870	875	721	731	no	S2; T cell Epitopes [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
750	S	1152	828	801	818	23810	732	787	750	816	732	733	871	876	722	732	no	S2; T cell Epitopes [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
751	N	1153	829	802	819	23813	733	788	751	817	733	734	872	877	723	733	no	S2; T cell Epitopes [1] ; 		[1](10.1016/j.chom.2020.03.002) ; 
752	L	1154	830	803	820	23816	734	789	752	818	734	735	873	878	724	734	no	"S2; T cell Epitopes [1] ;  HLA-A*02:01 [2] ;	"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ;
753	L	1155	831	804	821	23819	735	790	753	819	735	736	874	879	725	735	no	"S2; T cell Epitopes [1] ;  HLA-A*02:01 [2] ;	"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ;
754	L	1156	832	805	822	23822	736	791	754	820	736	737	875	880	726	736	no	"S2; T cell Epitopes [1] ;  HLA-A*02:01 [2] ;	"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ;
755	Q	1157	833	806	823	23825	737	792	755	821	737	738	876	881	727	737	no	"S2; T cell Epitopes [1] ;  HLA-A*02:01 , HLA-A*68:01 [2] ;	"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ;
756	Y	1158	834	807	824	23828	738	793	756	822	738	739	877	882	728	738	no	"S2; T cell Epitopes [1] ;  HLA-A*02:01 , HLA-A*68:01 [2] ;	"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ;
757	G	1159	835	808	825	23831	739	794	757	823	739	740	878	883	729	739	no	"S2; T cell Epitopes [1] ;  HLA-A*02:01, HLA-A*01:01 , HLA-A*03:0c ,  HLA-A*11:01, HLA-A*68:01, HLA-A*31:01 [2] ;	"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ;
758	S	1160	836	809	826	23834	740	795	758	824	740	741	879	884	730	740	no	"S2; T cell Epitopes [1] ;  HLA-A*02:01, HLA-A*01:01 , HLA-A*03:0c ,  HLA-A*11:01, HLA-A*68:01, HLA-A*31:01 [2] ;	"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ;
759	F	1161	837	810	827	23837	741	796	759	825	741	742	880	885	731	741	no	"S2; T cell Epitopes [1] ;  HLA-A*02:01, HLA-A*01:01 , HLA-A*03:0c ,  HLA-A*11:01, HLA-A*68:01, HLA-A*31:01 [2] ;	"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ;
760	C	1162	838	811	828	23840	742	797	760	826	742	743	881	886	732	742	no	"S2; T cell Epitopes [1] ;  HLA-A*02:01, HLA-A*01:01 , HLA-A*03:0c ,  HLA-A*11:01, HLA-A*68:01, HLA-A*31:01 [2] ;	"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ;
761	T	1163	839	812	829	23843	743	798	761	827	743	744	882	887	733	743	no	"S2; T cell Epitopes [1] ;  HLA-A*02:01, HLA-A*01:01 , HLA-A*03:0c ,  HLA-A*11:01, HLA-A*68:01, HLA-A*31:01 [2] ;	"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ;
762	Q	1164	840	813	830	23846	744	799	762	828	744	745	883	888	734	744	no	"S2; T cell Epitopes [1] ;  HLA-A*02:01, HLA-A*01:01 , HLA-A*03:0c ,  HLA-A*11:01, HLA-A*68:01, HLA-A*31:01 [2] ;	"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ;
763	L	1165	841	814	831	23849	745	800	763	829	745	746	884	889	735	745	no	"S2; T cell Epitopes [1] ;  HLA-A*02:01, HLA-A*01:01 , HLA-A*03:0c ,  HLA-A*11:01, HLA-A*68:01, HLA-A*31:01 [2] ;	"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ;
764	N	1166	842	815	832	23852	746	801	764	830	746	747	885	890	736	746	no	"S2; HLA-A*01:01 , HLA-A*03:01  ,  HLA-A*11:01, HLA-A*68:01 , HLA-A*31:01[1] "		[1](10.3390/v12030254) ;
765	R	1167	843	816	833	23855	747	802	765	831	747	748	886	891	737	747	no	"S2; R765L observed in at least two continents with 20 <1% frequency [1] ; HLA-A*01:01 , HLA-A*03:01  ,  HLA-A*11:01, HLA-A*68:01 , HLA-A*31:01[2] ;	"		[1](10.1101/2020.05.21.108563) ; [2](10.3390/v12030254) ;
766	A	1168	844	817	834	23858	748	803	766	832	748	749	887	892	738	748	no	"S2;  HLA-A*01:01 , HLA-A*03:01 ,  HLA-A*11:01, HLA-A*68:01 , HLA-A*31:01 [1] ; "		[1](10.3390/v12030254) ;
767	L	1169	845	818	835	23861	749	804	767	833	749	750	888	893	739	749	no	S2; 		
768	T	1170	846	819	836	23864	750	805	768	834	750	751	889	894	740	750	no	S2; 		
769	G	1171	847	820	837	23867	751	806	769	835	751	752	890	895	741	751	no	S2; 		
770	I	1172	848	821	838	23870	752	807	770	836	752	753	891	896	742	752	no	S2; 		
771	A	1173	849	822	839	23873	753	808	771	837	753	754	892	897	743	753	no	S2; Fusion Peptide [1]		[1](10.1038/s41423-020-0374-2) ; 
772	V	1174	850	823	840	23876	754	809	772	838	754	755	893	898	744	754	no	S2; 		
773	E	1175	851	824	841	23879	755	810	773	839	755	756	894	899	745	755	no	S2; 		
774	Q	1176	852	825	842	23882	756	811	774	840	756	757	895	900	746	756	no	S2; Fusion Peptide [1]		[1](10.1038/s41423-020-0374-2) ; 
775	D	1177	853	826	843	23885	757	812	775	841	757	758	896	901	747	757	no	S2; 		
776	K	1178	854	827	844	23888	758	813	776	842	758	759	897	902	748	758	no	S2; 		
777	N	1179	855	828	845	23891	759	814	777	843	759	760	898	903	749	759	no	S2; 		
778	T	1180	856	829	846	23894	760	815	778	844	760	761	899	904	750	760	no	S2; 		
779	Q	1181	857	830	847	23897	761	816	779	845	761	762	900	905	751	761	no	S2; 		
780	E	1182	858	831	848	23900	762	817	780	846	762	763	901	906	752	762	no	S2; 		
781	V	1183	859	832	849	23903	763	818	781	847	763	764	902	907	753	763	no	S2; Fusion Peptide [1]		[1](10.1038/s41423-020-0374-2) ; 
782	F	1184	860	833	850	23906	764	819	782	848	764	765	903	908	754	764	no	S2; 		
783	A	1185	861	834	851	23909	765	820	783	849	765	766	904	909	755	765	no	S2; 		
784	Q	1186	862	835	852	23912	766	821	784	850	766	767	905	910	756	766	no	S2; 		
785	V	1187	863	836	853	23915	767	822	785	851	767	768	906	911	757	767	no	S2; Fusion Peptide [1] ; T cell Epitopes [2] ; 		[1](10.1038/s41423-020-0374-2) ; [2](10.1016/j.chom.2020.03.002) ; 
786	K	1188	864	837	854	23918	768	823	786	852	768	769	907	912	758	768	no	S2; predicted epitopes for T-cytotoxic cells with [1] ;  B cell epitope [1] ; T cell Epitopes [2] ; 		[1](10.1101/2020.05.21.108563) ;  [2](10.1016/j.chom.2020.03.002) ; 
787	Q	1189	865	838	855	23921	769	824	787	853	769	770	908	913	759	769	no	S2; Fusion Peptide [1] ; predicted epitopes for T-cytotoxic cells with [2] ;    B cell epitope [2] ; T cell Epitopes [3] ; 		[1](10.1038/s41423-020-0374-2) ; [2](10.1101/2020.05.21.108563) ; [3](10.1016/j.chom.2020.03.002) ; 
788	I	1192	868	839	856	23924	770	827	788	854	770	771	909	914	760	770	no	S2; predicted epitopes for T-cytotoxic cells with [1] ;   B cell epitope [1] ; T cell Epitopes [2] ; 		[1](10.1101/2020.05.21.108563) ;  [2](10.1016/j.chom.2020.03.002) ; 
789	Y	1193	869	840	857	23927	771	828	789	855	771	772	910	915	761	771	no	S2; predicted epitopes for T-cytotoxic cells with [1] ;   B cell epitope [1] ; T cell Epitopes [2] ; 		[1](10.1101/2020.05.21.108563) ;  [2](10.1016/j.chom.2020.03.002) ; 
790	K	1194	870	841	858	23930	772	829	790	856	772	773	911	916	762	772	no	S2; predicted epitopes for T-cytotoxic cells with [1] ;   B cell epitope [1] ; T cell Epitopes [2] ; 		[1](10.1101/2020.05.21.108563) ;  [2](10.1016/j.chom.2020.03.002) ; 
791	T	1195	871	842	859	23933	773	830	791	857	773	774	912	917	763	773	no	S2; Fusion Peptide [1] ; predicted epitopes for T-cytotoxic cells with [2] ; T cell Epitopes [3] ; 		[1](10.1038/s41423-020-0374-2) ; [2](10.1101/2020.05.21.108563) ; [3](10.1016/j.chom.2020.03.002) ; 
792	P	1196	872	843	860	23936	774	831	792	858	774	775	913	918	764	774	no	S2; predicted epitopes for T-cytotoxic cells with [1] ;   B cell epitope [1] ; T cell Epitopes [2] ; 		[1](10.1101/2020.05.21.108563) ;  [2](10.1016/j.chom.2020.03.002) ; 
793	P	1197	873	844	861	23939	775	832	793	859	775	776	914	919	765	775	no	S2; predicted epitopes for T-cytotoxic cells with [1] ;   B cell epitope [1] ; T cell Epitopes [2] ; 		[1](10.1101/2020.05.21.108563) ;  [2](10.1016/j.chom.2020.03.002) ; 
794	I	1198	874	845	862	23942	776	833	794	860	776	777	915	920	766	776	no	S2; predicted epitopes for T-cytotoxic cells with [1] ;   B cell epitope [1] ; T cell Epitopes [2] ; 		[1](10.1101/2020.05.21.108563) ;  [2](10.1016/j.chom.2020.03.002) ; 
795	K	1199	875	846	863	23945	777	834	795	861	777	778	916	921	767	777	no	S2;   B cell epitope [1] ; T cell Epitopes [2] ; 		[1](10.1101/2020.05.21.108563) ;  [2](10.1016/j.chom.2020.03.002) ; 
796	D	1200	876	847	864	23948	778	835	796	862	778	779	917	922	768	778	no	S2;   B cell epitope [1] ; T cell Epitopes [2] ; 		[1](10.1101/2020.05.21.108563) ;  [2](10.1016/j.chom.2020.03.002) ; 
797	F	1201	877	848	865	23951	779	836	797	863	779	780	918	923	769	779	no	S2;   B cell epitope [1] ; T cell Epitopes [2] ; 		[1](10.1101/2020.05.21.108563) ;  [2](10.1016/j.chom.2020.03.002) ; 
798	G	1202	878	0	866	23954	780	837	798	864	780	781	919	924	770	780	no	S2;   B cell epitope [1] ; T cell Epitopes [2] ; 		[1](10.1101/2020.05.21.108563) ;  [2](10.1016/j.chom.2020.03.002) ; 
799	G	1203	879	849	867	23957	781	838	799	865	781	782	920	925	771	781	no	S2;   B cell epitope [1] ; T cell Epitopes [2] ; 		[1](10.1101/2020.05.21.108563) ;  [2](10.1016/j.chom.2020.03.002) ; 
800	F	1217	884	851	869	23960	782	843	800	868	782	783	934	939	772	782	no	S2;   B cell epitope [1] ; T cell Epitopes [2] ; 		[1](10.1101/2020.05.21.108563) ;  [2](10.1016/j.chom.2020.03.002) ; 
801	N	1218	885	852	870	23963	783	844	801	869	783	784	935	940	773	783	no	S2 ; T cell Epitopes [1] ; predominantly oligomannose-type [2]; 		[1](10.1016/j.chom.2020.03.002) ; [2](10.1101/2020.03.26.010322) ; 
802	F	1219	886	853	871	23966	784	845	802	870	784	785	936	941	774	784	no	S2; B Cell Epitope [1] ; T cell Epitopes [2] ; 		[1](10.1016/j.chom.2020.03.002) ; 
803	S	1220	887	854	872	23969	785	846	803	871	785	786	937	942	775	785	no	S2; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
804	Q	1221	888	855	873	23972	786	847	804	872	786	787	938	943	776	786	no	S2; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
805	I	1222	889	856	874	23975	787	848	805	873	787	788	939	944	777	787	no	S2; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
806	L	1223	890	857	875	23978	788	849	806	874	788	789	940	945	778	788	no	S2; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
807	P	1224	891	0	876	23981	789	850	807	875	789	790	941	946	779	789	no	S2; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
808	D	1225	892	0	877	23984	790	851	808	876	790	791	942	947	780	790	no	S2; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
809	P	1235	902	865	881	23987	791	861	809	884	791	792	950	955	781	791	no	S2; variation observed with frequency <1% [1] ;  B Cell Epitope [2] ;  forecasted as components of discontinuous B-cell epitopes [3];		[1](10.1101/2020.05.21.108563) ; [2](10.1016/j.chom.2020.03.002) ; [3](10.21203/rs.3.rs-16262/v1); 
810	S	1238	903	866	882	23990	792	864	810	885	792	793	951	956	782	792	no	S2; B Cell Epitope [1] ; forecasted as components of discontinuous B-cell epitopes [2]; 		[1](10.1016/j.chom.2020.03.002) ; [2](10.21203/rs.3.rs-16262/v1); 
811	K	1239	904	867	883	23993	793	865	811	886	793	794	952	957	783	793	no	S2; B Cell Epitope [1] ; forecasted as components of discontinuous B-cell epitopes [2]; 		[1](10.1016/j.chom.2020.03.002) ; [2](10.21203/rs.3.rs-16262/v1); 
812	P	1240	905	868	884	23996	794	866	812	887	794	795	953	958	784	794	no	S2; B Cell Epitope [1] ; forecasted as components of discontinuous B-cell epitopes [2]; 		[1](10.1016/j.chom.2020.03.002) ; [2](10.21203/rs.3.rs-16262/v1); 
813	S	1241	906	0	885	23999	795	867	813	888	795	796	954	959	785	795	no	S2; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
814	K	1242	907	869	886	24002	796	868	814	889	796	797	955	960	786	796	no	S2; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
815	R	1243	908	870	887	24005	797	869	815	890	797	798	956	961	787	797	no	S2; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
816	S	1244	909	871	888	24008	798	870	816	891	798	799	957	962	788	798	no	S2; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
817	F	1245	910	872	889	24011	799	871	817	892	799	800	958	963	789	799	no	S2; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
818	I	1246	911	873	890	24014	800	872	818	893	800	801	959	964	790	800	no	S2; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
819	E	1247	912	874	891	24017	801	873	819	894	801	802	960	965	791	801	no	S2; B Cell Epitope [1] ;  		[1](10.1016/j.chom.2020.03.002) ; 
820	D	1248	913	875	892	24020	802	874	820	895	802	803	961	966	792	802	no	S2; 		
821	L	1249	914	876	893	24023	803	875	821	896	803	804	962	967	793	803	no	S2; 		
822	L	1250	915	877	894	24026	804	876	822	897	804	805	963	968	794	804	no	S2; 		
823	F	1251	916	878	895	24029	805	877	823	898	805	806	964	969	795	805	no	S2; 		
824	N	1252	917	879	896	24032	806	878	824	899	806	807	965	970	796	806	no	S2; 		
825	K	1253	918	880	897	24035	807	879	825	900	807	808	966	971	797	807	no	S2; 		
826	V	1254	919	881	898	24038	808	880	826	901	808	809	967	972	798	808	no	S2; 		
827	T	1255	920	882	899	24041	809	881	827	902	809	810	968	973	799	809	no	S2; 		
828	L	1256	921	883	900	24044	810	882	828	903	810	811	969	974	800	810	no	S2;   B cell epitope [1] ;		[1](10.1101/2020.05.21.108563) ; 
829	A	1257	922	884	901	24047	811	883	829	904	811	812	970	975	801	811	no	S2;   B cell epitope [1] ;		[1](10.1101/2020.05.21.108563) ; 
830	D	1258	923	885	902	24050	812	884	830	905	812	813	971	976	802	812	no	S2;   B cell epitope [1] ;		[1](10.1101/2020.05.21.108563) ; 
831	A	1259	924	886	903	24053	813	885	831	906	813	814	972	977	803	813	no	S2;   B cell epitope [1] ;		[1](10.1101/2020.05.21.108563) ; 
832	G	1260	925	887	904	24056	814	886	832	907	814	815	973	978	804	814	no	S2;   B cell epitope [1] ;		[1](10.1101/2020.05.21.108563) ; 
833	F	1261	926	888	905	24059	815	887	833	908	815	816	974	979	805	815	no	S2;   B cell epitope [1] ;		[1](10.1101/2020.05.21.108563) ; 
834	I	1262	927	889	906	24062	816	888	834	909	816	817	975	980	806	816	no	S2;   B cell epitope [1] ;		[1](10.1101/2020.05.21.108563) ; 
835	K	1264	928	891	907	24065	817	889	835	911	817	818	977	982	807	817	no	S2;   B cell epitope [1] ;		[1](10.1101/2020.05.21.108563) ; 
836	Q	1265	929	892	908	24068	818	890	836	912	818	819	978	983	808	818	no	S2;   B cell epitope [1]		[1](10.1016/j.chom.2020.03.002) ; 
837	Y	1266	930	893	909	24071	819	891	837	913	819	820	979	984	809	819	no	S2;   B cell epitope [1] ;		[1](10.1101/2020.05.21.108563) ; 
838	G	1267	931	894	910	24074	820	892	838	914	820	821	980	985	810	820	no	S2;   B cell epitope [1] ;		[1](10.1101/2020.05.21.108563) ; 
839	D	1268	932	895	911	24077	821	893	839	915	821	822	981	986	811	821	no	S2; variation observed with frequency >1% [1] ; 		[1](10.1101/2020.05.21.108563) ;
840	C	1269	933	896	912	24080	822	894	840	916	822	823	982	987	812	822	no	S2; one of the most conserved residues in that region and across the Coronaviridae. [1] ; B cell epitope [2] ;		[1](10.1016/j.virol.2009.07.038) ; [2](10.1101/2020.05.21.108563)
841	L	1270	934	897	913	24083	823	895	841	917	823	824	983	988	813	823	no	S2;   B cell epitope [1] ;		[1](10.1101/2020.05.21.108563) ; 
842	G	1273	935	898	916	24086	824	896	842	918	824	825	984	989	814	824	no	S2;   B cell epitope [1] ;		[1](10.1101/2020.05.21.108563) ; 
843	D	1274	936	899	917	24089	825	897	843	919	825	826	985	990	815	825	no	S2;   B cell epitope [1] ;		[1](10.1101/2020.05.21.108563) ; 
844	I	1275	937	900	918	24092	826	898	844	920	826	827	986	991	816	826	no	S2; 		
845	A	1276	938	901	919	24095	827	899	845	921	827	828	987	992	817	827	no	S2; 		
846	A	1277	939	902	920	24098	828	900	846	922	828	829	988	993	818	828	no	S2; 		
847	R	1278	940	903	921	24101	829	901	847	923	829	830	989	994	819	829	no	S2; 		
848	D	1279	941	904	922	24104	830	902	848	924	830	831	990	995	820	830	no	S2; one of the most conserved residues in that region and across the Coronaviridae. [1] ;		[1](10.1016/j.virol.2009.07.038) ; 
849	L	1280	942	905	923	24107	831	903	849	925	831	832	991	996	821	831	no	S2; one of the most conserved residues in that region and across the Coronaviridae. [1] ;		[1](10.1016/j.virol.2009.07.038) ; 
850	I	1281	943	906	924	24110	832	904	850	926	832	833	992	997	822	832	no	S2; 		
851	C	1282	944	907	925	24113	833	905	851	927	833	834	993	998	823	833	no	S2; one of the most conserved residues in that region and across the Coronaviridae. [1] ;		[1](10.1016/j.virol.2009.07.038) ; 
852	A	1283	945	908	926	24116	834	906	852	928	834	835	994	999	824	834	no	"S2; B-cell epitope, HLA-DRB1*01:01 [1] ;"		[1](10.3390/v12030254)   ; 
853	Q	1284	946	909	927	24119	835	907	853	929	835	836	995	1000	825	835	no	"S2; B-cell epitope, HLA-DRB1*01:01 [1] ;"		[1](10.3390/v12030254)   ; 
854	K	1285	947	910	928	24122	836	908	854	930	836	837	996	1001	826	836	no	"S2; B-cell epitope, HLA-DRB1*01:01 [1] ;"		[1](10.3390/v12030254)   ; 
855	F	1286	948	911	929	24125	837	909	855	931	837	838	997	1002	827	837	no	"S2; B-cell epitope, HLA-DRB1*01:01 [1] ;"		[1](10.3390/v12030254)   ; 
856	N	1287	949	912	930	24128	838	910	856	932	838	839	998	1003	828	838	no	"S2; B-cell epitope, HLA-DRB1*01:01 [1] ;"		[1](10.3390/v12030254)   ; 
857	G	1288	950	913	931	24131	839	911	857	933	839	840	999	1004	829	839	no	"S2; B-cell epitope, HLA-DRB1*01:01 [1] ;"		[1](10.3390/v12030254)   ; 
858	L	1289	951	914	932	24134	840	912	858	934	840	841	1000	1005	830	840	no	"S2; B-cell epitope, HLA-DRB1*01:01 [1] ;"		[1](10.3390/v12030254)   ; 
859	T	1290	952	915	933	24137	841	913	859	935	841	842	1001	1006	831	841	no	"S2; B-cell epitope, HLA-DRB1*01:01 [1] ;"		[1](10.3390/v12030254)   ; 
860	V	1291	953	916	934	24140	842	914	860	936	842	843	1002	1007	832	842	no	"S2; B-cell epitope, HLA-DRB1*01:01 [1] ;"		[1](10.3390/v12030254)   ; 
861	L	1292	954	917	935	24143	843	915	861	937	843	844	1003	1008	833	843	no	"S2; B-cell epitope, HLA-DRB1*01:01 [1] ;"		[1](10.3390/v12030254)   ; 
862	P	1293	955	918	936	24146	844	916	862	938	844	845	1004	1009	834	844	no	"S2; B-cell epitope, HLA-DRB1*01:01 [1] ;"		[1](10.3390/v12030254)   ; 
863	P	1294	956	919	937	24149	845	917	863	939	845	846	1005	1010	835	845	no	"S2; B-cell epitope, HLA-DRB1*01:01 [1] ;"		[1](10.3390/v12030254)   ; 
864	L	1295	957	920	938	24152	846	918	864	940	846	847	1006	1011	836	846	no	"S2; B-cell epitope, HLA-DRB1*01:01 [1] ;"		[1](10.3390/v12030254)   ; 
865	L	1296	958	921	939	24155	847	919	865	941	847	848	1007	1012	837	847	no	"S2; B-cell epitope, HLA-DRB1*01:01 [1] ;"		[1](10.3390/v12030254)   ; 
866	T	1297	959	922	940	24158	848	920	866	942	848	849	1008	1013	838	848	no	"S2; B-cell epitope, HLA-DRB1*01:01 [1] ;"		[1](10.3390/v12030254)   ; 
867	D	1298	960	923	941	24161	849	921	867	943	849	850	1009	1014	839	849	no	"S2; B-cell epitope, HLA-DRB1*01:01 [1] ;"		[1](10.3390/v12030254)   ; 
868	E	1299	961	924	942	24164	850	922	868	944	850	851	1010	1015	840	850	no	S2; 		
869	M	1300	962	925	943	24167	851	923	869	945	851	852	1011	1016	841	851	no	S2; Fusion peptide in MERS [1]; 		 [1](10.1038/ncomms4067) ; 
870	I	1301	963	926	944	24170	852	924	870	946	852	853	1012	1017	842	852	no	S2; Fusion peptide in MERS [1]; 		 [1](10.1038/ncomms4067) ; 
871	A	1302	964	927	945	24173	853	925	871	947	853	854	1013	1018	843	853	no	S2; Fusion peptide in MERS [1]; 		 [1](10.1038/ncomms4067) ; 
872	Q	1303	965	928	946	24176	854	926	872	948	854	855	1014	1019	844	854	no	S2; Fusion peptide in MERS [1]; 		 [1](10.1038/ncomms4067) ; 
873	Y	1304	966	929	947	24179	855	927	873	949	855	856	1015	1020	845	855	no	S2; Fusion peptide in MERS [1]; 		 [1](10.1038/ncomms4067) ; 
874	T	1305	967	930	948	24182	856	928	874	950	856	857	1016	1021	846	856	no	S2; Fusion peptide in MERS [1]; 		 [1](10.1038/ncomms4067) ; 
875	S	1306	968	931	949	24185	857	929	875	951	857	858	1017	1022	847	857	no	S2; Fusion peptide in MERS [1]; 		 [1](10.1038/ncomms4067) ; 
876	A	1307	969	932	950	24188	858	930	876	952	858	859	1018	1023	848	858	no	S2; Fusion peptide in MERS [1]; 		 [1](10.1038/ncomms4067) ; 
877	L	1308	970	933	951	24191	859	931	877	953	859	860	1019	1024	849	859	no	S2; Fusion peptide in MERS [1]; 		 [1](10.1038/ncomms4067) ; 
878	L	1309	971	934	952	24194	860	932	878	954	860	861	1020	1025	850	860	no	S2; Fusion peptide in MERS [1]; 		 [1](10.1038/ncomms4067) ; 
879	A	1310	972	935	953	24197	861	933	879	955	861	862	1021	1026	851	861	no	S2; Fusion peptide in MERS [1]; 		 [1](10.1038/ncomms4067) ; 
880	G	1311	973	936	954	24200	862	934	880	956	862	863	1022	1027	852	862	no	S2; Fusion peptide in MERS [1]; 		 [1](10.1038/ncomms4067) ; 
881	T	1312	974	937	955	24203	863	935	881	957	863	864	1023	1028	853	863	no	S2; Fusion peptide in MERS [1]; 		 [1](10.1038/ncomms4067) ; 
882	I	1313	975	938	956	24206	864	936	882	958	864	865	1024	1029	854	864	no	S2; Fusion peptide in MERS [1]; 		 [1](10.1038/ncomms4067) ; 
883	T	1314	976	939	957	24209	865	937	883	959	865	866	1025	1030	855	865	no	S2; Fusion peptide in MERS [1]; 		 [1](10.1038/ncomms4067) ; 
884	S	1315	977	940	958	24212	866	938	884	960	866	867	1026	1031	856	866	no	S2; Fusion peptide in MERS [1]; 		 [1](10.1038/ncomms4067) ; 
885	G	1316	978	941	959	24215	867	939	885	961	867	868	1027	1032	857	867	no	"S2; Fusion peptide in MERS [1]; B-cell epitope, HLA-DRB1*01:01 [2] ;"		 [1](10.1038/ncomms4067) ;  [2](10.3390/v12030254) ; 
886	W	1317	979	942	960	24218	868	940	886	962	868	869	1028	1033	858	868	no	"S2; Fusion peptide in MERS [1]; B-cell epitope, HLA-DRB1*01:01 [2] ;"		 [1](10.1038/ncomms4067) ;  [2](10.3390/v12030254) ; 
887	T	1318	980	943	961	24221	869	941	887	963	869	870	1029	1034	859	869	no	"S2; Fusion peptide in MERS [1]; B-cell epitope, HLA-DRB1*01:01 [2] ;"		 [1](10.1038/ncomms4067) ;  [2](10.3390/v12030254) ; 
888	F	1319	0	0	962	24224	870	0	888	0	870	871	0	0	860	870	no	"S2; putative fusion peptide region;  B Cell Epitope [1] ;  Fusion peptide in MERS [2]; B-cell epitope, HLA-DRB1*01:01 [3] ;"		[1](10.1016/j.chom.2020.03.002) ;  [2](10.1038/ncomms4067) ; [3](10.3390/v12030254) ; 
889	G	1320	0	0	963	24227	871	0	889	0	871	872	0	0	861	871	no	"S2; putative fusion peptide region;  B Cell Epitope [1] ;  Fusion peptide in MERS [2]; B-cell epitope, HLA-DRB1*01:01 [3] ;"		[1](10.1016/j.chom.2020.03.002) ;  [2](10.1038/ncomms4067) ; [3](10.3390/v12030254) ; 
890	A	1321	0	0	964	24230	872	0	890	0	872	873	0	0	862	872	no	"S2; putative fusion peptide region;  B Cell Epitope [1] ;  Fusion peptide in MERS [2]; B-cell epitope, HLA-DRB1*01:01 [3] ;"		[1](10.1016/j.chom.2020.03.002) ;  [2](10.1038/ncomms4067) ; [3](10.3390/v12030254) ; 
891	G	1322	0	0	965	24233	873	0	891	0	873	874	1030	1035	863	873	no	"S2; putative fusion peptide region;  B Cell Epitope [1] ;  Fusion peptide in MERS [2]; B-cell epitope, HLA-DRB1*01:01 [3] ; T-cell epitope, HLA-DRA*01:01, HLA-DRB1*07:01 [3] ;"		[1](10.1016/j.chom.2020.03.002) ;  [2](10.1038/ncomms4067) ; [3](10.3390/v12030254) ; 
892	A	1323	981	944	966	24236	874	942	892	964	874	875	1031	1036	864	874	no	"S2; putative fusion peptide region;  B Cell Epitope [1] ;  Fusion peptide in MERS [2]; B-cell epitope, HLA-DRB1*01:01 [3] ; T-cell epitope, HLA-DRA*01:01, HLA-DRB1*07:01 [3] ;"		[1](10.1016/j.chom.2020.03.002) ;  [2](10.1038/ncomms4067) ; [3](10.3390/v12030254) ; 
893	A	1324	982	945	967	24239	875	943	893	965	875	876	1032	1037	865	875	no	"S2; putative fusion peptide region;  B Cell Epitope [1] ;  Fusion peptide in MERS [2]; B-cell epitope, HLA-DRB1*01:01 [3] ; T-cell epitope, HLA-DRA*01:01, HLA-DRB1*07:01 [3] ;"		[1](10.1016/j.chom.2020.03.002) ;  [2](10.1038/ncomms4067) ; [3](10.3390/v12030254) ; 
894	L	1325	983	946	968	24242	876	944	894	966	876	877	1033	1038	866	876	no	"S2; putative fusion peptide region;  B Cell Epitope [1] ;  Fusion peptide in MERS [2]; B-cell epitope, HLA-DRB1*01:01, HLA-B*35:01, HLA-B*15:01, HLA-B*58:01, HLA-C*15:02 [3] ; T-cell epitope, HLA-DRA*01:01, HLA-DRB1*07:01 [3] ;"		[1](10.1016/j.chom.2020.03.002) ;  [2](10.1038/ncomms4067) ; [3](10.3390/v12030254) ; 
895	Q	1326	984	947	969	24245	877	945	895	967	877	878	1034	1039	867	877	no	"S2; putative fusion peptide region;  B Cell Epitope [1] ;  Fusion peptide in MERS [2]; B-cell epitope, HLA-DRB1*01:01, HLA-B*35:01, HLA-B*15:01, HLA-B*58:01, HLA-C*15:02 [3] ; T-cell epitope, HLA-DRA*01:01, HLA-DRB1*07:01 [3] ;"		[1](10.1016/j.chom.2020.03.002) ;  [2](10.1038/ncomms4067) ; [3](10.3390/v12030254) ; 
896	I	1327	985	948	970	24248	878	946	896	968	878	879	1035	1040	868	878	no	"S2; putative fusion peptide region;  B Cell Epitope [1] ;  Fusion peptide in MERS [2]; B-cell epitope, HLA-DRB1*01:01 , HLA-B*35:01, HLA-B*15:01, HLA-B*58:01, HLA-C*15:02[3] ; T-cell epitope, HLA-DRA*01:01, HLA-DRB1*07:01 [3] ;"		[1](10.1016/j.chom.2020.03.002) ;  [2](10.1038/ncomms4067) ; [3](10.3390/v12030254) ; 
897	P	1328	986	949	971	24251	879	947	897	969	879	880	1036	1041	869	879	no	"S2; putative fusion peptide region;  B Cell Epitope [1] ;  Fusion peptide in MERS [2]; B-cell epitope, HLA-DRB1*01:01 , HLA-B*35:01, HLA-B*15:01, HLA-B*58:01, HLA-C*15:02[3] ; T-cell epitope, HLA-DRA*01:01, HLA-DRB1*07:01 [3] ;"		[1](10.1016/j.chom.2020.03.002) ;  [2](10.1038/ncomms4067) ; [3](10.3390/v12030254) ; 
898	F	1329	987	950	972	24254	880	948	898	970	880	881	1037	1042	870	880	no	"S2; putative fusion peptide region;  strictly conserved in coronaviruses [1] ;  B Cell Epitope [2] [3] ;  Fusion peptide in MERS [4]; B-cell epitope, HLA-DRB1*01:01 , HLA-B*35:01, HLA-B*15:01, HLA-B*58:01, HLA-C*15:02[5] ; T-cell epitope, HLA-DRA*01:01, HLA-DRB1*07:01 [5] ;"		[1](10.1016/j.virol.2005.02.022) ;  [2](10.1016/j.chom.2020.03.002) ; [3](10.21203/rs.3.rs-16262/v1) ;  [4](10.1038/ncomms4067) ; [5](10.3390/v12030254) ; 
899	A	1330	988	951	973	24257	881	949	899	971	881	882	1038	1043	871	881	no	"S2; putative fusion peptide region; “HR1”; position a in the heptad repeat abcdefg pattern. Often hydrophobic, strictly conserved in coronaviruses [1] ;  B Cell Epitope [3] [4] ;  	Fusion peptide in MERS [5]; B-cell epitope, HLA-B*35:01, HLA-B*15:01, HLA-B*58:01, HLA-C*15:02 ,HLA-DRB1*01:01 [6] ; T-cell epitope, HLA-DRA*01:01, HLA-DRB1*07:01 [6] ;"	"No change in hydrophobicity, no impact expected"	[1](10.1016/j.virol.2005.02.022) ;  [2](10.1016/S0140-6736(04)15788-7); [3](10.1016/j.chom.2020.03.002) ; [4](10.21203/rs.3.rs-16262/v1) ;  [5](10.1038/ncomms4067) ; [6](10.3390/v12030254) ; 
900	M	1331	989	952	974	24260	882	950	900	972	882	883	1039	1044	872	882	no	"S2; HR1;  B Cell Epitope [1] [2] ; Fusion peptide in MERS [3]; B-cell epitope, HLA-DRB1*01:01 , HLA-B*35:01, HLA-B*15:01, HLA-B*58:01, HLA-C*15:02[4] ; T-cell epitope, HLA-DRA*01:01, HLA-DRB1*07:01 [4] ;"		[1](10.1016/j.chom.2020.03.002) ; [2](10.21203/rs.3.rs-16262/v1) ;  [3](10.1038/ncomms4067) ; [4](10.3390/v12030254); 
901	Q	1332	990	953	975	24263	883	951	901	973	883	884	1040	1045	873	883	no	"S2; HR1;  B Cell Epitope [1] [2] ; Fusion peptide in MERS [3]; B-cell epitope, HLA-DRB1*01:01, HLA-B*35:01, HLA-B*15:01, HLA-B*58:01, HLA-C*15:02 [4] ; T-cell epitope, HLA-DRA*01:01, HLA-DRB1*07:01 [4] ;"		[1](10.1016/j.chom.2020.03.002) ; [2](10.21203/rs.3.rs-16262/v1) ;  [3](10.1038/ncomms4067) ; [4](10.3390/v12030254); 
902	M	1333	991	954	976	24266	884	952	902	974	884	885	1041	1046	874	884	no	"S2; HR1;  B Cell Epitope [1] [2] ; Fusion peptide in MERS [3]; B-cell epitope, HLA-DRB1*01:01, HLA-B*35:01, HLA-B*15:01, HLA-B*58:01, HLA-C*15:02 [4] ; T-cell epitope, HLA-DRA*01:01, HLA-DRB1*07:01, HLA-DRB1*04:01 [4] ;"		[1](10.1016/j.chom.2020.03.002) ; [2](10.21203/rs.3.rs-16262/v1) ;  [3](10.1038/ncomms4067) ; [4](10.3390/v12030254); 
903	A	1334	992	955	977	24269	885	953	903	975	885	886	1042	1047	875	885	no	"S2; HR1;  B Cell Epitope [1] [2] ; Fusion peptide in MERS [3]; B-cell epitope, HLA-DRB1*01:01, HLA-B*35:01, HLA-B*15:01, HLA-B*58:01, HLA-C*15:02 [4] ; T-cell epitope, HLA-DRA*01:01, HLA-DRB1*07:01, HLA-DRB1*04:01 [4] ;"		[1](10.1016/j.chom.2020.03.002) ; [2](10.21203/rs.3.rs-16262/v1) ;  [3](10.1038/ncomms4067) ; [4](10.3390/v12030254); 
904	Y	1335	993	956	978	24272	886	954	904	976	886	887	1043	1048	876	886	no	"S2; HR1;  B Cell Epitope [1] [2] ; Fusion peptide in MERS [3]; B-cell epitope, HLA-DRB1*01:01 [4] ; T-cell epitope, HLA-DRA*01:01, HLA-DRB1*07:01, HLA-DRB1*04:01 [4] ;"		[1](10.1016/j.chom.2020.03.002) ; [2](10.21203/rs.3.rs-16262/v1) ;  [3](10.1038/ncomms4067) ; [4](10.3390/v12030254); 
905	R	1336	994	957	979	24275	887	955	905	977	887	888	1044	1049	877	887	no	"S2; HR1; strictly conserved in coronaviruses [1] ;   B Cell Epitope [2]  [3] ;  Fusion peptide in MERS [3]; B-cell epitope, HLA-DRB1*01:01 [4] ; T-cell epitope, HLA-DRA*01:01, HLA-DRB1*07:01 , HLA-DRB1*04:01[4] ;"		[1](10.1016/j.chom.2020.03.002) ; [2](10.21203/rs.3.rs-16262/v1) ;  [3](10.1038/ncomms4067) ; [4](10.3390/v12030254); 
906	F	1337	995	958	980	24278	888	956	906	978	888	889	1045	1050	878	888	no	"S2; HR1;  B Cell Epitope [1] [2] ;  Fusion peptide in MERS [3]; B-cell epitope, HLA-DRB1*01:01 [4] ;T-cell epitope, HLA-DRA*01:01, HLA-DRB1*07:01 , HLA-DRB1*04:01[4] ;"		[1](10.1016/j.virol.2005.02.022); [2](10.21203/rs.3.rs-16262/v1) ; ;  [3](10.1038/ncomms4067) ; [4](10.3390/v12030254):
907	N	1338	996	959	981	24281	889	957	907	979	889	890	1046	1051	879	889	no	"S2; HR1; strictly conserved in coronaviruses [1] ;  ; B Cell Epitope [2] [3]  ;  Fusion peptide in MERS [4]; B-cell epitope, HLA-DRB1*01:01 [5] ; T-cell epitope,  HLA-DRB1*04:01[5] ; "		[1](10.1016/j.virol.2005.02.022) ;  [2](10.1016/j.chom.2020.03.002) ; [3](10.21203/rs.3.rs-16262/v1) ;  [4](10.1038/ncomms4067) ; [5](10.3390/v12030254):
908	G	1339	997	960	982	24284	890	958	908	980	890	891	1047	1052	880	890	no	"S2; HR1; Helix break [1] ;  B Cell Epitope [2] [3]   ;  Fusion peptide in MERS [4]; B-cell epitope, HLA-DRB1*01:01 [5] ; T-cell epitope,  HLA-DRB1*04:01[5] ; "		[1](10.1016/j.virol.2005.02.022) ;  [2](10.1016/j.chom.2020.03.002) ; [3](10.21203/rs.3.rs-16262/v1) ;  [4](10.1038/ncomms4067) ; [5](10.3390/v12030254):
909	I	1340	998	961	983	24287	891	959	909	981	891	892	1048	1053	881	891	no	"S2; HR1; Helix break [1] ;  B Cell Epitope [2] [3]  ;B-cell epitope, HLA-DRB1*01:01 [4] ; T-cell epitope,  HLA-DRB1*04:01[54] ; "		[1](10.1016/j.virol.2005.02.022) ;  [2](10.1016/j.chom.2020.03.002) ; [3](10.21203/rs.3.rs-16262/v1) ; [4](10.3390/v12030254):
910	G	1341	999	962	984	24290	892	960	910	982	892	893	1049	1054	882	892	no	"S2; HR1; Helix break [1 ;  B Cell Epitope [2] ; B-cell epitope, HLA-DRB1*01:01 [3] ; T-cell epitope,  HLA-DRB1*04:01[3] ; "		[1](10.1016/j.virol.2005.02.022) ; [2](10.21203/rs.3.rs-16262/v1) ; [3](10.3390/v12030254):
911	V	1342	1000	963	985	24293	893	961	911	983	893	894	1050	1055	883	893	no	"S2; HR1; ;  B Cell Epitope [1]; B Cell Epitope , HLA-DRB1*01:01 [2]; T-cell epitope,  HLA-DRB1*04:01[2] ; "		[1](10.21203/rs.3.rs-16262/v1) ; [2](10.3390/v12030254) ; 
912	T	1343	1001	964	986	24296	894	962	912	984	894	895	1051	1056	884	894	no	"S2; HR1; ;  B Cell Epitope [1]  ; B Cell Epitope , HLA-A*03:01 ,  HLA-A*11:01, HLA-A*68:01 , HLA-DRB1*01:01 , HLA-A*31:01[2] ; T-cell epitope,  HLA-DRB1*04:01[2] ; "		[1](10.21203/rs.3.rs-16262/v1) ; [2](10.3390/v12030254) ; 
913	Q	1344	1002	965	987	24299	895	963	913	985	895	896	1052	1057	885	895	no	"S2; HR1; ;  B Cell Epitope [1]  ; B Cell Epitope , HLA-A*03:01 ,  HLA-A*11:01, HLA-A*68:01 , HLA-DRB1*01:01, HLA-A*31:01[2] ; T-cell epitope,  HLA-DRB1*04:01[2] ; "		[1](10.21203/rs.3.rs-16262/v1) ; [2](10.3390/v12030254) ; 
914	N	1345	1003	966	988	24302	896	964	914	986	896	897	1053	1058	886	896	no	"S2; HR1; B Cell Epitope , HLA-A*03:01 ,  HLA-A*11:01, HLA-A*68:01 , HLA-A*31:01[1] ; T-cell epitope,  HLA-DRB1*04:01[1] ; "		[1](10.3390/v12030254) ; 
915	V	1346	1004	967	989	24305	897	965	915	987	897	898	1054	1059	887	897	no	"S2; HR1; B Cell Epitope , HLA-A*03:01 ,  HLA-A*11:01, HLA-A*68:01 , HLA-DRB1*01:01, HLA-A*31:01 [1] ; T-cell epitope,  HLA-DRB1*04:01 [1] ; "		[1](10.3390/v12030254) ; 
916	L	1347	1005	968	990	24308	898	966	916	988	898	899	1055	1060	888	898	no	"S2; HR1; strictly conserved in coronaviruses [1] ; B Cell Epitope ,  HLA-A*03:01 ,  HLA-A*11:01, HLA-A*68:01 , HLA-A*31:01 [2] ; T-cell epitope,  HLA-DRB1*04:01 , HLA-DRB1*01:01 [2] ; "		[1](10.1016/j.virol.2005.02.022) ; [2](10.3390/v12030254) ; 
917	Y	1348	1006	969	991	24311	899	967	917	989	899	900	1056	1061	889	899	no	"S2; HR1; B Cell Epitope ,  HLA-A*03:01 ,  HLA-A*11:01, HLA-A*68:01 , HLA-DRB1*01:01, HLA-A*31:01 [1] ;"		[1](10.3390/v12030254) ; 
918	E	1349	1007	970	992	24314	900	968	918	990	900	901	1057	1062	890	900	no	"S2; HR1; alternative Salt bridge 1 in some species;  B Cell Epitope ,  HLA-A*03:01 ,  HLA-A*11:01, HLA-A*68:01 , HLA-DRB1*01:01, HLA-A*31:01 [2] ;"		[1](10.1016/j.virol.2005.02.022) ; [2](10.3390/v12030254) ; 
919	N	1350	1008	971	993	24317	901	969	919	991	901	902	1058	1063	891	901	no	"S2; HR1; Interaction with central chloride ion [1];  B Cell Epitope ,  HLA-A*03:01 ,  HLA-A*11:01, HLA-A*68:01, HLA-A*31:01  [2] ;"		[1](10.1016/j.virol.2005.02.022) ; [2](10.3390/v12030254) ; 
920	Q	1351	1009	972	994	24320	902	970	920	992	902	903	1059	1064	892	902	no	"S2; HR1; Interaction with central chloride ion [1]; Deep hydrophobic groove [2] ; B Cell Epitope ,  HLA-A*03:01 ,  HLA-A*11:01, HLA-A*68:01 , HLA-A*31:01 [3] ;"		[1](10.1016/j.virol.2005.02.022) ; [2](10.1074/jbc.M408782200) ; [3](10.3390/v12030254) ; 
921	K	1352	1010	973	995	24323	903	971	921	993	903	904	1060	1065	893	903	no	"S2; HR1; Salt Bridge 1 involved in HR1/HR2 hairpin structure [1]; Deep hydrophobic groove [3] ; B Cell Epitope , HLA-A*03:01 ,  HLA-A*11:01, HLA-A*68:01, HLA-A*31:01  [4] ;"	Disappearance of a Salt Bridge involved in HR1/HR2 hairpin structure. Expected to have high impact on the S2 protein structure	[1](10.1016/j.chom.2020.03.002) ;  [2]( doi.org/10.1016/S0140-6736(04)15788-7);  [3](10.1074/jbc.M408782200) ; ; [4](10.3390/v12030254) ; 
922	L	1353	1011	974	996	24326	904	972	922	994	904	905	1061	1066	894	904	no	"S2; HR1; Deep hydrophobic groove [2] ; B Cell Epitope , HLA-A*03:01 ,  HLA-A*11:01, HLA-A*68:01 , HLA-A*31:01 [3] ;"		[2](10.1074/jbc.M408782200) ; ; [2](10.3390/v12030254) ; 
923	I	1354	1012	975	997	24329	905	973	923	995	905	906	1062	1067	895	905	no	S2; HR1; Deep hydrophobic groove [2] ;		[2](10.1074/jbc.M408782200) ; 
924	A	1355	1013	976	998	24332	906	974	924	996	906	907	1063	1068	896	906	no	S2; HR1; strictly conserved in coronaviruses [1] ; 		[1](10.1016/j.virol.2005.02.022) ; [2](10.1074/jbc.M408782200) 
925	N	1356	1014	977	999	24335	907	975	925	997	907	908	1064	1069	897	907	no	S2; HR1; Deep hydrophobic groove [2] ;		[2](10.1074/jbc.M408782200) ; 
926	Q	1357	1015	978	1000	24338	908	976	926	998	908	909	1065	1070	898	908	no	S2; HR1; Deep hydrophobic groove [2] ;		[2](10.1074/jbc.M408782200) ; 
927	F	1358	1016	979	1001	24341	909	977	927	999	909	910	1066	1071	899	909	no	S2; HR1; strictly conserved in coronaviruses [1] ; 		[1](10.1016/j.virol.2005.02.022) ; [2](10.1074/jbc.M408782200) 
928	N	1359	1017	980	1002	24344	910	978	928	1000	910	911	1067	1072	900	910	no	S2; HR1; strictly conserved in coronaviruses [1] ; 		[1](10.1016/j.virol.2005.02.022) ; [2](10.1074/jbc.M408782200) 
929	S	1360	1018	981	1003	24347	911	979	929	1001	911	912	1068	1073	901	911	no	S2; HR1; Deep hydrophobic groove [2] ;		[2](10.1074/jbc.M408782200) ; 
930	A	1361	1019	982	1004	24350	912	980	930	1002	912	913	1069	1074	902	912	yes	S2; HR1; strictly conserved in coronaviruses [1] ; Mutation A930V observed [2] ;		[1](10.1016/j.virol.2005.02.022) ; [2](10.1101/2020.04.07.029132)
931	I	1362	1020	983	1005	24353	913	981	931	1003	913	914	1070	1075	903	913	no	S2; HR1; Deep hydrophobic groove [2] ;		[2](10.1074/jbc.M408782200) ; 
932	G	1363	1021	984	1006	24356	914	982	932	1004	914	915	1071	1076	904	914	no	S2; HR1; Deep hydrophobic groove [2] ;		[2](10.1074/jbc.M408782200) ; 
933	K	1364	1022	985	1007	24359	915	983	933	1005	915	916	1072	1077	905	915	no	S2; HR1; Deep hydrophobic groove [2] ;		[2](10.1074/jbc.M408782200) ; 
934	I	1365	1023	986	1008	24362	916	984	934	1006	916	917	1073	1078	906	916	no	S2; HR1; Deep hydrophobic groove [2] ;		[2](10.1074/jbc.M408782200) ; 
935	Q	1366	1024	987	1009	24365	917	985	935	1007	917	918	1074	1079	907	917	no	S2; HR1; Deep hydrophobic groove [2] ;		[2](10.1074/jbc.M408782200) ; 
936	D	1367	1025	988	1010	24368	918	986	936	1008	918	919	1075	1080	908	918	no	S2; HR1; Deep hydrophobic groove [2] ;  T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ;  [2](10.1074/jbc.M408782200); 
937	S	1368	1026	989	1011	24371	919	987	937	1009	919	920	1076	1081	909	919	no	S2; HR1; Deep hydrophobic groove [2] ;  T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ;  [2](10.1074/jbc.M408782200); 
938	L	1369	1027	990	1012	24374	920	988	938	1010	920	921	1077	1082	910	920	no	S2; HR1; Deep hydrophobic groove [2] ;  T cell epitope [1] ; 		[1](10.1016/j.chom.2020.03.002) ;  [2](10.1074/jbc.M408782200); 
939	S	1384	1028	1005	1013	24377	921	989	939	1025	921	922	1092	1097	911	921	no	S2; HR1;  Fusion Core :  target of fusion/entry inhibitors; One of the 8 residues that differs from SARS-Cov Fusion Core;  position b in the heptad repeat abcdefg pattern ; Deep hydrophobic groove [2]  ;  T cell epitope [3] ; 	Change in impact of fusion/entry inhibitor drugs ; little to no impact expected on structure	[5](10.1038/s41423-020-0374-2) ; [3](10.1016/j.virol.2005.02.022) ; [4](10.1016/S0140-6736(04)15788-7) ;  [2](10.1074/jbc.M408782200) ; [1](10.1016/j.chom.2020.03.002)
940	S	1385	1029	1006	1014	24380	922	990	940	1026	922	923	1093	1098	912	922	no	"S2; HR1; Deep hydrophobic groove [2] ; S940F observed in at least two continents with 20 >1% frequency [1] ;  T cell epitope [3] ;		"		[1](10.1101/2020.05.21.108563) ;  [2](10.1074/jbc.M408782200) ; [3](10.1016/j.chom.2020.03.002)
941	T	1386	1030	1007	1015	24383	923	991	941	1027	923	924	1094	1099	913	923	no	S2; HR1; Deep hydrophobic groove [2] ;  T cell epitope [1] ; 		[2](10.1074/jbc.M408782200)  ; [3](10.1016/j.chom.2020.03.002)
942	A	1387	1031	1008	1016	24386	924	992	942	1028	924	925	1095	1100	914	924	no	S2; HR1; Fusion Core :  target of fusion/entry inhibitors; One of the 8 residues that differs from SARS-Cov Fusion Core ; position e in the heptad repeat abcdefg pattern ; Deep hydrophobic groove [2] ;  T cell epitope [1] ; 	Variant more similar to SARS-1 fusion Core; Change in impact of fusion/entry inhibitor drugs possible; little to no impact expected on HR structure	[5](10.1038/s41423-020-0374-2) ; [3](10.1016/j.virol.2005.02.022) ; [4](10.1016/S0140-6736(04)15788-7) ;  [2](10.1074/jbc.M408782200) ; [1](10.1016/j.chom.2020.03.002)
943	S	1388	1032	1009	1017	24389	925	993	943	1029	925	926	1096	1101	915	925	no	S2; HR1; Fusion Core :  target of fusion/entry inhibitors; One of the 8 residues that differs from SARS-Cov Fusion Core ; position f in the heptad repeat abcdefg pattern ; Deep hydrophobic groove [2] ;  T cell epitope [1] ; 	T variant more similar to SARS-1 fusion Core; Change in impact of fusion/entry inhibitor drugs; little to no impact expected on HR structure	[5](10.1038/s41423-020-0374-2) ; [3](10.1016/j.virol.2005.02.022) ; [4](10.1016/S0140-6736(04)15788-7) ;  [2](10.1074/jbc.M408782200) ; [1](10.1016/j.chom.2020.03.002)
944	A	1389	1033	1010	1018	24392	926	994	944	1030	926	927	1097	1102	916	926	no	S2; HR1; strictly conserved in coronaviruses [1] ;  Deep hydrophobic groove [2] ;   T cell epitope [3] ; 		[1](10.1016/j.virol.2005.02.022) ; [2](10.1074/jbc.M408782200) ; [3](10.1016/j.chom.2020.03.002) ; 
945	L	1390	1034	1011	1019	24395	927	995	945	1031	927	928	1098	1103	917	927	no	S2; HR1; strictly conserved in coronaviruses [1] ;  Deep hydrophobic groove [2] ;   T cell epitope [3] ; 		[1](10.1016/j.virol.2005.02.022) ; [2](10.1074/jbc.M408782200) ; [3](10.1016/j.chom.2020.03.002) ; 
946	G	1391	1035	1012	1020	24398	928	996	946	1032	928	929	1099	1104	918	928	no	S2; HR1; Shallow hydrophobic groove [2] ;   T cell epitope [3] ; 		[2](10.1074/jbc.M408782200)  ; [3](10.1016/j.chom.2020.03.002)
947	K	1392	1036	1013	1021	24401	929	997	947	1033	929	930	1100	1105	919	929	no	S2; HR1; Shallow hydrophobic groove [2] ;   T cell epitope [3] ; 		[2](10.1074/jbc.M408782200)  ; [3](10.1016/j.chom.2020.03.002)
948	L	1393	1037	1014	1022	24404	930	998	948	1034	930	931	1101	1106	920	930	no	"S2; HR1;  Salt bridge 2 [1];  Highly conserved; Fusion Core :  target of fusion/entry inhibitors; position d in the heptad repeat abcdefg pattern ; Shallow hydrophobic groove [2] ;   T cell epitope [3] ; B-cell epitope, HLA-DRB1*01:01 [4] ; "	Hydrophobicity Conserved; little to no impact expected on HR structure 	[1](10.1016/j.virol.2005.02.022;10.1038/s41423-020-0374-2); [5](10.1016/j.virol.2005.02.022); [4](doi.org/10.1016/S0140-6736(04)15788-7); [2](10.1074/jbc.M408782200); [3](10.1016/j.chom.2020.03.002); [4](10.3390/v12030254) ; 
949	Q	1394	1038	1015	1023	24407	931	999	949	1035	931	932	1102	1107	921	931	no	"S2; HR1; strictly conserved in coronaviruses [1] ; Shallow hydrophobic groove [2] ;   T cell epitope [3] ; B-cell epitope, HLA-DRB1*01:01 [4] ; "		[1](10.1016/j.virol.2005.02.022) ; [2](10.1074/jbc.M408782200) ; [3](10.1016/j.chom.2020.03.002) ; [4](10.3390/v12030254) ; 
950	D	1395	1039	1016	1024	24410	932	1000	950	1036	932	933	1103	1108	922	932	no	"S2; HR1;   position f in the heptad repeat abcdefg pattern Shallow hydrophobic groove [2] ;   T cell epitope [3] ; B-cell epitope, HLA-DRB1*01:01 [4] ; "		[1](10.1016/j.virol.2005.02.022) ; [4](10.1016/S0140-6736(04)15788-7) ; [2](10.1074/jbc.M408782200) ; [3](10.1016/j.chom.2020.03.002) ; [4](10.3390/v12030254) ; 
951	V	1396	1040	1017	1025	24413	933	1001	951	1037	933	934	1104	1109	923	933	no	"S2; HR1; strictly conserved in coronaviruses [1] ; Shallow hydrophobic groove [2] ;   T cell epitope [3] ; B-cell epitope, HLA-DRB1*01:01 [4] ; "		[1](10.1016/j.virol.2005.02.022) ; [2](10.1074/jbc.M408782200) ; [3](10.1016/j.chom.2020.03.002) ; [4](10.3390/v12030254) ; 
952	V	1397	1041	1018	1026	24416	934	1002	952	1038	934	935	1105	1110	924	934	no	"S2; HR1; strictly conserved in coronaviruses [1] ; Shallow hydrophobic groove [2] ;   T cell epitope [3] ; B-cell epitope, HLA-DRB1*01:01 [4] ; "		[1](10.1016/j.virol.2005.02.022) ; [2](10.1074/jbc.M408782200) ; [3](10.1016/j.chom.2020.03.002) ; [4](10.3390/v12030254) ; 
953	N	1398	1042	1019	1027	24419	935	1003	953	1039	935	936	1106	1111	925	935	no	"Shallow hydrophobic groove [2] ; B-cell epitope, HLA-DRB1*01:01 [1] ; "		[1](10.3390/v12030254) ; [2](10.1074/jbc.M408782200)
954	Q	1399	1043	1020	1028	24422	936	1004	954	1040	936	937	1107	1112	926	936	no	"Shallow hydrophobic groove [2] ; B-cell epitope, HLA-DRB1*01:01 [1] ; "		[1](10.3390/v12030254) ; [2](10.1074/jbc.M408782200)
955	N	1400	1044	1021	1029	24425	937	1005	955	1041	937	938	1108	1113	927	937	no	"S2; HR1; Interaction with central chloride ion [1]; Shallow hydrophobic groove [2] ; B-cell epitope, HLA-DRB1*01:01 [3] ; "		[1](10.1016/j.virol.2005.02.022) ; [2](10.1074/jbc.M408782200) ; [3](10.3390/v12030254) ; 
956	A	1401	1045	1022	1030	24428	938	1006	956	1042	938	939	1109	1114	928	938	no	"S2; HR1; Shallow hydrophobic groove [2] ; B-cell epitope, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01[1]"		[1](10.3390/v12030254) ; [2](10.1074/jbc.M408782200)
957	Q	1402	1046	1023	1031	24431	939	1007	957	1043	939	940	1110	1115	929	939	no	"S2; HR1; Shallow hydrophobic groove [2] ; B-cell epitope, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01 [1] ; T-cell epitope,  HLA-DRB1*04:01 [1] ;"		[1](10.3390/v12030254) ; [2](10.1074/jbc.M408782200)
958	A	1403	1047	1024	1032	24434	940	1008	958	1044	940	941	1111	1116	930	940	no	"S2; HR1; Shallow hydrophobic groove [2] ; T cell epitope [3] ;  S2; HLA-A*02:01 , HLA-A*03:01 ,  HLA-A*11:01, HLA-A*68:01  [1] ; B-cell epitope, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01 [1];  T-cell epitope,  HLA-DRB1*04:01 [1] ;"		[1](10.3390/v12030254) ; [2](10.1074/jbc.M408782200)  ; [3](10.1016/j.chom.2020.03.002)
959	L	1404	1048	1025	1033	24437	941	1009	959	1045	941	942	1112	1117	931	941	no	"S2; HR1; strictly conserved in coronaviruses [1] ; Shallow hydrophobic groove [2] ; T cell epitope [3] ; B-cell epitope, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*02:01 [4] ;T-cell epitope,  HLA-DRB1*04:01 [4] ;"		[1](10.1016/j.virol.2005.02.022) ;   [2]10.1074/jbc.M408782200) ; [3](10.1016/j.chom.2020.03.002) ; [4](10.3390/v12030254) ;
960	N	1405	1049	1026	1034	24440	942	1010	960	1046	942	943	1113	1118	932	942	no	"S2; HR1; Shallow hydrophobic groove [2] ; T cell epitope [3] ; B-cell epitope, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*02:01, HLA-DRB1*01:01 [1] ; T-cell epitope,  HLA-DRB1*04:01 [1] ;"		[1](10.3390/v12030254) ; [2](10.1074/jbc.M408782200)  ; [3](10.1016/j.chom.2020.03.002)
961	T	1406	1050	1027	1035	24443	943	1011	961	1047	943	944	1114	1119	933	943	no	"S2; HR1; Shallow hydrophobic groove [2] ; T cell epitope [3] ; B-cell epitope, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*02:01, HLA-DRB1*01:01 [1] ;	T-cell epitope,  HLA-DRB1*04:01 [1] ;"		[1](10.3390/v12030254) ; [2](10.1074/jbc.M408782200)  ; [3](10.1016/j.chom.2020.03.002)
962	L	1407	1051	1028	1036	24446	944	1012	962	1048	944	945	1115	1120	934	944	no	"S2; HR1; Shallow hydrophobic groove [2] ; T cell epitope [3] ; B-cell epitope, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*02:01, HLA-DRB1*01:01 [1] ; T-cell epitope,  HLA-DRB1*04:01 [1] ;"		[1](10.3390/v12030254) ; [2](10.1074/jbc.M408782200)  ; [3](10.1016/j.chom.2020.03.002)
963	V	1408	1052	1029	1037	24449	945	1013	963	1049	945	946	1116	1121	935	945	no	"S2; HR1; Shallow hydrophobic groove [2] ; T cell epitope [3] ; B-cell epitope, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*02:01, HLA-DRB1*01:01 [1] ; T-cell epitope,  HLA-DRB1*04:01 [1] ;"		[1](10.3390/v12030254) ; [2](10.1074/jbc.M408782200)  ; [3](10.1016/j.chom.2020.03.002)
964	K	1409	1053	1030	1038	24452	946	1014	964	1050	946	947	1117	1122	936	946	no	"S2; HR1; Shallow hydrophobic groove [2] ; T cell epitope [3] ; B-cell epitope, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*02:01, HLA-DRB1*01:01 [1] ; T-cell epitope,  HLA-DRB1*04:01 [1] ;"		[1](10.3390/v12030254) ; [2](10.1074/jbc.M408782200)  ; [3](10.1016/j.chom.2020.03.002)
965	Q	1410	1054	1031	1039	24455	947	1015	965	1051	947	948	1118	1123	937	947	no	"S2; HR1; Shallow hydrophobic groove [2] ; T cell epitope [3] ; B-cell epitope, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*02:01, HLA-DRB1*01:01 [1] ; T-cell epitope,  HLA-DRB1*04:01 [1] ;"		[1](10.3390/v12030254) ; [2](10.1074/jbc.M408782200)  ; [3](10.1016/j.chom.2020.03.002)
966	L	1411	1055	1032	1040	24458	948	1016	966	1052	948	949	1119	1124	938	948	no	"S2; HR1; strictly conserved in coronaviruses [1] ; T cell epitope [2] ; HLA-A*02:01 [3] ;	B-cell epitope, HLA-A*02:01, HLA-DRB1*01:01 [3]; T-cell epitope,  HLA-DRB1*04:01 [3] ;"		[1](10.1016/j.virol.2005.02.022) ;  [2](10.1016/j.chom.2020.03.002) ; [3](10.3390/v12030254) ;
967	S	1412	1056	1033	1041	24461	949	1017	967	1053	949	950	1120	1125	939	949	no	"S2; HR1; B-cell epitope, HLA-A*02:01, HLA-DRB1*01:01 [1] ; T-cell epitope,  HLA-DRB1*04:01 [1] ;"		[1](10.3390/v12030254) ; 
968	S	1413	1057	1034	1042	24464	950	1018	968	1054	950	951	1121	1126	940	950	no	"S2; HR1; B-cell epitope, HLA-DRB1*01:01 [1] ; T-cell epitope,  HLA-DRB1*04:01 [1] ;"		[1](10.3390/v12030254) ; 
969	N	1414	1058	1035	1043	24467	951	1019	969	1055	951	952	1122	1127	941	951	no	"S2; HR1; B-cell epitope, HLA-DRB1*01:01 [1]; T-cell epitope,  HLA-DRB1*04:01 [1] ;"		[1](10.3390/v12030254) ; 
970	F	1415	1059	1036	1044	24470	952	1020	970	1056	952	953	1123	1128	942	952	no	"S2; HR1; strictly conserved in coronaviruses [1] ; B-cell epitope, HLA-DRB1*01:01 [1] ; T-cell epitope,  HLA-DRB1*04:01 [1] ;"		[1](10.1016/j.virol.2005.02.022) ; [2](10.3390/v12030254) ; 
971	G	1416	1060	1037	1045	24473	953	1021	971	1057	953	954	1124	1129	943	953	no	"S2; HR1;  position b in the heptad repeat abcdefg pattern [1];  B-cell epitope, HLA-DRB1*01:01 [2] ; T-cell epitope,  HLA-DRB1*04:01 [2] ;"		[1](10.1016/j.virol.2005.02.022) ; [2](10.1016/S0140-6736(04)15788-7);  [3](10.3390/v12030254) ; 
972	A	1417	1061	1038	1046	24476	954	1022	972	1058	954	955	1125	1130	944	954	no	"S2; HR1; strictly conserved in coronaviruses [1] ; B-cell epitope, HLA-DRB1*01:01 [2] ; T-cell epitope,  HLA-DRB1*04:01 [2] ;"		[1](10.1016/j.virol.2005.02.022) ; [2](10.3390/v12030254) ; 
973	I	1418	1062	1039	1047	24479	955	1023	973	1059	955	956	1126	1131	945	955	no	"S2; HR1; strictly conserved in coronaviruses [1] ; B-cell epitope, HLA-DRB1*01:01 [2] ; T-cell epitope,  HLA-DRB1*04:01 [2] ;"		[1](10.1016/j.virol.2005.02.022) ; [2](10.3390/v12030254) ; 
974	S	1419	1063	1040	1048	24482	956	1024	974	1060	956	957	1127	1132	946	956	no	"S2; HR1; strictly conserved in coronaviruses [1] ; position e in the heptad repeat abcdefg pattern [1] ; B-cell epitope, HLA-DRB1*01:01 [2] ; "		[1](10.1016/j.virol.2005.02.022) ; [2](doi.org/10.1016/S0140-6736(04)15788-7) ; [3](10.3390/v12030254) ; 
975	S	1420	1064	1041	1049	24485	957	1025	975	1061	957	958	1128	1133	947	957	no	"S2; HR1;B-cell epitope, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, [1]"		[1](10.3390/v12030254) ; 
976	V	1421	1065	1042	1050	24488	958	1026	976	1062	958	959	1129	1134	948	958	no	"S2; HR1 ; T cell epitope [1] ; B-cell epitope, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01,  [2] ;"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ;
977	L	1422	1066	1043	1051	24491	959	1027	977	1063	959	960	1130	1135	949	959	no	"S2; HR1 ; T cell epitope [1] ; B-cell epitope, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01,  [2] ;"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ;
978	N	1423	1067	1044	1052	24494	960	1028	978	1064	960	961	1131	1136	950	960	no	"S2; HR1 ; T cell epitope [1] ; B-cell epitope, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01,  [2] ;"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ;
979	D	1424	1068	1045	1053	24497	961	1029	979	1065	961	962	1132	1137	951	961	no	"S2; HR1;  position c in the heptad repeat abcdefg pattern [2]  ; T cell epitope [3] ; B-cell epitope, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01,   [4] ;"		[1](10.1016/j.virol.2005.02.022) ; [2](doi.org/10.1016/S0140-6736(04)15788-7) ; [3](10.1016/j.chom.2020.03.002) ; [4](10.3390/v12030254) ;
980	I	1425	1069	1046	1054	24500	962	1030	980	1066	962	963	1133	1138	952	962	no	"S2; HR1; strictly conserved in coronaviruses [1] ; T cell epitope [2] ;  B-cell epitope, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01,   [3] ;"		[1](10.1016/j.virol.2005.02.022) ;  [2](10.1016/j.chom.2020.03.002) ; [3](10.3390/v12030254) ;
981	L	1426	1070	1047	1055	24503	963	1031	981	1067	963	964	1134	1139	953	963	no	"S2; HR1 ; T cell epitope [1] ; B-cell epitope, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, [2] ;"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ;
982	S	1427	1071	1048	1056	24506	964	1032	982	1068	964	965	1135	1140	954	964	no	"S2; HR1 ; T cell epitope [1] ;B-cell epitope, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01,   [2] ;"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ;
983	R	1428	1072	1049	1057	24509	965	1033	983	1069	965	966	1136	1141	955	965	no	"S2; HR1 ; T cell epitope [1] ; B-cell epitope, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*02:01 [2] ;"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ;
984	L	1429	1073	1050	1058	24512	966	1034	984	1070	966	967	1137	1142	956	966	no	"S2; HR1 ; T cell epitope [1] ; B-cell epitope, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*02:01  [2] ;"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ;
985	D	1430	1074	1051	1059	24515	967	1035	985	1071	967	968	1138	1143	957	967	no	"S2; HR1 ; B-cell epitope, HLA-A*02:01 [1] ;"		[1](10.3390/v12030254) ;
986	K	1431	1075	1052	1060	24518	968	1036	986	1072	968	969	1139	1144	958	968	no	"S2; HR1 ; B-cell epitope, HLA-A*02:01 [1] ;"		[1](10.3390/v12030254) ;
987	V	1432	1076	1053	1061	24521	969	1037	987	1073	969	970	1140	1145	959	969	no	"S2; HR1 ; B-cell epitope, HLA-A*02:01 [1] ;"		[1](10.3390/v12030254) ;
988	E	1433	1077	1054	1062	24524	970	1038	988	1074	970	971	1141	1146	960	970	no	"S2; HR1 ; B-cell epitope, HLA-A*02:01 [1] ;"		[1](10.3390/v12030254) ;
989	A	1434	1078	1055	1063	24527	971	1039	989	1075	971	972	1142	1147	961	971	no	"S2; HR1; strictly conserved in coronaviruses [1] ; B-cell epitope, HLA-A*02:01 [2] ;"		[1](10.1016/j.virol.2005.02.022) ; [2](10.3390/v12030254) ;
990	E	1435	1079	1056	1064	24530	972	1040	990	1076	972	973	1143	1148	962	972	no	"S2; HR1 ; B-cell epitope, HLA-A*02:01 [1] ;"		[1](10.3390/v12030254) ;
991	V	1436	1080	1057	1065	24533	973	1041	991	1077	973	974	1144	1149	963	973	no	"S2; HR1;  position a in the heptad repeat abcdefg pattern ; B-cell epitope, HLA-A*02:01, HLA-A*03:01, HLA-A*11:01 HLA-A*68:01 HLA-A*31:01 HLA-A*33:01,  [2] ;"	Hydrophobicity Conserved; little to no impact expected on HR structure 	[1](10.1016/j.virol.2005.02.022)  ; [2](10.3390/v12030254) ;
992	Q	1437	1081	1058	1066	24536	974	1042	992	1078	974	975	1145	1150	964	974	no	"S2; B-cell epitope, HLA-A*02:01, HLA-A*03:01, HLA-A*11:01 HLA-A*68:01 HLA-A*31:01 HLA-A*33:01,   [1] ;"		[1](10.3390/v12030254) ;
993	I	1438	1082	1059	1067	24539	975	1043	993	1079	975	976	1146	1151	965	975	no	"S2; B-cell epitope, HLA-A*03:01, HLA-A*11:01 HLA-A*68:01 HLA-A*31:01 HLA-A*33:01, HLA-DRB1*01:01 [1]"		[1](10.3390/v12030254) ;
994	D	1439	1083	1060	1068	24542	976	1044	994	1080	976	977	1147	1152	966	976	no	"S2; strictly conserved in coronaviruses [1] ; B-cell epitope, HLA-A*03:01, HLA-A*11:01 HLA-A*68:01 HLA-A*31:01 HLA-A*33:01, HLA-DRB1*01:01,HLA-A*02:01[2]"		[1](10.1016/j.virol.2005.02.022)
995	R	1440	1084	1061	1069	24545	977	1045	995	1081	977	978	1148	1153	967	977	no	"S2; strictly conserved in coronaviruses [1] ; B-cell epitope, HLA-A*03:01, HLA-A*11:01 HLA-A*68:01 HLA-A*31:01 HLA-A*33:01, HLA-DRB1*01:01,HLA-A*02:01[2]"		[1](10.1016/j.virol.2005.02.022)
996	L	1441	1085	1062	1070	24548	978	1046	996	1082	978	979	1149	1154	968	978	no	"S2; strictly conserved in coronaviruses [1] ; T cell epitope [2] ; B-cell epitope, HLA-A*03:01, HLA-A*11:01 HLA-A*68:01 HLA-A*31:01 HLA-A*33:01, HLA-DRB1*01:01,HLA-A*02:01  [3] ;	"		[1](10.1016/j.virol.2005.02.022) ;  [2](10.1016/j.chom.2020.03.002) ; [3](10.3390/v12030254) ; 
997	I	1442	1086	1063	1071	24551	979	1047	997	1083	979	980	1150	1155	969	979	no	"S2; strictly conserved in coronaviruses [1] ; T cell epitope [2] ;	B-cell epitope, HLA-A*03:01, HLA-A*11:01 HLA-A*68:01 HLA-A*31:01 HLA-A*33:01, HLA-DRB1*01:01,HLA-A*02:01  [3] ;	"		[1](10.1016/j.virol.2005.02.022) ;  [2](10.1016/j.chom.2020.03.002) ; [3](10.3390/v12030254) ; 
998	T	1443	1087	1064	1072	24554	980	1048	998	1084	980	981	1151	1156	970	980	no	"S2 ; T cell epitope [1] ; B-cell epitope, HLA-A*03:01, HLA-A*11:01 HLA-A*68:01 HLA-A*31:01 HLA-A*33:01, HLA-DRB1*01:01,HLA-A*02:01 [2] ;		"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
999	G	1444	1088	1065	1073	24557	981	1049	999	1085	981	982	1152	1157	971	981	no	"S2; strictly conserved in coronaviruses [1] ; T cell epitope [2] ; B-cell epitope, HLA-A*03:01, HLA-A*11:01 HLA-A*68:01 HLA-A*31:01 HLA-A*33:01, HLA-DRB1*01:01,HLA-A*02:01, HLA-DRB1*01:01,HLA-B*27:05, [3] ;		"		[1](10.1016/j.virol.2005.02.022) ;  [2](10.1016/j.chom.2020.03.002) ; [3](10.3390/v12030254) ; 
1000	R	1445	1089	1066	1074	24560	982	1050	1000	1086	982	983	1153	1158	972	982	no	"S2; strictly conserved in coronaviruses [1] ; T cell epitope [2] ; B-cell epitope, HLA-A*03:01, HLA-A*11:01 HLA-A*68:01 HLA-A*31:01 HLA-A*33:01, HLA-DRB1*01:01,HLA-A*02:01, HLA-DRB1*01:01,HLA-B*27:05,   [3] ;		"		[1](10.1016/j.virol.2005.02.022) ;  [2](10.1016/j.chom.2020.03.002) ; [3](10.3390/v12030254) ; 
1001	L	1446	1090	1067	1075	24563	983	1051	1001	1087	983	984	1154	1159	973	983	no	"S2 ; T cell epitope [1] ;	B-cell epitope, HLA-A*03:01, HLA-A*11:01 HLA-A*68:01 HLA-A*31:01 HLA-A*33:01, HLA-DRB1*01:01,HLA-A*02:01, HLA-DRB1*01:01,HLA-B*27:05,   [2] ;	"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
1002	Q	1447	1091	1068	1076	24566	984	1052	1002	1088	984	985	1155	1160	974	984	no	"S2 ; T cell epitope [1] ;	B-cell epitope, HLA-DRB1*01:01,HLA-A*02:01, HLA-B*27:05  [2] ;	"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
1003	S	1448	1092	1069	1077	24569	985	1053	1003	1089	985	986	1156	1161	975	985	no	"S2 ; T cell epitope [1] ;B-cell epitope, HLA-DRB1*01:01,HLA-A*02:01, HLA-B*27:05  [2] ;	"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
1004	L	1449	1093	1070	1078	24572	986	1054	1004	1090	986	987	1157	1162	976	986	no	"S2 ; T cell epitope [1] ;	B-cell epitope, HLA-DRB1*01:01,HLA-A*02:01, HLA-B*27:05 [2] ;	"		[1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
1005	Q	1450	1094	1071	1079	24575	987	1055	1005	1091	987	988	1158	1163	977	987	no	"S2; B-cell epitope, HLA-DRB1*01:01,HLA-A*02:01, HLA-B*27:05  [1] ;	"		[1](10.3390/v12030254) ; 
1006	T	1451	1095	1072	1080	24578	988	1056	1006	1092	988	989	1159	1164	978	988	no	"S2; B-cell epitope, HLA-DRB1*01:01,HLA-A*02:01, HLA-B*27:05  [1] ;	"		[1](10.3390/v12030254) ; 
1007	Y	1452	1096	1073	1081	24581	989	1057	1007	1093	989	990	1160	1165	979	989	no	"S2; B-cell epitope, HLA-DRB1*01:01,HLA-A*02:01, HLA-B*27:05  [1] ;	"		[1](10.3390/v12030254) ; 
1008	V	1453	1097	1074	1082	24584	990	1058	1008	1094	990	991	1161	1166	980	990	no	"S2; B-cell epitope, HLA-DRB1*01:01,HLA-A*02:01, HLA-B*27:05  [1] ;	"		[1](10.3390/v12030254) ; 
1009	T	1454	1098	1075	1083	24587	991	1059	1009	1095	991	992	1162	1167	981	991	no	"S2; B-cell epitope, HLA-DRB1*01:01,HLA-A*02:01,[1] ;	"		[1](10.3390/v12030254) ; 
1010	Q	1455	1099	1076	1084	24590	992	1060	1010	1096	992	993	1163	1168	982	992	no	"S2; B-cell epitope, HLA-DRB1*01:01 [1]"		[1](10.3390/v12030254) ; 
1011	Q	1456	1100	1077	1085	24593	993	1061	1011	1097	993	994	1164	1169	983	993	no	"S2 ; T cell epitope [1] ; B-cell epitope, HLA-DRB1*01:01 [2] ; T-cell epitope,  HLA-DRB1*04:01 [2] ;"		 [1](10.1016/j.chom.2020.03.002); [2](10.3390/v12030254) ; 
1012	L	1457	1101	1078	1086	24596	994	1062	1012	1098	994	995	1165	1170	984	994	no	"S2 ; T cell epitope [1] ; B-cell epitope, HLA-DRB1*01:01 [2] ; T-cell epitope,  HLA-DRB1*04:01 [2] ;"		 [1](10.1016/j.chom.2020.03.002); [2](10.3390/v12030254) ; 
1013	I	1458	1102	1079	1087	24599	995	1063	1013	1099	995	996	1166	1171	985	995	no	"S2 ; T cell epitope [1] ; B-cell epitope, HLA-DRB1*01:01 [2] ; T-cell epitope,  HLA-DRB1*04:01 [2] ;"		 [1](10.1016/j.chom.2020.03.002); [2](10.3390/v12030254) ; 
1014	R	1459	1103	1080	1088	24602	996	1064	1014	1100	996	997	1167	1172	986	996	no	"S2 ; T cell epitope [1] ; B-cell epitope, HLA-DRB1*01:01 [2] ; T-cell epitope,  HLA-DRB1*04:01 [2] ;"		 [1](10.1016/j.chom.2020.03.002); [2](10.3390/v12030254) ; 
1015	A	1460	1104	1081	1089	24605	997	1065	1015	1101	997	998	1168	1173	987	997	no	"S2 ; T cell epitope [1] ; B-cell epitope, HLA-DRB1*01:01 [2] ; T-cell epitope,  HLA-DRB1*04:01 [2] ;"		 [1](10.1016/j.chom.2020.03.002); [2](10.3390/v12030254) ; 
1016	A	1461	1105	1082	1090	24608	998	1066	1016	1102	998	999	1169	1174	988	998	no	"S2 ; T cell epitope [1] ; B-cell epitope, HLA-DRB1*01:01 [2] ; T-cell epitope,  HLA-DRB1*04:01 [2] ;"		 [1](10.1016/j.chom.2020.03.002); [2](10.3390/v12030254) ; 
1017	E	1462	1106	1083	1091	24611	999	1067	1017	1103	999	1000	1170	1175	989	999	no	"S2 ; T cell epitope [1] ; B-cell epitope, HLA-DRB1*01:01 [2] ; T-cell epitope,  HLA-DRB1*04:01 [2] ;"		 [1](10.1016/j.chom.2020.03.002); [2](10.3390/v12030254) ; 
1018	I	1463	1107	1084	1092	24614	1000	1068	1018	1104	1000	1001	1171	1176	990	1000	no	"S2 ; T cell epitope [1] ; B-cell epitope, HLA-DRB1*01:01 [2] ; T-cell epitope,  HLA-DRB1*04:01 [2] ;"		 [1](10.1016/j.chom.2020.03.002); [2](10.3390/v12030254) ; 
1019	R	1464	1108	1085	1093	24617	1001	1069	1019	1105	1001	1002	1172	1177	991	1001	no	"S2 ; T cell epitope [1] ; B-cell epitope, HLA-DRB1*01:01 [2] ; T-cell epitope,  HLA-DRB1*04:01 [2] ;"		 [1](10.1016/j.chom.2020.03.002); [2](10.3390/v12030254) ; 
1020	A	1465	1109	1086	1094	24620	1002	1070	1020	1106	1002	1003	1173	1178	992	1002	no	"S2 ; T cell epitope [1] ; B-cell epitope, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01 ,HLA-A*31:01[2] ; T-cell epitope,  HLA-DRB1*04:01 [2] ;"		 [1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
1021	S	1466	1110	1087	1095	24623	1003	1071	1021	1107	1003	1004	1174	1179	993	1003	no	"S2 ; T cell epitope [1] ; B-cell epitope, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01 ,HLA-A*31:01[2] ; T-cell epitope,  HLA-DRB1*04:01 [2] ;"		 [1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
1022	A	1467	1111	1088	1096	24626	1004	1072	1022	1108	1004	1005	1175	1180	994	1004	no	"S2 ; T cell epitope [1] ; B-cell epitope, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01 ,HLA-A*31:01[2]"		 [1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
1023	N	1468	1112	1089	1097	24629	1005	1073	1023	1109	1005	1006	1176	1181	995	1005	no	"S2 ; T cell epitope [1] ; B-cell epitope, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01 ,HLA-A*31:01[2]"		 [1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
1024	L	1469	1113	1090	1098	24632	1006	1074	1024	1110	1006	1007	1177	1182	996	1006	no	"S2 ; T cell epitope [1] ; B-cell epitope, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01 ,HLA-A*31:01[2]"		 [1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
1025	A	1470	1114	1091	1099	24635	1007	1075	1025	1111	1007	1008	1178	1183	997	1007	no	"S2 ; T cell epitope [1] ; B-cell epitope, HLA-DRB1*01:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01 ,HLA-A*31:01[2]"		 [1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
1026	A	1471	1115	1092	1100	24638	1008	1076	1026	1112	1008	1009	1179	1184	998	1008	no	"S2 ; T cell epitope [1] ; B-cell epitope, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01 ,HLA-A*31:01[2]"		 [1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
1027	T	1472	1116	1093	1101	24641	1009	1077	1027	1113	1009	1010	1180	1185	999	1009	no	"S2 ; T cell epitope [1] ; B-cell epitope, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01 ,HLA-A*31:01  [2]"		 [1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
1028	K	1473	1117	1094	1102	24644	1010	1078	1028	1114	1010	1011	1181	1186	1000	1010	no	"S2 ; T cell epitope [1] ; B-cell epitope, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01 ,HLA-A*31:01 [2]"		 [1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
1029	M	1474	1118	1095	1103	24647	1011	1079	1029	1115	1011	1012	1182	1187	1001	1011	no	"S2 ; T cell epitope [1] ; B-cell epitope, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01 ,HLA-A*31:01 [2]"		
1030	S	1475	1119	1096	1104	24650	1012	1080	1030	1116	1012	1013	1183	1188	1002	1012	no	S2; 		
1031	E	1476	1120	1097	1105	24653	1013	1081	1031	1117	1013	1014	1184	1189	1003	1013	no	S2; 		
1032	C	1477	1121	1098	1106	24656	1014	1082	1032	1118	1014	1015	1185	1190	1004	1014	no	S2; 		
1033	V	1478	1122	1099	1107	24659	1015	1083	1033	1119	1015	1016	1186	1191	1005	1015	no	S2; 		
1034	L	1479	1123	1100	1108	24662	1016	1084	1034	1120	1016	1017	1187	1192	1006	1016	no	S2; 		
1035	G	1480	1124	1101	1109	24665	1017	1085	1035	1121	1017	1018	1188	1193	1007	1017	no	S2; 		
1036	Q	1481	1125	1102	1110	24668	1018	1086	1036	1122	1018	1019	1189	1194	1008	1018	no	S2; 		
1037	S	1482	1126	1103	1111	24671	1019	1087	1037	1123	1019	1020	1190	1195	1009	1019	no	S2; RBD ; B-cell epitope [1]		[1](10.21203/rs.3.rs-16262/v1) ;
1038	K	1483	1127	1104	1112	24674	1020	1088	1038	1124	1020	1021	1191	1196	1010	1020	no	S2; RBD ; B-cell epitope [1] 		[1](10.21203/rs.3.rs-16262/v1) ;
1039	R	1484	1128	1105	1113	24677	1021	1089	1039	1125	1021	1022	1192	1197	1011	1021	no	S2; RBD ; B-cell epitope [1]		[1](10.21203/rs.3.rs-16262/v1) ;
1040	V	1485	1129	1106	1114	24680	1022	1090	1040	1126	1022	1023	1193	1198	1012	1022	no	S2; RBD ; B-cell epitope [1]		[1](10.21203/rs.3.rs-16262/v1) ;
1041	D	1486	1130	1107	1115	24683	1023	1091	1041	1127	1023	1024	1194	1199	1013	1023	no	S2; RBD ; B-cell epitope [1]		[1](10.21203/rs.3.rs-16262/v1) ;
1042	F	1487	1131	1108	1116	24686	1024	1092	1042	1128	1024	1025	1195	1200	1014	1024	no	S2; RBD ; B-cell epitope [1]		[1](10.21203/rs.3.rs-16262/v1) ;
1043	C	1488	1132	1109	1117	24689	1025	1093	1043	1129	1025	1026	1196	1201	1015	1025	no	S2; RBD ; B-cell epitope [1]		[1](10.21203/rs.3.rs-16262/v1) ;
1044	G	1490	1133	1110	1118	24692	1026	1094	1044	1131	1026	1027	1197	1202	1016	1026	no	S2; RBD ; B-cell epitope [1]		[1](10.21203/rs.3.rs-16262/v1) ;
1045	K	1491	1134	1111	1119	24695	1027	1095	1045	1132	1027	1028	1198	1203	1017	1027	no	S2; RBD ; B-cell epitope [1]		[1](10.21203/rs.3.rs-16262/v1) ;
1046	G	1492	1135	1112	1120	24698	1028	1096	1046	1133	1028	1029	1199	1204	1018	1028	no	S2; 		
1047	Y	1493	1136	1113	1121	24701	1029	1097	1047	1134	1029	1030	1200	1205	1019	1029	no	S2; 		
1048	H	1494	1137	1114	1122	24704	1030	1098	1048	1135	1030	1031	1201	1206	1020	1030	no	S2; 		
1049	L	1495	1138	1115	1123	24707	1031	1099	1049	1136	1031	1032	1202	1207	1021	1031	no	S2; 		
1050	M	1496	1139	1116	1124	24710	1032	1100	1050	1137	1032	1033	1203	1208	1022	1032	no	S2; 		
1051	S	1497	1140	1117	1125	24713	1033	1101	1051	1138	1033	1034	1204	1209	1023	1033	no	S2; 		
1052	F	1498	1141	1118	1126	24716	1034	1102	1052	1139	1034	1035	1205	1210	1024	1034	no	S2; 		
1053	P	1499	1142	1119	1127	24719	1035	1103	1053	1140	1035	1036	1206	1211	1025	1035	no	S2; 		
1054	Q	1500	1143	1120	1128	24722	1036	1104	1054	1141	1036	1037	1207	1212	1026	1036	no	S2; 		
1055	S	1501	1144	1121	1129	24725	1037	1105	1055	1142	1037	1038	1208	1213	1027	1037	no	S2; 		
1056	A	1502	1145	1122	1130	24728	1038	1106	1056	1143	1038	1039	1209	1214	1028	1038	no	S2; 		
1057	P	1503	1146	1123	1131	24731	1039	1107	1057	1144	1039	1040	1210	1215	1029	1039	no	S2; 		
1058	H	1504	1147	1124	1132	24734	1040	1108	1058	1145	1040	1041	1211	1216	1030	1040	no	S2; 		
1059	G	1505	1148	1125	1133	24737	1041	1109	1059	1146	1041	1042	1212	1217	1031	1041	no	"S2; , HLA-A*03:01 , HLA-A*68:01 [1];"		[1](10.3390/v12030254) ; 
1060	V	1506	1149	1126	1134	24740	1042	1110	1060	1147	1042	1043	1213	1218	1032	1042	no	"S2; HLA-A*02:01 , HLA-A*03:01, HLA-A*68:01 [1] ; T-cell epitope,  HLA-A*02:01 [1] ;"		[1](10.3390/v12030254) ; 
1061	V	1507	1150	1127	1135	24743	1043	1111	1061	1148	1043	1044	1214	1219	1033	1043	no	"S2; HLA-A*02:01 , HLA-A*03:01, HLA-A*68:01 [1] ; T-cell epitope,  HLA-A*02:01 [1] ;"		[1](10.3390/v12030254) ; 
1062	F	1508	1151	1128	1136	24746	1044	1112	1062	1149	1044	1045	1215	1220	1034	1044	no	"S2; HLA-A*02:01 , HLA-A*03:01, HLA-A*68:01 [1] ; T-cell epitope,  HLA-A*02:01 [1] ;"		[1](10.3390/v12030254) ; 
1063	L	1509	1152	1129	1137	24749	1045	1113	1063	1150	1045	1046	1216	1221	1035	1045	no	"S2; HLA-A*02:01 , HLA-A*03:01, HLA-A*68:01 [1] ; T-cell epitope,  HLA-A*02:01 [1] ;"		[1](10.3390/v12030254) ; 
1064	H	1510	1153	1130	1138	24752	1046	1114	1064	1151	1046	1047	1217	1222	1036	1046	no	"S2; B-cell epitopes, high antigenicity score and good surface accessibility [1] ; HLA-A*02:01, HLA-A*03:01, HLA-A*68:01  [2] ; T-cell epitope,  HLA-A*02:01 [2] ;	"		[1](10.21203/rs.3.rs-16262/v1); [2](10.3390/v12030254) ; 
1065	V	1511	1154	1131	1139	24755	1047	1115	1065	1152	1047	1048	1218	1223	1037	1047	no	"S2; B-cell epitopes, high antigenicity score and good surface accessibility [1] ; HLA-A*02:01, HLA-A*03:01, HLA-A*68:01  [2] ; T-cell epitope,  HLA-A*02:01 [2] ;	"		[1](10.21203/rs.3.rs-16262/v1); [2](10.3390/v12030254) ; 
1066	T	1512	1155	1132	1140	24758	1048	1116	1066	1153	1048	1049	1219	1224	1038	1048	no	"S2; B-cell epitopes, high antigenicity score and good surface accessibility [1] ; HLA-A*02:01, HLA-A*03:01, HLA-A*68:01  [2] ; T-cell epitope,  HLA-A*02:01 [2] ;	"		[1](10.21203/rs.3.rs-16262/v1); [2](10.3390/v12030254) ; 
1067	Y	1513	1156	1133	1141	24761	1049	1117	1067	1154	1049	1050	1220	1225	1039	1049	no	"S2; B-cell epitopes, high antigenicity score and good surface accessibility [1] ; HLA-A*02:01, HLA-A*03:01, HLA-A*68:01  [2] ; T-cell epitope,  HLA-A*02:01 [2] ;	"		[1](10.21203/rs.3.rs-16262/v1); [2](10.3390/v12030254) ; 
1068	V	1514	1157	1134	1142	24764	1050	1118	1068	1155	1050	1051	1221	1226	1040	1050	no	"S2; B-cell epitopes, high antigenicity score and good surface accessibility [1] ; HLA-A*02:01, HLA-A*03:01, HLA-A*68:01  [2] ; T-cell epitope,  HLA-A*02:01 [2] ;	"		[1](10.21203/rs.3.rs-16262/v1); [2](10.3390/v12030254) ; 
1069	P	1515	1158	1135	1143	24767	1051	1119	1069	1156	1051	1052	1222	1227	1041	1051	no	"S2; B-cell epitopes, high antigenicity score and good surface accessibility [1] ; T-cell epitope,  HLA-A*02:01  [2] ;	"		[1](10.21203/rs.3.rs-16262/v1); [2](10.3390/v12030254) ; 
1070	A	1516	1159	1136	1144	24770	1052	1120	1070	1157	1052	1053	1223	1228	1042	1052	no	"S2; B-cell epitopes, high antigenicity score and good surface accessibility [1];"		[1](10.21203/rs.3.rs-16262/v1);
1071	Q	1517	1160	1137	1145	24773	1053	1121	1071	1158	1053	1054	1224	1229	1043	1053	no	"S2; B-cell epitopes, high antigenicity score and good surface accessibility [1];"		[1](10.21203/rs.3.rs-16262/v1);
1072	E	1518	1161	1138	1146	24776	1054	1122	1072	1159	1054	1055	1225	1230	1044	1054	no	"S2; B-cell epitopes, high antigenicity score and good surface accessibility [1];"		[1](10.21203/rs.3.rs-16262/v1);
1073	K	1519	1162	1139	1147	24779	1055	1123	1073	1160	1055	1056	1226	1231	1045	1055	no	"S2; B-cell epitopes, high antigenicity score and good surface accessibility [1]; "		[1](10.21203/rs.3.rs-16262/v1);
1074	N	1520	1163	1140	1148	24782	1056	1124	1074	1161	1056	1057	1227	1232	1046	1056	no	"S2; B-cell epitopes, high antigenicity score and good surface accessibility [1]; S2; mixture of oligomannose-type glycans and complex-type glycans [2] ;"		[1](10.21203/rs.3.rs-16262/v1); [2](10.1101/2020.03.26.010322) ; 
1075	F	1521	1164	1141	1149	24785	1057	1125	1075	1162	1057	1058	1228	1233	1047	1057	no	"S2; B-cell epitopes, high antigenicity score and good surface accessibility [1];"		[1](10.21203/rs.3.rs-16262/v1);
1076	T	1522	1165	1142	1150	24788	1058	1126	1076	1163	1058	1059	1229	1234	1048	1058	no	"S2; B-cell epitopes, high antigenicity score and good surface accessibility [1];"		[1](10.21203/rs.3.rs-16262/v1);
1077	T	1523	1166	1143	1151	24791	1059	1127	1077	1164	1059	1060	1230	1235	1049	1059	no	"S2; B-cell epitopes, high antigenicity score and good surface accessibility [1];"		[1](10.21203/rs.3.rs-16262/v1);
1078	A	1524	1167	1144	1152	24794	1060	1128	1078	1165	1060	1061	1231	1236	1050	1060	no	"S2; B-cell epitopes, high antigenicity score and good surface accessibility [1];"		[1](10.21203/rs.3.rs-16262/v1);
1079	P	1525	1168	1145	1153	24797	1061	1129	1079	1166	1061	1062	1232	1237	1051	1061	no	"S2; B-cell epitopes, high antigenicity score and good surface accessibility [1];"		[1](10.21203/rs.3.rs-16262/v1);
1080	A	1526	1169	1146	1154	24800	1062	1130	1080	1167	1062	1063	1233	1238	1052	1062	no	S2; 		
1081	I	1527	1170	1147	1155	24803	1063	1131	1081	1168	1063	1064	1234	1239	1053	1063	no	S2; 		
1082	C	1528	1171	1148	1156	24806	1064	1132	1082	1169	1064	1065	1235	1240	1054	1064	no	S2; 		
1083	H	1529	1172	1149	1157	24809	1065	1133	1083	1170	1065	1066	1236	1241	1055	1065	no	S2; 		
1084	D	1530	1173	1150	1158	24812	1066	1134	1084	1171	1066	1067	1237	1242	1056	1066	no	S2; 		
1085	G	1531	1174	1151	1159	24815	1067	1135	1085	1172	1067	1068	1238	1243	1057	1067	no	S2; 		
1086	K	1535	1176	0	1163	24818	1068	1137	1086	0	1068	1069	1241	1246	1058	1068	no	S2; 		
1087	A	1536	1177	1152	1164	24821	1069	1138	1087	1173	1069	1070	1242	1247	1059	1069	no	S2; 		
1088	H	1537	1178	1153	1165	24824	1070	1139	1088	1174	1070	1071	1243	1248	1060	1070	no	S2; 		
1089	F	1538	1179	1154	1166	24827	1071	1140	1089	1175	1071	1072	1244	1249	1061	1071	no	S2; 		
1090	P	1544	1180	1160	1167	24830	1072	1141	1090	1181	1072	1073	1250	1255	1062	1072	no	S2; 		
1091	R	1545	1181	1161	1168	24833	1073	1142	1091	1182	1073	1074	1251	1256	1063	1073	no	S2; 		
1092	E	1546	1182	1162	1169	24836	1074	1143	1092	1183	1074	1075	1252	1257	1064	1074	no	S2; 		
1093	G	1547	1183	1163	1170	24839	1075	1144	1093	1184	1075	1076	1253	1258	1065	1075	no	S2; 		
1094	V	1548	1184	1164	1171	24842	1076	1145	1094	1185	1076	1077	1254	1259	1066	1076	no	S2; 		
1095	F	1549	1185	1165	1172	24845	1077	1146	1095	1186	1077	1078	1255	1260	1067	1077	no	S2; 		
1096	V	1550	1186	1166	1173	24848	1078	1147	1096	1187	1078	1079	1256	1261	1068	1078	no	S2; 		
1097	S	1551	1187	0	1174	24851	1079	1148	1097	1188	1079	1080	1257	1262	1069	1079	no	S2; 		
1098	N	1557	1188	1167	1175	24854	1080	1149	1098	1194	1080	1081	1258	1263	1070	1080	no	S2; 		
1099	G	1558	1189	1168	1176	24857	1081	1150	1099	1195	1081	1082	1259	1264	1071	1081	no	S2; 		
1100	T	1559	1190	1169	1177	24860	1082	1151	1100	1196	1082	1083	1260	1265	1072	1082	no	S2; 		
1101	H	1565	1191	1170	1183	24863	1083	1152	1101	1197	1083	1084	1261	1266	1073	1083	no	"S2 ; T cell epitope [1] ;	"		 [1](10.1016/j.chom.2020.03.002)
1102	W	1566	1192	1171	1184	24866	1084	1153	1102	1198	1084	1085	1262	1267	1074	1084	no	"S2 ; T cell epitope [1] ;	"		 [1](10.1016/j.chom.2020.03.002)
1103	F	1567	1193	1172	1185	24869	1085	1154	1103	1199	1085	1086	1263	1268	1075	1085	no	"S2 ; T cell epitope [1] ;	"		 [1](10.1016/j.chom.2020.03.002)
1104	V	1568	1194	1173	1186	24872	1086	1155	1104	1200	1086	1087	1264	1269	1076	1086	no	"S2 ; T cell epitope [1] ;	"		 [1](10.1016/j.chom.2020.03.002)
1105	T	1569	1195	1174	1187	24875	1087	1156	1105	1201	1087	1088	1265	1270	1077	1087	no	"S2 ; T cell epitope [1] ;	"		 [1](10.1016/j.chom.2020.03.002)
1106	Q	1570	1196	1175	1188	24878	1088	1157	1106	1202	1088	1089	1266	1271	1078	1088	no	"S2 ; T cell epitope [1] ;	"		 [1](10.1016/j.chom.2020.03.002)
1107	R	1571	1197	1176	1189	24881	1089	1158	1107	1203	1089	1090	1267	1272	1079	1089	no	"S2 ; T cell epitope [1] ;	"		 [1](10.1016/j.chom.2020.03.002)
1108	N	1572	1198	1177	1190	24884	1090	1159	1108	1204	1090	1091	1268	1273	1080	1090	no	"S2 ; T cell epitope [1] ;	"		 [1](10.1016/j.chom.2020.03.002)
1109	F	1573	1199	1178	1191	24887	1091	1160	1109	1205	1091	1092	1269	1274	1081	1091	no	"S2 ; T cell epitope [1] ;	"		 [1](10.1016/j.chom.2020.03.002)
1110	Y	1574	1200	1179	1192	24890	1092	1161	1110	1206	1092	1093	1270	1275	1082	1092	no	"S2 ; T cell epitope [1] ;	"		 [1](10.1016/j.chom.2020.03.002)
1111	E	1575	1201	1180	1193	24893	1093	1162	1111	1207	1093	1094	1271	1276	1083	1093	no	"S2 ; T cell epitope [1] ;	"		 [1](10.1016/j.chom.2020.03.002)
1112	P	1576	1202	1181	1194	24896	1094	1163	1112	1208	1094	1095	1272	1277	1084	1094	no	"S2 ; T cell epitope [1] ;	"		 [1](10.1016/j.chom.2020.03.002)
1113	Q	1577	1203	1182	1195	24899	1095	1164	1113	1209	1095	1096	1273	1278	1085	1095	no	"S2 ; T cell epitope [1] ;	"		 [1](10.1016/j.chom.2020.03.002)
1114	I	1578	1204	1183	1196	24902	1096	1165	1114	1210	1096	1097	1274	1279	1086	1096	no	"S2 ; T cell epitope [1] ;	B-cell epitope, HLA-A*02:01[2] ;"		 [1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
1115	I	1579	1205	1184	1197	24905	1097	1166	1115	1211	1097	1098	1275	1280	1087	1097	no	"S2 ; T cell epitope [1] ; B-cell epitope, HLA-A*02:01[2] ;"		 [1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
1116	T	1580	1206	1185	1198	24908	1098	1167	1116	1212	1098	1099	1276	1281	1088	1098	no	"S2; B-cell epitope, HLA-A*02:01 [1] ;"		[1](10.3390/v12030254) ; 
1117	T	1581	1207	1186	1199	24911	1099	1168	1117	1213	1099	1100	1277	1282	1089	1099	no	"S2; B-cell epitope, HLA-A*02:01 [1] ;"		[1](10.3390/v12030254) ; 
1118	D	1582	1208	1187	1200	24914	1100	1169	1118	1214	1100	1101	1278	1283	1090	1100	no	"S2; B-cell epitope, HLA-A*02:01 [1] ;"		[1](10.3390/v12030254) ; 
1119	N	1583	1209	1188	1201	24917	1101	1170	1119	1215	1101	1102	1279	1284	1091	1101	no	"S2; B-cell epitope, HLA-A*02:01 [1] ;"		[1](10.3390/v12030254) ; 
1120	T	1584	1210	1189	1202	24920	1102	1171	1120	1216	1102	1103	1280	1285	1092	1102	no	"S2; B-cell epitope, HLA-A*02:01 [1] ;"		[1](10.3390/v12030254) ; 
1121	F	1585	1211	1190	1203	24923	1103	1172	1121	1217	1103	1104	1281	1286	1093	1103	no	"S2; B-cell epitope, HLA-A*02:01 [1] ;"		[1](10.3390/v12030254) ; 
1122	V	1586	1212	1191	1204	24926	1104	1173	1122	1218	1104	1105	1282	1287	1094	1104	no	"S2; B-cell epitope, HLA-A*02:01 [1] ;"		[1](10.3390/v12030254) ; 
1123	S	1587	1213	1192	1205	24929	1105	1174	1123	1219	1105	1106	1283	1288	1095	1105	no	"S2; B-cell epitope, HLA-A*02:01 [1] ;"		[1](10.3390/v12030254) ; 
1124	G	1588	1214	1193	1206	24932	1106	1175	1124	1220	1106	1107	1284	1289	1096	1106	no	S2; 		
1125	N	1589	1215	1194	1207	24935	1107	1176	1125	1221	1107	1108	1285	1290	1097	1107	no	S2; 		
1126	C	1590	1216	1195	0	24938	1108	1177	1126	1222	1108	1109	1286	1291	1098	1108	no	S2; 		
1127	D	1591	1217	1196	1208	24941	1109	1178	1127	1223	1109	1110	1287	1292	1099	1109	no	S2; 		
1128	V	1592	1218	1197	1209	24944	1110	1179	1128	1224	1110	1111	1288	1293	1100	1110	no	S2; 		
1129	V	1593	1219	1198	1210	24947	1111	1180	1129	1225	1111	1112	1289	1294	1101	1111	no	S2; 		
1130	I	1594	1220	1199	1211	24950	1112	1181	1130	1226	1112	1113	1290	1295	1102	1112	no	S2; 		
1131	G	1595	1221	1200	1212	24953	1113	1182	1131	1227	1113	1114	1291	1296	1103	1113	no	S2; 		
1132	I	1596	1222	1201	1213	24956	1114	1183	1132	1228	1114	1115	1292	1297	1104	1114	no	S2; 		
1133	V	1597	1223	1202	1214	24959	1115	1184	1133	1229	1115	1116	1293	1298	1105	1115	no	S2; 		
1134	N	1598	1224	1203	1215	24962	1116	1185	1134	1230	1116	1117	1294	1299	1106	1116	no	S2; 		
1135	N	1599	1225	1204	1216	24965	1117	1186	1135	1231	1117	1118	1295	1300	1107	1117	no	S2; 		
1136	T	1600	1226	1205	1217	24968	1118	1187	1136	1232	1118	1119	1296	1301	1108	1118	no	S2; 		
1137	V	1601	1227	1206	1218	24971	1119	1188	1137	1233	1119	1120	1297	1302	1109	1119	no	S2; 		
1138	Y	1602	1228	1207	1219	24974	1120	1189	1138	1234	1120	1121	1298	1303	1110	1120	no	S2; 		
1139	D	1603	1229	1208	1220	24977	1121	1190	1139	1235	1121	1122	1299	1304	1111	1121	no	S2; 		
1140	P	1604	1230	1209	1221	24980	1122	1191	1140	1236	1122	1123	1300	1305	1112	1122	no	S2; 		
1141	L	1605	1231	1210	1222	24983	1123	1192	1141	1237	1123	1124	1301	1306	1113	1123	no	S2; 		
1142	Q	1606	1232	1211	1223	24986	1124	1193	1142	1238	1124	1125	1302	1307	1114	1124	no	S2; 		
1143	P	1607	1233	1212	1224	24989	1125	1194	1143	1239	1125	1126	1303	1308	1115	1125	no	S2; 		
1144	E	1608	1234	1213	1225	24992	1126	1195	1144	1240	1126	1127	1304	1309	1116	1126	no	S2; 		
1145	L	1609	1235	1214	1226	24995	1127	1196	1145	1241	1127	1128	1305	1310	1117	1127	no	S2; 		
1146	D	1610	1236	1215	1227	24998	1128	1197	1146	1242	1128	1129	1306	1311	1118	1128	no	"S2;  B-cell epitope,  HLA-A*01:01 [1] ;"		[1](10.3390/v12030254) ; 
1147	S	1615	1237	1220	1230	25001	1129	1198	1147	1247	1129	1130	1311	1316	1119	1129	no	"S2;  B-cell epitope,  HLA-A*01:01 [1] ;"		[1](10.3390/v12030254) ; 
1148	F	1616	1238	1221	1231	25004	1130	1199	1148	1248	1130	1131	1312	1317	1120	1130	no	"S2;  B-cell epitope,  HLA-A*01:01 [1] ;"		[1](10.3390/v12030254) ; 
1149	K	1617	1239	1222	1232	25007	1131	1200	1149	1249	1131	1132	1313	1318	1121	1131	no	"S2;  B-cell epitope,  HLA-A*01:01 [1] ;"		[1](10.3390/v12030254) ; 
1150	E	1618	1240	1223	1233	25010	1132	1201	1150	1250	1132	1133	1314	1319	1122	1132	no	"S2;  B-cell epitope,  HLA-A*01:01 [1] ;"		[1](10.3390/v12030254) ; 
1151	E	1619	1241	1224	1234	25013	1133	1202	1151	1251	1133	1134	1315	1320	1123	1133	no	"S2;  B-cell epitope,  HLA-A*01:01 [1] ;"		[1](10.3390/v12030254) ; 
1152	L	1620	1242	1225	1235	25016	1134	1203	1152	1252	1134	1135	1316	1321	1124	1134	no	"S2;  B-cell epitope,  HLA-A*01:01 , HLA-DRB1*01:01 [1] ; "		[1](10.3390/v12030254) ; 
1153	D	1621	1243	1226	1236	25019	1135	1204	1153	1253	1135	1136	1317	1322	1125	1135	no	"S2;  B-cell epitope,  HLA-A*01:01 , HLA-DRB1*01:01 [1] ; "		[1](10.3390/v12030254) ; 
1154	K	1622	1244	1227	1237	25022	1136	1205	1154	1254	1136	1137	1318	1323	1126	1136	no	"S2;  B-cell epitope,  HLA-A*01:01 , HLA-DRB1*01:01 [1] ; "		[1](10.3390/v12030254) ; 
1155	Y	1623	1245	1228	1238	25025	1137	1206	1155	1255	1137	1138	1319	1324	1127	1137	no	"S2;  B-cell epitope,  HLA-A*01:01 , HLA-DRB1*01:01 [1] ; "		[1](10.3390/v12030254) ; 
1156	F	1624	1246	0	1239	25028	1138	1207	1156	0	1138	1139	1320	1325	1128	1138	no	"S2;  B-cell epitope,  HLA-A*01:01 , HLA-DRB1*01:01 [1] ; "		[1](10.3390/v12030254) ; 
1157	K	1625	1247	1229	1240	25031	1139	1208	1157	1256	1139	1140	1321	1326	1129	1139	no	"S2; B-cell epitope,  HLA-DRB1*01:01 [1] ; "		[1](10.3390/v12030254) ; 
1158	N	1626	1248	1230	1241	25034	1140	1209	1158	1257	1140	1141	1322	1327	1130	1140	no	"S2; B-cell epitope,  HLA-DRB1*01:01 [1] ; "		[1](10.3390/v12030254) ; 
1159	H	1627	1249	1231	1242	25037	1141	1210	1159	1258	1141	1142	1323	1328	1131	1141	no	"S2; B-cell epitope,  HLA-DRB1*01:01 [1] ; "		[1](10.3390/v12030254) ; 
1160	T	1628	1250	1232	1243	25040	1142	1211	1160	1259	1142	1143	1324	1329	1132	1142	no	"S2; B-cell epitope,  HLA-DRB1*01:01 [1] ; "		[1](10.3390/v12030254) ; 
1161	S	1629	1251	1233	1244	25043	1143	1212	1161	1260	1143	1144	1325	1330	1133	1143	no	S2; strictly conserved in coronaviruses [1] ;   HLA-DRB1*01:01 [2] ; 		[1](10.1016/j.virol.2005.02.022) ; [2](10.3390/v12030254) ; 
1162	P	1632	1254	1234	1247	25046	1144	1215	1162	1261	1144	1145	1326	1331	1134	1144	no	"S2; B-cell epitope,  HLA-DRB1*01:01 [1] ; "		[1](10.3390/v12030254) ; 
1163	D	1633	1255	1235	1248	25049	1145	1216	1163	1262	1145	1146	1327	1332	1135	1145	no	"S2; B-cell epitope,  HLA-DRB1*01:01 [1] ; "		[1](10.3390/v12030254) ; 
1164	V	1634	1256	1236	1249	25052	1146	1217	1164	1263	1146	1147	1328	1333	1136	1146	no	"S2; B-cell epitope,  HLA-DRB1*01:01 [1] ; "		[1](10.3390/v12030254) ; 
1165	D	1635	1257	1237	1250	25055	1147	1218	1165	1264	1147	1148	1329	1334	1137	1147	no	"S2; B-cell epitope,  HLA-DRB1*01:01 [1] ; "		[1](10.3390/v12030254) ; 
1166	L	1636	1258	1238	0	25058	1148	1219	1166	1265	1148	1149	1330	1335	1138	1148	no	"S2; B-cell epitope,  HLA-DRB1*01:01 [1] ; "		[1](10.3390/v12030254) ; 
1167	G	1637	0	0	0	25061	1149	0	1167	0	1149	1150	0	0	1139	1149	no	"S2; B-cell epitope,  HLA-DRB1*01:01 [1] ; "		[1](10.3390/v12030254) ; 
1168	D	1638	1259	1239	1251	25064	1150	1220	1168	1266	1150	1151	1331	1336	1140	1150	no	"S2; B-cell epitope,  HLA-DRB1*01:01 [1] ; "		[1](10.3390/v12030254) ; 
1169	I	1639	1260	1240	1252	25067	1151	1221	1169	1267	1151	1152	1332	1337	1141	1151	no	"S2; B-cell epitope,  HLA-DRB1*01:01 [1] ; "		[1](10.3390/v12030254) ; 
1170	S	1640	1261	0	1253	25070	1152	1222	1170	0	1152	1153	0	0	1142	1152	no	"S2; B-cell epitope,  HLA-DRB1*01:01 [1] ; "		[1](10.3390/v12030254) ; 
1171	G	1641	1262	0	1254	25073	1153	1223	1171	0	1153	1154	0	0	1143	1153	no	"S2; B-cell epitope,  HLA-DRB1*01:01 [1] ; "		[1](10.3390/v12030254) ; 
1172	I	1642	1263	1241	1255	25076	1154	1224	1172	1268	1154	1155	1333	1338	1144	1154	no	"S2; B-cell epitope,  HLA-DRB1*01:01 [1] ; "		[1](10.3390/v12030254) ; 
1173	N	1643	1264	1242	1256	25079	1155	1225	1173	1269	1155	1156	1334	1339	1145	1155	no	"S2; B-cell epitope,  HLA-DRB1*01:01 [1] ; "		[1](10.3390/v12030254) ; 
1174	A	1644	1265	1243	1257	25082	1156	1226	1174	1270	1156	1157	1335	1340	1146	1156	no	"S2; B-cell epitope,  HLA-DRB1*01:01 [1] ; "		[1](10.3390/v12030254) ; 
1175	S	1645	1266	1244	1258	25085	1157	1227	1175	1271	1157	1158	1336	1341	1147	1157	no	"S2; B-cell epitope,  HLA-DRB1*01:01 [1] ; "		[1](10.3390/v12030254) ; 
1176	V	1646	1267	1245	1259	25088	1158	1228	1176	1272	1158	1159	1337	1342	1148	1158	no	"S2; variation observed with frequency <1% [1] ; B-cell epitope,  HLA-DRB1*01:01 [2] ; "		[1](10.1101/2020.05.21.108563) ; [2](10.3390/v12030254) ; 
1177	V	1647	1268	1246	1260	25091	1159	1229	1177	1273	1159	1160	1338	1343	1149	1159	no	"S2; Oy atom of Asn 1159 accepts a hydrogen bond from the amide group of residue 1161, and at the same time interacts with the amide group 1162 via ordered water molecules (in SARS cov) [1]; B-cell epitope,  HLA-DRB1*01:01 [2] ; "		[1](10.1016/j.virol.2005.02.022) ; [2](10.3390/v12030254) ; 
1178	N	1648	1269	1247	1261	25094	1160	1230	1178	1274	1160	1161	1339	1344	1150	1160	no	"S2;  hydrogen bond to residue 1163 and 1064  (in SARS cov) [1] ; B-cell epitope,  HLA-DRB1*01:01 [2] ; "		[1](10.1016/j.virol.2005.02.022) ; [2](10.3390/v12030254) ; 
1179	I	1649	1270	1248	1262	25097	1161	1231	1179	1275	1161	1162	1340	1345	1151	1161	no	"S2; HR2 N-terminus; exposed amide groups capped by Asn 1159 (in SARS cov) [1]; B-cell epitope,  HLA-DRB1*01:01 [2] ; "		[1](10.1016/j.virol.2005.02.022) ; [2](10.3390/v12030254) ; 
1180	Q	1650	1271	1249	1263	25100	1162	1232	1180	1276	1162	1163	1341	1346	1152	1162	no	"S2; HR2 N-terminus; exposed amide groups capped by Asn 1159 (in SARS cov) [1]; B-cell epitope,  HLA-DRB1*01:01 [2] ; "		[1](10.1016/j.virol.2005.02.022) ; [2](10.3390/v12030254) ; 
1181	K	1651	1272	1250	1264	25103	1163	1233	1181	1277	1163	1164	1342	1347	1153	1163	no	"S2; HR2 N-terminus; exposed amide groups capped by Asn 1159 [1] ; strictly conserved in coronaviruses (in SARS cov)  [1] ; Salt bridge 2 [1];  hydrogen bond to the main chain carbonyl of residue 1160  (in SARS cov) [1]  ; B-cell epitope,  HLA-DRB1*01:01 [2] ; "		[1](10.1016/j.virol.2005.02.022) ; [2](10.3390/v12030254) ; 
1182	E	1652	1273	1251	1265	25106	1164	1234	1182	1278	1164	1165	1343	1348	1154	1164	no	"S2; HR2; hydrogen bond to the main chain carbonyl of residue 1160  (in SARS cov) [1] ; B-cell epitope,  HLA-DRB1*01:01 [2] ; "		[1](10.1016/j.virol.2005.02.022) ; [2](10.3390/v12030254) ; 
1183	I	1653	1274	1252	1266	25109	1165	1235	1183	1279	1165	1166	1344	1349	1155	1165	no	"S2; HR2; B-cell epitope,  HLA-DRB1*01:01 [1] ; "		[1](10.3390/v12030254) ; 
1184	D	1654	1275	1253	1267	25112	1166	1236	1184	1280	1166	1167	1345	1350	1156	1166	no	"S2;  HR2;  B-cell epitope,  HLA-DRB1*01:01 [1] ; "		[1](10.3390/v12030254) ; 
1185	R	1655	1276	1254	1268	25115	1167	1237	1185	1281	1167	1168	1346	1351	1157	1167	no	"S2;  HR2; T cell epitope [1] ; B-cell epitope, HLA-A*02:01 [2] ;  T-cell epitope, HLA-A*02:01 [2] ;"		 [1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
1186	L	1656	1277	1255	1269	25118	1168	1238	1186	1282	1168	1169	1347	1352	1158	1168	no	"S2;  HR2; T cell epitope [1] ; B-cell epitope, HLA-A*02:01 [2] ;  T-cell epitope, HLA-A*02:01 [2] ;"		 [1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
1187	N	1657	1278	1256	1270	25121	1169	1239	1187	1283	1169	1170	1348	1353	1159	1169	no	"S2;  HR2; T cell epitope [1] ; B-cell epitope, HLA-A*02:01 [2] ;  T-cell epitope, HLA-A*02:01 [2] ;"		 [1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
1188	E	1658	1279	1257	1271	25124	1170	1240	1188	1284	1170	1171	1349	1354	1160	1170	no	"S2;  HR2; T cell epitope [1] ; B-cell epitope, HLA-A*02:01 [2] ;  T-cell epitope, HLA-A*02:01 [2] ;"		 [1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
1189	V	1673	1280	1272	1272	25127	1171	1241	1189	1299	1171	1172	1364	1369	1161	1171	no	"S2; HR2;  Highly conserved; position a in the heptad repeat abcdefg pattern; T cell epitope [2] ; B-cell epitope, HLA-A*02:01 [3] ; T-cell epitope, HLA-A*02:01 [3] ;"	Hydrophobicity Conserved; little to no impact expected on HR structure 	[1](10.1016/j.virol.2005.02.022) ;  [2](10.1016/j.chom.2020.03.002) ;  [3](10.3390/v12030254) ; 
1190	A	1674	1281	1273	1273	25130	1172	1242	1190	1300	1172	1173	1365	1370	1162	1172	no	"S2;  HR2; T cell epitope [1] ; B-cell epitope, HLA-A*02:01 [2] ; T-cell epitope, HLA-A*02:01 [2] ;"		 [1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
1191	K	1675	1282	1274	1274	25133	1173	1243	1191	1301	1173	1174	1366	1371	1163	1173	no	"S2;  HR2; T cell epitope [1] ; B-cell epitope, HLA-A*02:01 [2] ; T-cell epitope, HLA-A*02:01 [2] ;"		 [1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
1192	N	1676	1283	1275	1275	25136	1174	1244	1192	1302	1174	1175	1367	1372	1164	1174	no	"S2;  HR2; T cell epitope [1] ; B-cell epitope, HLA-A*02:01 [2] ; T-cell epitope, HLA-A*02:01 [2] ;"		 [1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
1193	L	1677	1284	1276	1276	25139	1175	1245	1193	1303	1175	1176	1368	1373	1165	1175	no	"S2; HR2; strictly conserved in coronaviruses [1]  ; T cell epitope [2] ; B-cell epitope, HLA-A*02:01 [3] ; T-cell epitope, HLA-A*02:01 [3] ;"		[1](10.1016/j.virol.2005.02.022) ; [2](10.1016/j.chom.2020.03.002) ; [3](10.3390/v12030254) ; 
1194	N	1678	1285	1277	1277	25142	1176	1246	1194	1304	1176	1177	1369	1374	1166	1176	no	"S2;  HR2; T cell epitope [1] ; B-cell epitope, HLA-A*02:01 [2] ; T-cell epitope, HLA-A*02:01 [2] ; "		 [1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
1195	E	1679	1286	1278	1278	25145	1177	1247	1195	1305	1177	1178	1370	1375	1167	1177	no	"S2;  HR2; T cell epitope [1] ; B-cell epitope, HLA-A*02:01 [2] ; T-cell epitope, HLA-A*02:01 [2] ;"		 [1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
1196	S	1680	1287	1279	1279	25148	1178	1248	1196	1306	1178	1179	1371	1376	1168	1178	no	"S2;  HR2; T cell epitope [1] ; B-cell epitope, HLA-A*02:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*33:01  [2] ;  T-cell epitope, HLA-A*02:01 [2] ;"		 [1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
1197	L	1681	1288	1280	1280	25151	1179	1249	1197	1307	1179	1180	1372	1377	1169	1179	no	"S2;  HR2; T cell epitope [1] ; B-cell epitope, HLA-A*02:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*33:01, HLA-A*01:01 [2] ; T-cell epitope, HLA-A*02:01 [2] ;"		 [1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
1198	I	1682	1289	1281	1281	25154	1180	1250	1198	1308	1180	1181	1373	1378	1170	1180	no	"S2;  HR2; T cell epitope [1] ; B-cell epitope, HLA-A*02:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*33:01, HLA-A*01:01 [2] ; T-cell epitope, HLA-A*02:01 [2] ;"		 [1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
1199	D	1683	1290	1282	1282	25157	1181	1251	1199	1309	1181	1182	1374	1379	1171	1181	no	"S2; HR2; strictly conserved in coronaviruses [1] ; T cell epitope [2] ; B-cell epitope, HLA-A*02:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*33:01, HLA-A*01:01 [3] ; T-cell epitope, HLA-A*02:01 [3] ;"		[1](10.1016/j.virol.2005.02.022) ;  [2](10.1016/j.chom.2020.03.002) ;  [3](10.3390/v12030254) ; 
1200	L	1684	1291	1283	1283	25160	1182	1252	1200	1310	1182	1183	1375	1380	1172	1182	no	"S2; HR2;  Highly conserved; position e in the heptad repeat abcdefg pattern [1] ;  T cell epitope [2] ;	B-cell epitope, HLA-A*02:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*33:01, HLA-A*01:01 [3] ; T-cell epitope, HLA-A*02:01 [3] ;"	Hydrophobicity Conserved; little to no impact expected on HR structure 	[1](10.1016/j.virol.2005.02.022) ;  [2](10.1016/j.chom.2020.03.002) ; [3](10.3390/v12030254) ; 
1201	Q	1685	1292	1284	1284	25163	1183	1253	1201	1311	1183	1184	1376	1381	1173	1183	no	"S2; HR2; Salt bridge 1 [1]; B-cell epitope, HLA-A*02:01, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*33:01, HLA-A*01:01 [2] ; T-cell epitope, HLA-A*02:01 [2] ;"		 [1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
1202	E	1686	1293	1285	1285	25166	1184	1254	1202	1312	1184	1185	1377	1382	1174	1184	no	"S2; HR2; B-cell epitope, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*33:01 [1] ;"		[1](10.3390/v12030254) ; 
1203	L	1687	1294	1286	1286	25169	1185	1255	1203	1313	1185	1186	1378	1383	1175	1185	no	"S2; HR2; B-cell epitope, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*33:01 [1] ;"		[1](10.3390/v12030254) ; 
1204	G	1688	1295	1287	1287	25172	1186	1256	1204	1314	1186	1187	1379	1384	1176	1186	no	"S2; HR2 ; B-cell epitope [1] ; B-cell epitope, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*33:01 [2] ;"		[1](10.21203/rs.3.rs-16262/v1) ; [2](10.3390/v12030254) ; 
1205	K	1689	1296	1288	1288	25175	1187	1257	1205	1315	1187	1188	1380	1385	1177	1187	no	"S2; HR2 ; B-cell epitope [1] ; B-cell epitope, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*33:01 [2] ;"		[1](10.21203/rs.3.rs-16262/v1) ; [2](10.3390/v12030254) ; 
1206	Y	1690	1297	1289	1289	25178	1188	1258	1206	1316	1188	1189	1381	1386	1178	1188	no	"S2; HR2; alternative Salt bridge 1 [1]; B Cell Epitope [2]  ;B-cell epitope, HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*33:01 , HLA-B*18:01   [3] ;"		[1](10.1016/j.virol.2005.02.022) ; [2](10.21203/rs.3.rs-16262/v1) ; [3](10.3390/v12030254) ; 
1207	E	1691	1298	1290	1290	25181	1189	1259	1207	1317	1189	1190	1382	1387	1179	1189	no	"S2; HR2; B Cell Epitope [1]  ; B-cell epitope, HLA-A*01:01 , HLA-B*18:01 [2] ;"		[1](10.21203/rs.3.rs-16262/v1) ; [2](10.3390/v12030254) ; 
1208	Q	1692	1299	1291	1291	25184	1190	1260	1208	1318	1190	1191	1383	1388	1180	1190	no	"S2; HR2; strictly conserved in coronaviruses [1] ; B Cell Epitope [2]  ; B-cell epitope, HLA-B*18:01 [3] ; "		[1](10.1016/j.virol.2005.02.022) ; [2](10.21203/rs.3.rs-16262/v1) ; [3](10.3390/v12030254) ; 
1209	Y	1693	1300	1292	1292	25187	1191	1261	1209	1319	1191	1192	1384	1389	1181	1191	no	"S2; Transmembrane region; B Cell Epitope [1]  ; B-cell epitope, HLA-B*18:01 [2] ; "		[1](10.21203/rs.3.rs-16262/v1) ; [2](10.3390/v12030254) ; 
1210	I	1694	1301	1293	1293	25190	1192	1262	1210	1320	1192	1193	1385	1390	1182	1192	no	"S2; Transmembrane region; ; strictly conserved in coronaviruses [1] ; B-cell epitope, HLA-B*18:01 [2] ; "		[1](10.1016/j.virol.2005.02.022) ;  [2](10.3390/v12030254) ; 
1211	K	1695	1302	1294	1294	25193	1193	1263	1211	1321	1193	1194	1386	1391	1183	1193	no	"S2; Transmembrane region; B Cell Epitope [1]  ; B-cell epitope, HLA-B*18:01 [2] ; "		[1](10.21203/rs.3.rs-16262/v1) ; [2](10.3390/v12030254) ; 
1212	W	1696	1303	1295	1295	25196	1194	1264	1212	1322	1194	1195	1387	1392	1184	1194	no	"S2; Transmembrane region; B Cell Epitope [1]  ; B-cell epitope, HLA-B*18:01 [2] ; "		[1](10.21203/rs.3.rs-16262/v1) ; [2](10.3390/v12030254) ; 
1213	P	1697	1304	1296	1296	25199	1195	1265	1213	1323	1195	1196	1388	1393	1185	1195	no	"S2; Transmembrane region; B Cell Epitope [1]  ; B-cell epitope, HLA-B*18:01 [2] ; "		[1](10.21203/rs.3.rs-16262/v1) ; [2](10.3390/v12030254) ; 
1214	W	1698	1305	1297	1297	25202	1196	1266	1214	1324	1196	1197	1389	1394	1186	1196	no	"S2; Transmembrane region; B Cell Epitope [1]  ; B-cell epitope, HLA-B*18:01 [2] ; "		[1](10.21203/rs.3.rs-16262/v1) ; [2](10.3390/v12030254) ; 
1215	Y	1699	1306	1298	1298	25205	1197	1267	1215	1325	1197	1198	1390	1395	1187	1197	no	"S2; Transmembrane region; B Cell Epitope [1]  ; B-cell epitope, HLA-B*18:01 [2] ; "		[1](10.21203/rs.3.rs-16262/v1) ; [2](10.3390/v12030254) ; 
1216	I	1700	1307	1299	1299	25208	1198	1268	1216	1326	1198	1199	1391	1396	1188	1198	no	"S2; Transmembrane region; B Cell Epitope [1]  ; B-cell epitope, HLA-B*18:01 [2] ; "		[1](10.21203/rs.3.rs-16262/v1) ; [2](10.3390/v12030254) ; 
1217	W	1701	1308	1300	1300	25211	1199	1269	1217	1327	1199	1200	1392	1397	1189	1199	no	"S2; Transmembrane region; B Cell Epitope [1]  ;  B-cell epitope, HLA-DRB1*01:01 [2] ; "		[1](10.21203/rs.3.rs-16262/v1) ; [2](10.3390/v12030254) ; 
1218	L	1702	1309	1301	1301	25214	1200	1270	1218	1328	1200	1201	1393	1398	1190	1200	no	"S2; Transmembrane region; B Cell Epitope [1]  ; B-cell epitope, HLA-DRB1*01:01 [2] ; "		[1](10.21203/rs.3.rs-16262/v1) ; [2](10.3390/v12030254) ; 
1219	G	1703	1310	1302	1302	25217	1201	1271	1219	1329	1201	1202	1394	1399	1191	1201	no	"S2; Transmembrane region; B Cell Epitope [1]  ; B-cell epitope, HLA-DRB1*01:01 [2] ; "		[1](10.21203/rs.3.rs-16262/v1) ; [2](10.3390/v12030254) ; 
1220	F	1704	1311	1303	1303	25220	1202	1272	1220	1330	1202	1203	1395	1400	1192	1202	no	"S2;  Transmembrane region; T cell epitope [1] ;	B Cell Epitope [2]  ;  HLA-A*02:01 [3] ; T-cell epitope, HLA-A*02:01 [3] ; "		 [1](10.1016/j.chom.2020.03.002) ; [2](10.21203/rs.3.rs-16262/v1) ; [3](10.3390/v12030254)
1221	I	1705	1312	1304	1304	25223	1203	1273	1221	1331	1203	1204	1396	1401	1193	1203	no	"S2;  Transmembrane region; T cell epitope [1] ;	B Cell Epitope [2]  ;  HLA-A*02:01 [3] ; T-cell epitope, HLA-A*02:01 [3] ; "		 [1](10.1016/j.chom.2020.03.002) ; [2](10.21203/rs.3.rs-16262/v1) ; [3](10.3390/v12030254) ; 
1222	A	1706	1313	1305	1305	25226	1204	1274	1222	1332	1204	1205	1397	1402	1194	1204	no	"S2;  Transmembrane region; T cell epitope [1] ;	B-cell epitope, HLA-DRB1*01:01, HLA-A*02:01 [2] ; T-cell epitope, HLA-A*02:01 [2] ; "		 [1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
1223	G	1707	1314	1306	1306	25229	1205	1275	1223	1333	1205	1206	1398	1403	1195	1205	no	"S2;  Transmembrane region; T cell epitope [1] ;	B-cell epitope, HLA-DRB1*01:01, HLA-A*02:01 [2] ; T-cell epitope, HLA-A*02:01 [2] ; "		 [1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
1224	L	1708	1315	1307	1307	25232	1206	1276	1224	1334	1206	1207	1399	1404	1196	1206	no	"S2;  Transmembrane region; T cell epitope [1] ;	B-cell epitope, HLA-DRB1*01:01, HLA-A*02:01 [2] ; T-cell epitope, HLA-A*02:01 [2] ; "		 [1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
1225	I	1709	1316	1308	1308	25235	1207	1277	1225	1335	1207	1208	1400	1405	1197	1207	no	"S2;  Transmembrane region; T cell epitope [1] ;	B-cell epitope, HLA-DRB1*01:01, HLA-A*02:01 [2] ; T-cell epitope, HLA-A*02:01 [2] ; "		 [1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
1226	A	1710	1317	1309	1309	25238	1208	1278	1226	1336	1208	1209	1401	1406	1198	1208	no	"S2;  Transmembrane region; T cell epitope [1] ;	B-cell epitope, HLA-DRB1*01:01, HLA-A*02:01 [2] ; T-cell epitope, HLA-A*02:01 [2] ; "		 [1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
1227	I	1711	1318	1310	1310	25241	1209	1279	1227	1337	1209	1210	1402	1407	1199	1209	no	"S2;  Transmembrane region; T cell epitope [1] ;	B-cell epitope, HLA-DRB1*01:01, HLA-A*02:01 [2] ; T-cell epitope, HLA-A*02:01 [2] ; "		 [1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
1228	V	1712	1319	1311	1311	25244	1210	1280	1228	1338	1210	1211	1403	1408	1200	1210	no	"S2;  Transmembrane region; T cell epitope [1] ;	B-cell epitope, HLA-DRB1*01:01, HLA-A*02:01 [2] ; T-cell epitope, HLA-A*02:01 [2] ; "		 [1](10.1016/j.chom.2020.03.002) ; [2](10.3390/v12030254) ; 
1229	M	1713	1320	1312	1312	25247	1211	1281	1229	1339	1211	1212	1404	1409	1201	1211	no	"S2; Transmembrane region;  B-cell epitope, HLA-DRB1*01:01, HLA-A*02:01 [1] ; T-cell epitope, HLA-A*02:01 [1] ; "		[1](10.3390/v12030254) ; 
1230	V	1714	1321	1313	1313	25250	1212	1282	1230	1340	1212	1213	1405	1410	1202	1212	no	"S2; Transmembrane region;  B-cell epitope, HLA-DRB1*01:01, HLA-A*02:01 [1] ;"		[1](10.3390/v12030254) ; 
1231	T	1715	1322	1314	1314	25253	1213	1283	1231	1341	1213	1214	1406	1411	1203	1213	no	"S2; Transmembrane region;  B-cell epitope, HLA-DRB1*01:01, HLA-A*02:01 [1] ;"		[1](10.3390/v12030254) ; 
1232	I	1716	1323	1315	1315	25256	1214	1284	1232	1342	1214	1215	1407	1412	1204	1214	no	"S2; Transmembrane region;  B-cell epitope, HLA-DRB1*01:01, HLA-A*02:01 [1] ;"		[1](10.3390/v12030254) ; 
1233	M	1717	1324	1316	1316	25259	1215	1285	1233	1343	1215	1216	1408	1413	1205	1215	no	"S2; Transmembrane region;  B-cell epitope, HLA-DRB1*01:01, HLA-A*02:01 [1] ;"		[1](10.3390/v12030254) ; 
1234	L	1718	1325	1317	1317	25262	1216	1286	1234	1344	1216	1217	1409	1414	1206	1216	no	S2; Intracellular domain [1]; 		[1](10.1016/S0140-6736(04)15788-7)
1235	C	1719	1326	1318	1318	25265	1217	1287	1235	1345	1217	1218	1410	1415	1207	1217	no	S2; Intracellular domain [1]; 		[1](10.1016/S0140-6736(04)15788-7) ; 
1236	C	1720	1327	1319	1319	25268	1218	1288	1236	1346	1218	1219	1411	1416	1208	1218	no	"S2; Intracellular domain [1]; HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*33:01 [2]"		[1](10.1016/S0140-6736(04)15788-7) ;  [2](10.3390/v12030254) ; 
1237	M	1721	1328	1320	1320	25271	1219	1289	1237	1347	1219	1220	1412	1417	1209	1219	no	"S2; Intracellular domain [1]; HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*33:01 [2]"		[1](10.1016/S0140-6736(04)15788-7) ;  [2](10.3390/v12030254) ; 
1238	T	1722	1329	1321	1321	25274	1220	1290	1238	1348	1220	1221	1413	1418	1210	1220	no	"S2; Intracellular domain [1]; HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*33:01 [2]"		[1](10.1016/S0140-6736(04)15788-7) ;  [2](10.3390/v12030254) ; 
1239	S	1723	1330	1322	1322	25277	1221	1291	1239	1349	1221	1222	1414	1419	1211	1221	no	"S2; Intracellular domain [1]; HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*33:01 [2]"		[1](10.1016/S0140-6736(04)15788-7) ;  [2](10.3390/v12030254) ; 
1240	C	1724	1331	1323	1323	25280	1222	1292	1240	1350	1222	1223	1415	1420	1212	1222	no	"S2; Intracellular domain [1]; HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*33:01 [2]"		[1](10.1016/S0140-6736(04)15788-7) ;  [2](10.3390/v12030254) ; 
1241	C	1725	1332	1324	1324	25283	1223	1293	1241	1351	1223	1224	1416	1421	1213	1223	no	"S2; Intracellular domain [1]; HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*33:01 [2]"		[1](10.1016/S0140-6736(04)15788-7) ;  [2](10.3390/v12030254) ; 
1242	S	1726	1333	1325	1325	25286	1224	1294	1242	1352	1224	1225	1417	1422	1214	1224	no	"S2; Intracellular domain [1]; HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*33:01 [2]"		[1](10.1016/S0140-6736(04)15788-7) ;  [2](10.3390/v12030254) ; 
1243	C	1727	1334	1326	1326	25289	1225	1295	1243	1353	1225	1226	1418	1423	1215	1225	no	"S2; Intracellular domain [1]; HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*33:01 [2]"		[1](10.1016/S0140-6736(04)15788-7) ;  [2](10.3390/v12030254) ; 
1244	L	1728	1335	1327	1327	25292	1226	1296	1244	1354	1226	1227	1419	1424	1216	1226	no	"S2; Intracellular domain [1]; HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*33:01 [2]"		[1](10.1016/S0140-6736(04)15788-7) ;  [2](10.3390/v12030254) ; 
1245	K	1729	1336	1328	1328	25295	1227	1297	1245	1355	1227	1228	1420	1425	1217	1227	no	"S2; Intracellular domain [1]; HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*33:01 [2]"		[1](10.1016/S0140-6736(04)15788-7) ;  [2](10.3390/v12030254) ; 
1246	G	1730	1337	1329	1329	25298	1228	1298	1246	1356	1228	1229	1421	1426	1218	1228	no	"S2; Intracellular domain [1]; HLA-A*03:01, HLA-A*11:01, HLA-A*68:01, HLA-A*31:01, HLA-A*33:01 [2]"		[1](10.1016/S0140-6736(04)15788-7) ;  [2](10.3390/v12030254) ; 
1247	C	1731	0	1330	1330	25301	1229	0	1247	1357	1229	1230	1422	1427	1219	1229	no	S2; Intracellular domain [1]; 		[1](10.1016/S0140-6736(04)15788-7) ; 
1248	C	1732	0	1331	1331	25304	1230	0	1248	1358	1230	1231	1423	1428	1220	1230	no	S2; Intracellular domain [1]; 		[1](10.1016/S0140-6736(04)15788-7) ; 
1249	S	1733	1338	1332	1332	25307	1231	1299	1249	1359	1231	1232	1424	1429	1221	1231	no	S2; Intracellular domain [1]; 		[1](10.1016/S0140-6736(04)15788-7) ; 
1250	C	1734	1339	1333	1333	25310	1232	1300	1250	1360	1232	1233	1425	1430	1222	1232	no	S2; Intracellular domain [1]; 		[1](10.1016/S0140-6736(04)15788-7) ; 
1251	G	1736	1340	1335	1334	25313	1233	1301	1251	1362	1233	1234	1427	1432	1223	1233	no	S2; Intracellular domain [1]; 		[1](10.1016/S0140-6736(04)15788-7) ; 
1252	S	1737	1341	1336	1335	25316	1234	1302	1252	1363	1234	1235	1428	1433	1224	1234	no	S2; Intracellular domain [1]; 		[1](10.1016/S0140-6736(04)15788-7) ; 
1253	C	1738	1342	1337	1336	25319	1235	1303	1253	1364	1235	1236	1429	1434	1225	1235	no	S2; Intracellular domain [1]; 		[1](10.1016/S0140-6736(04)15788-7) ; 
1254	C	1739	1343	1338	1337	25322	1236	1304	1254	1365	1236	1237	1430	1435	1226	1236	yes	S2; Intracellular domain [1];  S2; variation observed with frequency >1% [2] ;		[1](10.1016/S0140-6736(04)15788-7) ; [2](10.1101/2020.05.21.108563); 
1255	K	1741	1345	1341	1339	25325	1237	1306	1255	1367	1237	1238	1432	1437	1227	1237	no	S2; Intracellular domain [1]; 		[1](10.1016/S0140-6736(04)15788-7) ; 
1256	F	1742	1346	1342	1340	25328	1238	1307	1256	1368	1238	1239	1433	1438	1228	1238	no	S2; Intracellular domain [1]; 		[1](10.1016/S0140-6736(04)15788-7) ; 
1257	D	1743	1347	1343	1341	25331	1239	1308	1257	1369	1239	1240	1434	1439	1229	1239	no	S2; Intracellular domain [1]; 		[1](10.1016/S0140-6736(04)15788-7) ; 
1258	E	1744	1348	1344	1342	25334	1240	1309	1258	1370	1240	1241	1435	1440	1230	1240	yes	S2; Intracellular domain [1];  D1259H seen in North America sequences but not in Asia 7 and Europe [2] ; 		[1](10.1016/S0140-6736(04)15788-7) ; [2](10.1101/2020.05.21.108563); 
1259	D	1745	1349	1345	1343	25337	1241	1310	1259	1371	1241	1242	1436	1441	1231	1241	no	S2; Intracellular domain [1]; 		[1](10.1016/S0140-6736(04)15788-7) ; 
1260	D	1746	1350	1346	1344	25340	1242	1311	1260	1372	1242	1243	1437	1442	1232	1242	no	S2; Intracellular domain [1]; 		[1](10.1016/S0140-6736(04)15788-7) ; 
1261	S	1747	1351	1347	1345	25343	1243	1312	1261	1373	1243	1244	1438	1443	1233	1243	no	S2; Intracellular domain [1]; 		[1](10.1016/S0140-6736(04)15788-7) ; 
1262	E	1748	1352	1348	1346	25346	1244	1313	1262	1374	1244	1245	1439	1444	1234	1244	no	S2; Intracellular domain [1]; 		[1](10.1016/S0140-6736(04)15788-7) ; 
1263	P	1749	1353	1349	1347	25349	1245	1314	1263	1375	1245	1246	1440	1445	1235	1245	yes	S2; Intracellular domain [1];  S2; variation observed with frequency >1% [2] ;		[1](10.1016/S0140-6736(04)15788-7) ; [2](10.1101/2020.05.21.108563); 
1264	V	1750	1354	1350	0	25352	1246	1315	1264	1376	1246	1247	1441	1446	1236	1246	no	S2; Intracellular domain [1]; 		[1](10.1016/S0140-6736(04)15788-7) ; 
1265	L	1751	1355	0	0	25355	1247	1316	1265	0	1247	1248	0	0	1237	1247	no	S2; Intracellular domain [1]; 		[1](10.1016/S0140-6736(04)15788-7) ; 
1266	K	1752	1356	1351	1348	25358	1248	1317	1266	1377	1248	1249	1442	1447	1238	1248	no	S2; Intracellular domain [1]; 		[1](10.1016/S0140-6736(04)15788-7) ; 
1267	G	1753	1357	1352	1349	25361	1249	1318	1267	1378	1249	1250	1443	1448	1239	1249	no	S2; Intracellular domain [1]; 		[1](10.1016/S0140-6736(04)15788-7) ; 
1268	V	1754	1358	1353	1350	25364	1250	1319	1268	1379	1250	1251	1444	1449	1240	1250	no	S2; Intracellular domain [1]; 		[1](10.1016/S0140-6736(04)15788-7) ; 
1269	K	1755	1359	1354	1351	25367	1251	1320	1269	1380	1251	1252	1445	1450	1241	1251	no	S2; Intracellular domain [1]; 		[1](10.1016/S0140-6736(04)15788-7) ; 
1270	L	1756	1360	1355	1352	25370	1252	1321	1270	1381	1252	1253	1446	1451	1242	1252	no	S2; Intracellular domain [1]; 		[1](10.1016/S0140-6736(04)15788-7) ; 
1271	H	1757	1361	1356	1353	25373	1253	1322	1271	1382	1253	1254	1447	1452	1243	1253	no	S2; Intracellular domain [1]; 		[1](10.1016/S0140-6736(04)15788-7) ; 
1272	Y	1758	1362	0	0	25376	1254	1323	1272	0	1254	1255	0	0	1244	1254	no	S2; Intracellular domain [1]; 		[1](10.1016/S0140-6736(04)15788-7) ; 
1273	T	1759	1363	0	0	25379	1255	1324	1273	0	1255	1256	0	0	1245	1255	no	S2; Intracellular domain [1]; 		[1](10.1016/S0140-6736(04)15788-7) ; 
	*					25382											no	Stop		